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ABSTRACT OF DISSERTATION 
 
 
 
Determination of farm-specific Lawsonia intracellularis seroprevalence in central 
Kentucky Thoroughbreds and the identification of factors contributing to equine 
proliferative enteropathy 
 
Lawsonia intracellularis and the disease it causes in horses, equine proliferative 
enteropathy (EPE), is an emerging pathogen of increasing importance to the horse 
industry from both an economic and welfare standpoint.  Long recognized as an 
economically important disease of swine, the hallmark of EPE is a protein-losing 
enteropathy, where affected horses suffer weight loss and some ultimately succumb to the 
disease despite aggressive treatment.  There are currently no known EPE preventative 
measures and the epidemiology of the disease remains poorly defined.  While EPE is a 
sporadic disease affecting less than 25% of exposed horses, some farms experience 
clinical cases year after year.  Further, weanlings are uniquely susceptible to this disease, 
although no conclusive reason for this predisposition has been identified.  The overall 
hypothesis is that the host immune response plays a significant role in the susceptibility 
of weanlings to L. intracellularis infection and the occurrence of clinical equine 
proliferative enteropathy.  To test this hypothesis, four individual hypotheses were 
proposed: (H1) previous farm history of EPE does not have an effect on weanling 
seroprevalence, (H2) passively-acquired antibodies do not have an effect on susceptibility 
to L. intracellularis and the occurrence of EPE, (H3) the serological status of mares can 
be used to determine the role they play in the epidemiology of EPE on endemic farms, 
and (H4) L. intracellularis-specific IFN-γ expression is not associated with increased 
resistance to EPE. 
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CHAPTER ONE: 
Introduction & Literature Review 
 
Section I: Lawsonia intracellularis and Equine Proliferative Enteropathy 
 
Lawsonia intracellularis 
 Lawsonia intracellularis is the causative bacterial organism of proliferative 
enteropathies in a variety of species, but most notably in pigs, horses, and hamsters.1  
First described in pigs by Biester and Schwarte,2 it wasn't until 1973 that proliferative 
enteropathy was attributed to a bacterium.3  Difficulty with isolation, cultivation, and 
characterization delayed naming of the bacterium until 1995 when it was formally named 
Lawsonia intracellularis.4  L. intracellularis has been classified as a member of the delta 
subdivision of the Proteobacteria class, with closest genetic homology (91%) to 
Desulfovibrio desulfuricans.4  L. intracellularis is an obligately intracellular, flagellated,1 
curved, gram-negative rod which measures approximately 1.25-1.75 µm in length and 
0.26-1.5 µm in width,4,5 requiring a reduced oxygen atmosphere for in vitro cultivation.5,6 
 L. intracellularis is best recognized for causing porcine proliferative enteropathy 
(PPE), an economically devastating disease in the porcine industry due to its detrimental 
effect on average daily gain and market weight.7,8  As a result, the majority of what is 
known with respect to L. intracellularis has been discovered through work with pigs and 
largely extrapolated to the horse.  Porcine proliferative enteropathy encompasses several 
clinical entities, including the subclinical form in which affected pigs exhibit no clinical 
signs but shed the bacterium, the chronic form where affected pigs fail to grow as well as 
littermates (porcine intestinal adenomatosis), and the acute form (normally referred to as 
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porcine hemorrhagic enteritis or PHE), which is often characterized by hemorrhagic 
diarrhea and acute death.1  While acute morbidity and mortality has long been recognized 
as a common clinical presentation of Lawsonia intracellularis infection in swine,1 only 
recently has work demonstrated a similar presentation in horses, called the necrotizing 
form of EPE (N-EPE)(See Appendix), which, like PHE, leads to rapid clinical 
deterioration and death.9  Likewise, most EPE-affected horses exhibit signs similar to 
those of chronic PPE pigs with a more prolonged and less-severe outcome while a small 
portion of horses will experience subclinical EPE.10 
 
Equine Proliferative Enteropathy Introduction 
 Equine proliferative enteropathy (EPE) is an emerging disease of young horses 
with important economic and welfare concerns.9,11  Whether EPE is truly emerging or is 
more common as a result of better recognition by veterinarians and horse owners is not 
known, although unpublished data suggests that exposure to L. intracellularis in 
Kentucky has remained fairly static over that past 7+ years.12  Proliferative enteropathy 
was first reported in a horse from California by Duhamel and Wheeldon in 1982, when 
the disease was still referred to as “intestinal adenomatosis”,13 while Williams et al.14 in 
1996 published the first report of EPE in a horse from Kentucky using the correct name 
of L. intracellularis.  Since then, an expansive distribution of EPE has now been 
published across the world, although no cases have been reported in the literature, to date, 
in Asia or Africa.15-18   
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EPE Clinical Signs 
 The clinical signs associated with EPE are relatively non-specific and include 
anorexia, fever, dependent edema, depression, lethargy, rapid weight loss, and an 
unthrifty appearance/hair coat, while colic and diarrhea have been occasionally 
reported.11,18  EPE is typically seen in weanlings, a common characteristic of all L. 
intracellularis-induced PE's, with most cases in central Kentucky occurring between 
August and February.11,19,20  Most affected horses will respond well to treatment (see 
below) although some may develop secondary complications, such as salmonellosis or N-
EPE, which may prolong the recovery period or result in death.  For those horses that do 
recover, the recovery period can take weeks to months before they regain the appearance 
of unaffected cohorts (author's personal experience). 
 Unique amongst the species that L. intracellularis infects, hypoproteinemia and 
hypoalbuminemia are considered one of the antemortem hallmarks of EPE11 and the 
reason that dependent edema is seen with EPE cases.  Loss of protein and albumin 
through an unknown mechanism, likely a combination of decreased food intake, 
malabsorption,21 and possibly protein loss through compromised small intestine,9 results 
in lower plasma oncotic pressure and a net movement of free fluid from the circulation 
into tissues.   
 
Treatment of EPE 
 Treatment of EPE requires the use of antimicrobials that reach therapeutic 
concentrations within the cytoplasm of infected enterocytes because of the intracellular 
location of the pathogen.  A variety of various antimicrobials have been demonstrated to 
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exhibit in vitro inhibition of L. intracellularis;22,23 primarily the use of chloramphenicol, 
macrolides with or without rifampin, and tetracycline-related drugs have been 
described.16,18,24-26  If it is needed, supportive care of affected horses is typically aimed at 
restoring circulating oncotic pressure through the use of equine plasma or synthetic 
colloids.11  Horses with severe anorexia and weight loss may require partial or total 
parenteral nutrition in a hospital setting.  Further, horses with antemortem signs of N-
EPE require immediate and aggressive care to blunt the sequelae that result in these 
cases; treatment with broad-spectrum antimicrobials to ensure coverage against both 
Gram-positive and Gram-negative bacteria, anti-thrombotics, and anti-endotoxic 
measures such as low-dose flunixin meglumine27 and/or intravenous polymyxin-B.28  
Due to their potential nephrotoxic effects, care should be taken when administering non-
steroidal anti-inflammatory drugs and/or polymyxin-B; likewise, tetracycline-class drugs 
(particularly intravenous oxytetracycline) can be nephrotoxic and should be used 
carefully in hypovolemic patients.29 
 
Antemortem Diagnostic Tests for EPE 
 Given that the hallmark of proliferative enteropathies caused by L. intracellularis 
is mucosal hyperplasia, abdominal ultrasonography can be a useful diagnostic test in 
horses.  Small intestinal wall thickness in excess of 3mm anywhere in the abdominal 
cavity of young horses is suggestive of EPE,19 while increased thickness is highly 
suspicious for EPE when accompanied by compatible clinical and/or clinicopathologic 
signs.  Care should be exercised when no small intestinal thickening is observed as there 
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have been reports of clinical EPE cases where wall thickness was reported to be within 
normal limits.11   
 In horses, it is well reported that hypoalbuminemia and hypoproteinemia are non-
specific, but highly suggestive findings seen with EPE.11,18,30  These changes likely 
reflect both protein loss and malabsorption in the affected small intestine.  As a result, 
and as demonstrated in previous studies, total protein and albumin levels can drop rapidly 
in the span of 4-7 days.10  While reference ranges will vary based on the population and 
testing method, total protein concentrations below 5.3 mg/dL and albumin concentrations 
below 3.2 mg/dL should be considered hypoproteinemic and hypoalbuminemic, 
respectively (see Chapter 3 below).  It is important to note though that there are a number 
of conditions, including renal disease, colitis, salmonellosis, and intestinal parasites, that 
can also result in decreased in albumin levels.  With respect to other clinicopathologic 
testing, complete blood counts, and fibrinogen levels19 are not typically considered useful 
for EPE screening because routine clinical cases of EPE are devoid of a detectable 
intestinal inflammatory response1 and L. intracellularis infection is primarily localized to 
the intestinal enterocytes.  Additionally, metabolic derangements are rare unless severe 
diarrhea is present, the case has been ongoing for a prolonged period of time, or there is 
concurrent disease.11,31 
 Fecal polymerase chain reaction (PCR) for L. intracellularis is probably the most 
specific test available in that it detects sequences of DNA unique to the bacterium.1,32  
Issues arise, however, with L. intracellularis PCR in that the bacterium may be 
intermittently shed by infected horses and there are a variety of PCR inhibitors in feces.33  
Further, fecal shedding of the bacterium in horses has been reported to stop within 4-6 
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days of antimicrobial administration.30  It is likely for these reasons that the sensitivity of 
L. intracellularis-specific fecal PCR testing is variable.32,34-36 
 Currently, there are several L. intracellularis-specific serologic assays available 
for use in horses.  The original assay, the immunoperoxidase monolayer assay (IPMA), 
was initially created for use in pigs37 and has been adapted for commercial use in horses; 
a newer version of the IPMA is also commercially available as it reportedly has less 
background staining artifact, although no manuscripts detailing its use have been 
published.  Outside of the United States, a blocking ELISA is commercially available for 
use in horses, while a newly equine-validated ELISA20 is currently available in the U.S. 
on a research and limited commercial basis.  With the exception of the blocking ELISA 
available outside of the U.S., serologic tests appear to be highly specific for L. 
intracellularis exposure.38  It is important to note that these tests detect whole 
immunoglobulin (IgG) to the bacterium, which is a result of exposure and not indicative 
of clinical EPE or ongoing infection.  Further, individual horses respond differently to L. 
intracellularis exposure and the severity of exposure and infection cannot, as of yet, be 
inferred from the titer value obtained.  Based on experimental studies, horses challenged 
with L. intracellularis have been shown to seroconvert within 14 days of challenge while 
most begin showing clinical signs of EPE by day 19-21.10,39  These horses were 
administered doses likely far in excess of that which is normally encountered, which may 
have decreased the incubation period of the disease.   
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Pathological/Post-mortem Features of EPE 
 The pathological features of EPE and PPE typically identified on post-mortem 
examination of affected animals are fairly similar, namely small intestinal mucosal 
hyperplasia.  L. intracellularis in horses is most commonly identified in enterocytes of 
the terminal ileum, immediately prior to the ileo-cecal junction.  Intestinal mucosal 
hyperplasia is typically found in this region, and results from rapid and unchecked 
division of the crypt cells.  Histologically, these regions exhibit crypt epithelial 
hyperplasia with subsequent elongation and branching of the crypts and villi, a decreased 
goblet cell density,1 and typically a lack of evidence of a cellular inflammatory process 
(except in PHE and N-EPE cases where the inflammation is likely secondary to mucosal 
necrosis9).1   
 Though mucosal proliferation is a hallmark of this disease, the underlying 
mechanism remains unknown.  Several possible mechanisms for L. intracellularis 
virulence have been proposed including perturbations in cell cycle processes of crypt 
epithelia, alterations of factors involved in the differentiation of normally immature and 
proliferative crypt cells, disturbances of relevant growth factor receptors, and failure of 
apoptotic cell death in the crypt.40,41  A recent study examined the effect on differential 
expression of cell cycle and cell differentiation genes within mouse fibroblast cells 
infected with L. intracellularis.41  While this led to the identification of a large number of 
candidate genes potentially responsible for the proliferation and hyperplasia seen with L. 
intracellularis infection, mouse fibroblasts are not typically affected by L. intracellularis.  
Genomic sequencing studies have recently identified the genes for and expression of type 
III secretion system components by L. intracellularis.42,43  This finding is important as 
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type III secretion systems in other enteric pathogens have been shown to contribute to 
apoptosis perturbations, cellular invasion, and immune suppression.42 
 
Epidemiology of EPE 
 To date, the epidemiology of EPE remains poorly characterized, although a fecal-
oral route of transmission is widely suspected.30  With EPE, the most commonly affected 
age groups are weanling and short yearling horses (those yearlings that have not yet 
reached 12 months of age),11,20 although there are unpublished reports of rare cases in 
nursing foals and older horses.  Recent work has suggested a possible role for rabbits in 
the transmission of the bacterium as several weanling horses were nasogastrically 
intubated with feces from experimentally challenged rabbits, ultimately leading to 
seroconversion but no disease in the study horses.44  Further, a non-challenged sentinel 
horse that was co-housed with an experimentally challenged horse seroconverted during 
another study, but again, no signs of EPE were noted.39  Several studies have revealed the 
presence of L. intracellularis in a variety of species, including blacktailed jackrabbits, 
cottontailed rabbits, cats, striped skunks, Virginia opossums, coyotes, guinea pigs, mice, 
rats, hamsters, hedgehogs, ferrets, rabbits, wild pigs, dogs, foxes, calves, wolves, deer, 
ostriches, emus, monkeys, and giraffes;1,45-47 however, none have been successfully 
implicated in the induction of EPE.  Although there is recent evidence of species-
specificity with respect to L. intracellularis strains,48 a role for rodents, rats in particular, 
warrants further investigation in the future as work has shown a proportion of rats on 
PPE-endemic farms can shed up to 1010 L. intracellularis organisms per gram of feces.49  
This is of particular importance as experimental challenge studies in pigs have induced 
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PPE at bacterial doses as low as 105 per pig50 while EPE has been induced in using doses 
of 1010 per horse.10,39  Further, one study has shown that the bacterium may be capable of 
infectivity up to two weeks in the environment at temperatures of 5-15oC,51 raising the 
possibility of a prolonged period during which there is a risk of exposure. 
 Due to the significant impact of L. intracellularis on the swine industry, progress 
in understanding PPE epidemiology is much more evolved than it is with EPE.  It has 
been hypothesized that PPE persists and is transmitted within swine operations via 
poor/inadequate disinfection techniques as well as subclinical shedders of the bacterium.  
Indeed, work has shown that subclinically affected pigs can efficiently spread the 
bacterium amongst cohorts.52  Although a study with bi-monthly fecal PCR testing did 
identify several weanling horses that shed the bacterium in the absence of clinical signs,19 
the role, if any, subclinically affected horses play in transmission remains to be 
determined, especially given the management differences between swine and equine 
operations.  Sows are not believed to play a role in the transmission of the bacterium to 
their offspring, although they have been reported to occasionally shed the bacterium.53  
The possibility that mares could be exposing their foals to L. intracellularis is explored in 
Chapter 4. 
 
Prevention/Mitigation of EPE 
 A licensed and effective vaccine for the prevention of PPE exists in the United 
States (Enterisol Ileitis, Boehringer Ingelheim Vetmedica).54-56  Off-label research into 
the use of the porcine vaccine in horses has garnered mixed results with a small-scale 
experimental challenge study suggesting that the vaccine protects against clinical EPE57 
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while a field trial identified at least one vaccinated horse with clinical EPE.58  Anecdotal 
reports from equine veterinarians in central Kentucky with experience using the vaccine 
off-label suggest a decrease in the incidence of EPE on those farms that elect to utilize it. 
 As with any enteric disease, and especially given the suspected feco-oral 
transmission route and suggestion of horse-to-horse exposure, it seems prudent that those 
horses with suspected or confirmed EPE be isolated for a week following initiation of 
antimicrobial treatment to allow time for fecal shedding to cease.30  Work with pigs 
suggests that quarantine is an effective mechanism of preventing PPE,59 however, given 
the open nature of equine farms, as well as the potential for wildlife hosts/intermediaries, 
it seems unlikely that additional quarantine of new horses above what is routinely done 
would have a beneficial effect on the disease incidence.  
 The use of a regular screening program to detect L. intracellularis exposure and 
early EPE has been reported to be useful in the mitigation of EPE19 and variations on 
these programs are used on some EPE-endemic farms in central Kentucky.  These 
screening programs typically include weekly screening of total protein levels for 
abnormally low levels; those horses with low levels are then monitored closely for signs 
of EPE and may have additional diagnostic tests run, such as albumin determination, 
abdominal ultrasonography, fecal PCR, and/or serological testing.  Given the non-
specific nature of total protein and albumin level fluctuations, it is never recommended to 
treat horses with antimicrobials for suspected EPE based solely on these parameters. 
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Section II: Lawsonia intracellularis and Immunology 
 
Immune Response to Lawsonia intracellularis 
 Given the intracellular nature of L. intracellularis, it is likely that innate and cell-
mediated immunity is more important than humoral immunity with respect to clearance 
of the bacterium from infected animals.  While antibodies provide an excellent, 
antemortem indicator of exposure to L. intracellularis,20,37 their role in the prevention or 
clearance of L. intracellularis remains unclear. This review will therefore focus on the 
innate and, primarily, cell-mediated branches of the immune system. 
 The uptake of L. intracellularis into enterocytes appears to be via endocytosis.60  
Typically, this bacterium-containing endosome would fuse with a lysosome in the host-
cell cytosol for degradation and antigen processing; however, L. intracellularis, by an 
unknown mechanism, evades this process and is reportedly found free in the enterocyte 
cytoplasm within three hours of invasion.61  Throughout this process, and as evidenced 
by the typical lack of an inflammatory response to L. intracellularis,1 the bacterium 
seems to evade the innate immune system in the gastrointestinal tract. 
 Innate immunity exists to quickly detect and respond to non-self antigens 
expressed by a large variety of pathogens, including bacteria, viruses, and fungi.  By 
doing so, the innate immune system bridges the gap in time between pathogen 
presentation/invasion and the acquired cell-mediated and humoral immune responses.  
The innate immune system relies on highly conserved molecular signatures on pathogens, 
generally referred to as pathogen-associated molecular patterns (PAMP's), including but 
not limited to lipopolysaccharide (LPS), peptidoglycan, flagellin, DNA, and RNA.62  
24 
 
Most PAMP recognition by host cells is carried out via detection by either toll-like 
receptors (TLRs) or nucleotide-binding oligomerization domain receptors (NOD-like 
receptors or NLRs).  Of the various TLRs and NLRs which have been identified and 
characterized, the most important with respect to L. intracellularis based on their location 
and function likely would be TLR4, TLR5, Nlrc4, and Nlrp3.62,63  
 Immediately prior to and during invasion, L. intracellularis, a gram-negative, 
flagellated bacterium, must evade detection by TLR's 4 and 5.  Both are located on the 
outer surface of enterocytes where TLR4 is specific for LPS and TLR5 is specific for 
flagellin.62   Likewise, once free within the enterocyte cytoplasm, L. intracellularis 
evades intracellular Nlrc4 (detects flagellin) and Nlrp3 (detects bacterial RNA and 
LPS).63  Normally, once bound to their respective ligands, both TLRs and NLRs induce a  
pro-inflammatory response as TLRs will induce NF-κB via the MyD88 pathway and 
NLRs activate caspase-1, leading to the conversion of pro-IL-1β to IL-1β.  Interestingly, 
TLR4 has been suggested to play a role in the occurrence and severity of necrotizing 
enterocolitis in mice and humans.64,65  Given that PHE and N-EPE are characterized by 
mucosal necrosis while other forms of L. intracellularis infection are relatively devoid of 
an inflammatory response,1 it stands to reason that "accidental" detection of the bacterium 
by either the TLRs or NLRs could be the cause of these severe outcomes.   
 Similarly, it would be expected that the cell-mediated immune system should play 
a significant role in immunity to L. intracellularis.  The host's response to a pathogen via 
cell-mediated immunity (CMI) depends on whether that response is weighted in favor of 
T-helper 1 cells (Th1) or T-helper 2 cells (Th2).66  T-helper cells are CD4+ with an 
affinity for major histocompatability complex II (MHC-II), primarily located on the 
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surface of antigen presenting cells and B lymphocytes.  While initially present as 
undifferentiated T-helper 0 cells (Th0), whether these cells differentiate into Th1 and Th2 
cells is dependent upon the cytokines present in the local environment.66  In turn, the 
cytokines produced depend on the type and location (intra- vs. extracellular) of the 
pathogen of interest.  Another type of T-helper cell, the regulatory T cell (Treg), is 
important for immune-modulation and suppression.67  Tregs do this by migrating to sites 
of inflammation and suppressing lymphocytes, with T-helper cells being the main 
target.67  Further, Tregs can be induced in tissues by cytokines, such as TGF-β.67  Given 
recent work suggesting an increase in TGF-β production by enterocytes when infected 
with L. intracellularis,68 as well as the lack of inflammation during typical L. 
intracellularis infections,1 it seems feasible that L. intracellularis may utilize Tregs to 
prevent overwhelming inflammatory reactions in response to enterocyte infection. 
 With L. intracellularis, we are primarily interested in the Th1 response targeted 
towards CMI and killing of intracellular organisms.  Th2 responses are targeted towards a 
humoral response and antibody production for the killing of extracellular organisms.  Th1 
cells are produced in response to the presence of interleukin (IL) 2, IL-12, IL-18, 
interferon-gamma (IFN-γ), and tumor necrosis factor alpha (TNF-α); Th2 cells are 
produced due to the presence of IL-4, IL-5, IL-10, IL-13, and IL-β.69  Pathways taken by 
Th0 cells depend on cytokines from antigen presenting cells, either as a result of infection 
or antigen processing.  Once a Th0 differentiates into a Th1 or Th2 cell, this process 
typically continues with the recruitment of other nearby, antigen-specific Th0 cells as the 
newly differentiated T-helper cells release more cytokines that potentiate their 
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differentiation while inhibiting that of the other T-helper subtype.66  Thus, once an 
immune response begins on Th1 or Th2 paths, it typically continues in that fashion. 
 Multiple studies have detailed the induction of a CMI response to L. 
intracellularis infection.  This has primarily been done in experimentally infected pigs 
through L. intracellularis-stimulation of peripheral blood mononuclear cells (PBMCs) in 
vitro where an increase in IFN-γ production was noted as soon as 14 days post-
inoculation with either a pathogenic or vaccine strain of the bacterium.70  This increased 
production of IFN-γ in vitro can be augmented by co-culture of PBMCs in the presence 
of IL-18.71  Additionally, a recent study utilizing a commercially available vaccine 
showed that pigs vaccinated orally had significantly more TNF-α in small intestinal 
mucosal scrapings when compared to non-vaccinated and intramuscularly vaccinated 
controls, further suggesting a Th1 response to bacterial colonization.68   More germane to 
this review with regards to equids is the recent study that found PBMCs from L. 
intracellularis vaccinated and naturally occurring EPE horses produced increased 
amounts of IFN-γ mRNA in vitro when stimulated with the bacterium when compared to 
non-exposed controls.72  Further, vaccinated horses demonstrated an increased level of 
mRNA expression through the study's termination at 180 days post-vaccination, 
suggesting a long-lived memory recall with a Th1 bias.72  Interestingly, the amount of 
IFN-γ mRNA produced in response to the bacterium did not differ significantly between 
the vaccinated and EPE horses.  Given that primary infection with L. intracellularis 
protects against repeat colonization in pigs,50,73 vaccination of equids might provide 
protection against disease.  Except for what is presented in Chapter 5, the role of IFN-γ 
on the occurrence of PE in pigs and horses has not been reported. 
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 The best evidence for a significant role of IFN-γ in infection and immunity to L. 
intracellularis comes from studies using knockout mice.  Smith et al. 2000, showed that 
IFN-γ knockout mice developed more severe disease than wild-type mice of the same 
genetic background.74  This increased severity, compared to controls, manifested as a 
higher enterocyte infection rate, increased mucosal hyperplasia (small intestine and 
colonic), and a failure to clear the infection in 35 days.74  While the control group in this 
study did develop disease, the infection was cleared by day 28 post-challenge. The 
decreased amount of hyperplasia compared to the knockout group confirmed a previously 
reported75 anti-proliferative role for IFN-γ in enterocytes.74  An additional Short 
Communication provided some evidence of high levels of systemic IFN-γ in receptor 
knockout mice (severely afflicted with disease) compared to wild-type (and disease-
unaffected) controls, a finding the authors interpreted as indicating IFN-γ binding is 
vitally important to prevention of L. intracellularis-induced disease.76 
 The Th1 response to intracellular infection, mediated in large part by IFN-γ, 
generally functions to increase inflammation at the site of infection, as well as activate 
macrophages and increase cytotoxicity mediated by CD8+ cytotoxic lymphocytes (CTLs).  
Given the lack of an inflammatory response during normal L. intracellularis infections,1 
much like with the innate immune system, the bacterium seems to largely avoid the cell-
mediated immune response in affected animals.  One possible explanation for this would 
be the presence of an immature or incompetent Th1 response in those animals that are 
affected with L. intracellularis.  While recent work with foals has detailed many 
interesting findings supporting this assertion, little work has been conducted in the age 
group we are interested in, weanlings and young yearlings.   
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 It has now been shown that, like human neonates,77 neonatal foals are lacking in 
their ability to produce IFN-γ early in life.78  Even though the deficiency does abate 
quickly and a rapid maturation in the ability to produce IFN-γ is seen, it can take 10 
months or longer for the percentage of IFN-γ positive lymphocytes and the production of 
in vitro IFN-γ to approach that of adult horses.78  Interestingly, recent work in our lab 
showed that foal exposure to a barn atmosphere, which contained significantly more 
aerosolized fungi and bacteria compared to pasture, was associated with a significantly 
increased number of IFN-γ positive lymphocytes compared to those foals housed solely 
on pasture.79  While the finding that the environment can have a profound impact on CMI 
may be important with respect to a variety of young horse diseases, the effect only lasted 
through 3 months of age, so the potential significance with respect to L. intracellularis is 
unclear given that these horses are typically weaned at 4-6 months of age.  The process of 
weaning itself has been hypothesized as one of the reasons weanlings are predisposed to 
L. intracellularis infection.11  Recently it was shown that weaning can have a detrimental, 
albeit short, effect on IFN-γ production where abruptly weaned horses exhibited a rapid 
(within 7 days post-weaning) decrease in IFN-γ positive lymphocytes and IFN-γ mRNA 
expression which lasted until at least 14 days post-weaning.80  It was hypothesized that 
this decrease was caused by stress-induced hormones, so while very few horses exhibit 
clinical EPE in the weeks following weaning (see Chapter 3 below), it is possible that 
stressful events in the months following weaning may exhibit the same pattern and lead 
to L. intracellularis susceptibility.  Along these lines, the closest "relatives" of L. 
intracellularis, the Desulfovibrio genus, has some species which may exhibit 
opportunistic infection patterns.81   
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 While the mechanism(s) by which L. intracellularis escapes the immune system 
remains unknown, some work has indicated that the bacterium exerts an 
immunosuppressant effect on the small intestine of pigs.82  The suggested 
immunosuppressant effect of L. intracellularis, in addition to the identification of a Type 
III secretory system which is known to be immunosuppressive in other enteric 
organisms,42 involves a substantial decrease in small intestinal T (primarily CD8+) and B 
cells, as well as MHC II expression, within 14 days of challenge with the bacterium.82  
Interestingly, in vitro work using PBMCs from PPE cases has showed the opposite 
occurs, with an increase in lymphocyte proliferation due to stimulation with the 
bacterium.83  The finding that CD8+ cell numbers are decreased in vivo is important 
because, although the study had no negative controls for comparison, CD8+ CTLs from 
infected pigs have been shown to produce large amounts of IFN-γ following in vitro 
stimulation with L. intracellularis.84  Work with humans has also shown that MHC II-
restricted CTLs play an important role in enterocyte immunity,85 and CD8+ MHC II-
restricted T cells have been identified in pigs and horses.86,87  Though another L. 
intracellularis study showed CD8+ CTLs produced lower quantities of IFN-γ than Th1 
cells,71 a decrease in CD8+ cells within the small intestine following infection with L. 
intracellularis would be accompanied by a reduced IFN-γ response, possibly contributing 
to the immune evasion of the bacterium.  Additionally, a concurrent decrease of MHC II 
expression both in the lamina propria82 and on the enterocyte surface86 following L. 
intracellularis infection would further assist the bacterium with evasion.   
 As mentioned previously, both vaccination and prior clinical disease have been 
shown to prevent secondary disease caused by L. intracellularis.50,54,68,73  Disease in pigs 
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has been reportedly induced using doses of 105-1010 organisms/animal, and while there 
appears to be a dose-dependent severity of disease,50 all of the doses protected pigs from 
re-infection (not just clinical disease) when later re-challenged at 1010 
organisms/animal.50  Due to the solely enteric nature of L. intracellularis infections, all 
protective measures have been enterically-targeted, through either the use of oral54 or 
intra-rectal88 vaccination.  A recent paper, however, has suggested that intramuscular 
(IM) vaccination with the commercially available vaccine was as protective as the 
traditional oral route for vaccination in pigs.68  Given that IM vaccination would be 
unlikely to induce mucosal immunity and that elevated IgG serum titers resulted, IgG 
may confer possible protection against infection.68  However, another recent report 
suggested that maternal IgG in piglets (explored with respect to EPE in Chapter 3) had no 
protective effect against disease, although it was a secondary parameter that was not 
examined in depth.84  While the role, if any, IgG plays in infection and immunity to L. 
intracellularis remains unresolved, the role of the humoral system has been examined in 
several papers.  It has been widely reported that systemic IgG production occurs in 
response to natural infection and re-infection/challenge with L. intracellularis in both 
pigs and horses,11,20,50,88 although IgG detection in vaccinated animals is variable.68,88  It 
appears as though the detectable humoral response occurs faster than a detectable CMI 
response89 and the magnitude and duration of detectable IgG titers is dose-dependent in 
pigs.50   
 Unlike IgG, due to the enteric location of L. intracellularis, it seems likely that 
IgA would play a role in infection and immunity to the bacterium.  Indeed, work has 
shown that IgA accumulates in infected enterocytes.86 Although whether this was a 
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bacterium-specific accumulation or due to an effect of the bacterium on IgA passage 
through the infected enterocyte was not elucidated, it has been suggested that IgA may 
play a role in neutralizing intracellular organisms as it passes through infected 
enterocytes.90  L. intracellularis-specific IgA has been reported in the small intestinal 
lumen within 22 days post-infection89 although other studies have been unable to detect 
significant amounts of specific IgA in either the small intestine or serum following 
vaccination;68 whether this would be due to a dose or strain difference is unknown. 
 Our overall hypothesis is that the host immune response plays a significant role in 
the susceptibility of weanlings to L. intracellularis infection and the occurrence of equine 
proliferative enteropathy.  The large number of horses, particularly Thoroughbreds, 
around the central Kentucky region have provided an opportunity to study this relatively 
rare disease at a rate that is likely higher than elsewhere in North America.  The specific 
aims of the following studies are to : 
1. Develop and validate an ELISA for the detection of L. intracellularis-specific 
antibodies and then use this ELISA to determine whether previous farm history of 
EPE has an effect on seroprevalence (Chapter 2). 
2. Determine whether passively-acquired antibodies have an effect on the 
susceptibility to L. intracellularis and the occurrence of EPE (Chapter 3). 
3. Evaluate whether mares play a role in the epidemiology of EPE on endemic farms 
using mare serological status (Chapter 4). 
4. Determine whether L. intracellularis-specific IFN-γ expression is associated with 
resistance to EPE (Chapter 5). 
Copyright © Allen Edward Page 2013 
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CHAPTER TWO:  
Adaptation and validation of a bacteria-specific enzyme-linked 
immunosorbent assay for determination of farm-specific Lawsonia intracellularis 
seroprevalence in central Kentucky Thoroughbreds 
 
Summary 
 
 Lawsonia intracellularis is the causative agent of equine proliferative enteropathy 
(EPE), a bacterium for which no large-scale seroprevalence studies have been conducted.  
The objectives of this study were to validate and use an equine-specific ELISA for L. 
intracellularis to determine the seroprevalence of L. intracellularis on numerous farms 
and the effect of past EPE history on seroprevalence.  An ELISA was adapted from 
previous work in swine to use purified antigen.  A total of 337 Thoroughbreds from 25 
central Kentucky farms were enrolled and monthly serum samples collected from August 
2010 to January/February 2011.  Samples were screened for L. intracellularis-specific 
antibodies using a modified ELISA.  Farms were classified into one of three groups based 
on their recent (in the three years prior to the study) history with EPE.  The overall 
ELISA intra-assay coefficient of variation (CV) was 6.73 and inter-assay CV was 9.60.  
An overall seroprevalence of 68% was obtained, with farm specific seroprevalences 
ranging from 14-100%.  A significant difference was found in the average seroprevalence 
(p<0.05) on farms with recently presumptive cases of EPE.  Additionally, both lower 
average ELISA unit (EU) values (p=0.079) and maximum EU values (p=0.056) on farms 
with no recent EPE history were detected when compared with farms with recently 
presumptive or suspected cases of EPE.  Further, a bimodal exposure distribution to L. 
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intracellularis was detected in the fall and winter months.  With this work, we showed 
that recent history of EPE was associated with higher average seroprevalence indicating 
increased exposure on farms with prior cases of EPE; seasonally bimodal exposure was 
also observed.  The adapted ELISA appears to be useful for determination of L. 
intracellularis-specific antibody levels.  The high farm-specific seroprevalences and 
bimodal distribution of exposure to L. intracellularis detected here were unexpected and 
suggest that farms with a previous history of EPE remain at risk due to heightened 
exposure levels beyond early winter. 
 
This chapter has been previously published and the copyright is held by the Equine 
Veterinary Journal.  The manuscript is reproduced here in accordance with the 
EVJ Copyright Agreement.  An abstract from this manuscript was presented at the 
2011 American Association of Equine Practitioners Annual Convention. 
 
Page, A.E., Stills, H.F., Chander, Y., Gebhart, C.J., Horohov, D.W., 2011. Adaptation 
and validation of a bacteria-specific enzyme-linked immunosorbent assay for 
determination of farm-specific Lawsonia intracellularis seroprevalence in central 
Kentucky Thoroughbreds. Equine Veterinary Journal 43 Suppl 40, 25-31.
34 
 
Introduction 
 
 Lawsonia intracellularis, an obligate intracellular, gram-negative rod, is the 
causative agent of proliferative enteropathy.1  L. intracellularis is viewed as an emerging 
cause of proliferative enteropathy in a variety of mammalian species,91,92 including 
horses,14,93-95 where the bacteria causes equine proliferative enteropathy (EPE). 
Clinical signs of EPE, usually seen in weanlings or young yearlings,11,18,94-96 include 
anorexia, fever, lethargy, depression, dependent edema caused by 
hypoproteinemia/hypoalbuminemia, weight loss, colic, and diarrhea.  In addition, 
thickened small intestine detected by abdominal ultrasound is considered highly 
suggestive of EPE when accompanied by compatible clinical signs.  Commercially 
available antemortem tests for EPE include fecal L. intracellularis-specific PCR and the 
serum immunoperoxidase monolayer assay (IPMA), both of which have been adapted 
from their use in pigs where the tests are highly specific; sensitivity is reported to be high 
for the IPMA37,53 but variable for fecal PCR.32,34    
 Though the epidemiology of EPE is uncertain, it is believed that transmission 
occurs through the ingestion of L. intracellularis-contaminated fecal material from wild 
or domestic animals.46  While most cases of EPE typically occur in the fall and early 
winter,11,19 the reason for this seasonal predilection has not yet been determined.  One 
possibility is the known susceptibility of weanlings to this infection and weaning 
typically occurs during this time of year.11  Another possibility would be that the 
environmental conditions at that time favor transmission by increasing exposure burdens.    
35 
 
Previous work looking at L. intracellularis-specific antibodies demonstrated 
seroprevalences ranging from 33.8-45.5% on two California farms97 and up to 60% on a 
Kentucky farm,19 utilizing the IPMA method.  While these studies have focused on 
individual farms, none have determined the seroprevalence of L. intracellularis within a 
larger region.  Detection of L. intracellularis-specific antibodies using enzyme-linked 
immunosorbent assays have been developed for the pig and rabbit.98-101  Here we adapted 
a porcine ELISA99 and used this ELISA method to determine seroprevalences on 
Thoroughbreds farms located in central Kentucky. 
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Materials and Methods 
 
Farm selection and information gathering 
 A total of 25 Thoroughbred farms were recruited for participation in this study 
using various methods, including a presentation to the local farm managers club as well 
as emails and phone calls to local farm managers.  The only requirements for inclusion 
were that the farm population of horses be 75% or greater Thoroughbreds and that the 
farm be located within a 25 mile radius of Lexington, Kentucky.  Consent for inclusion of 
privately-owned horses was obtained from the farm managers, who were authorized to 
act on the behalf of any private owners. 
 After inclusion in the study, farms were asked to provide information regarding 
EPE cases in the preceding three years leading up to the study period.  These data were 
used to classify farms as having presumptive cases of EPE, suspected cases of EPE, or no 
recent cases of EPE.  Farms were considered to have had presumptive EPE cases if they 
had one or more weanlings with clinical signs compatible with EPE, hypoproteinemia 
and hypoalbuminemia, and either a concurrent positive fecal PCR or serum IPMA titer 
result (1:60 or greater) in the preceding three years.  For the purpose of this study, 
compatible clinical signs for EPE were anorexia, fever, lethargy, depression, dependent 
edema, rapid weight loss, colic, and diarrhea.  Farms were considered to have had 
suspected EPE cases if they had one or more weanlings with signs compatible with EPE, 
but neither a positive fecal PCR nor positive serum IPMA titer result (1:60 or greater).  
Farms were considered to have had no recent history of EPE if they experienced no 
horses with clinical signs of EPE within the preceding three years. 
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 After the conclusion of the study, all participating farms were requested to 
complete a questionnaire regarding EPE cases on the farm during the study period.  
Based on this information, farms were classified for the study period into the three 
categories as above.   
 
Study Period 
 The study began August 16th, 2010 and was to conclude January 5th, 2011.  For 
some farms, an optional sample collection period from January 31st to February 2nd, 2011 
was included in the study due to a large increase in the number of seropositive samples in 
January.  Samples were collected once during a three day period every four weeks from 
the farms. 
 
Horses 
 While some farms housed non-Thoroughbred horses, only Thoroughbred horses 
were included in the study.  All horses in the study were born during the 2010 foaling 
season and were weaned by November 2010.  Farms were requested to provide a list of 
all 2010 horses present on the farm in early-August 2010.  If a farm had fifteen or fewer 
2010 horses at this time, all horses were included in the study.  For those farms with 16 or 
more horses present in early-August, 15 horses were chosen randomly to participate 
(except for farm 19, from which all 16 horses were included in the study at the farm’s 
request).  Randomization was achieved by assigning each horse a sequential number and 
utilizing a random number generatorA to select the 15 horses for inclusion in the study.  
                                               
A Microsoft Excel, Microsoft Corporation, Redman, WA 
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Each horse included in the study was assigned a unique three-digit identification number 
for ease of results tracking, as well as maintaining anonymity. 
 
Sample collection and handling 
 Once every four weeks, a 10ml sample of whole blood was collected into 
individually labeled, sterile, red-top 10ml blood tubes via jugular venipuncture.  Samples 
were submitted and held at centralized laboratories at 4oC for less than 24hrs before they 
were collected and transported to the Maxwell H. Gluck Equine Research Center at the 
University of Kentucky.  Upon arrival, samples were immediately centrifuged at 800xg 
for 10 min.  Serum was transferred to tubes labeled with the month and the unique three-
digit code assigned to its horse and frozen at -20oC until analyzed. 
 For various reasons, including public sale, private sale, or a horse being returned 
to its owner, a number of blood samples were omitted from the study.  As such, any 
horses that left the study prior to November were completely excluded from the data set.  
Horses remained in the study even if one or more samples were not collected after 
October.   
 Serum samples obtained from six Lawsonia intracellularis-challenged weanlings 
and 15 uninfected controls were included for the validation of the ELISA, with 
information regarding the challenge reported elsewhere.10  
 
Lawsonia intracellularis-specific immunoperoxidase monolayer assay 
 The IPMA method for determining L. intracellularis-specific antibody titers was 
performed as previously described.37  
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Purification of L. intracellularis 
 Porcine-origin L. intracellularis was obtained from cell culture6 and purified 
using DEAE column chromatography which allowed the bacterium to be eluted as a 
whole organism.  The presence of L. intracellularis in the eluate was verified 
microscopically using Gimenez stain, in addition to PCR for L. intracellularis, as 
previously described.102  Additionally, no other bacteria were detected following aerobic 
and anaerobic culture, as well as Gram staining.  The pooled purified bacterial eluate with 
sodium azide was kept refrigerated (4oC).  Quantification of the purified, whole-
bacterium was performed using the BCA method.103   
 
Lawsonia intracellularis-specific enzyme-linked immunosorbent assay 
   The ELISA was based on a previously described method99 with respect to 
starting concentrations of reagents and a checkerboard titration scheme, as described 
elsewhere.98,99  Factors influencing background were minimized using previously 
described methods.99  From this, it was found that serum dilutions of 1:100 produced the 
most consistent results with minimal background.  Further, based on this approach, the 
optimum concentration of antigen was 2.5µg/mL and the use of a polyvinyl alcohol block 
was superior to 5 or 10% skim milk.   
 The ELISA plates wellsB were coated with 2.5µg/ml of purified L. intracellularis 
in carbonate bufferC, then covered with Parafilm-MD and allowed to sit overnight at 4oC.  
                                               
B Immunolon 1b Flat Bottom Microtiter Plates, Thermo Scientific, Rochester, NY 
C Sigma Aldrich, St. Louis, MO 
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After plates incubated overnight, they were washed three times with phosphate-buffered 
saline with 0.05% Tween-20E (PBST) using an ELISA plate washerF.  The coated plates 
were then blotted dry before adding 200µl/well of blocking buffer (polyvinyl alcoholG 
1% (w/v) in distilled water) for two hours at room temperature.  After blocking, the plates 
were washed three times, as above.  Sera were diluted at 1:100 in blocking buffer and 
added (100 µl) to duplicate wells.  Plates were then incubated at room temperature for 1 
hour.  Duplicate, serially diluted (1:60 through 1:3840) serum samples from a weanling 
exhibiting clinical signs compatible with EPE, including anorexia, weight loss, and 
dependent edema, were used to generate a standard curve.  This weanling tested positive 
repeatedly at 1:1920 using the IPMA method.  Negative control samples included serum 
from repeatedly L. intracellularis antibody-negative weanlings along with a duplicate 
sample of 100µl fetal equine serum diluted 1:100.  After 1 hour incubation with diluted 
test and control sera, the plate was washed three times and 100µl of murine anti-horse 
IgG (1:4000) conjugated with horseradish peroxidaseH (HRP) was added to each well.  
The plate was then incubated in the dark for 1 hour at room temperature before being 
washed three times.  To each well was then added 100µl of 3,3’,5,5’-tetra-
methylbenzidine (TMB) solutionI for two minutes before the reaction was stopped with 
TMB Stop solutionJ.  Absorbance at 450nm was read within 5 minutes using an ELISA 
                                                                                                                                            
D Bennis Flexible Packaging, Neehah, WI 
E Sigma Aldrich, St. Louis, MO 
F MW 96/384, Beckman Coulter, Brea, CA 
G Mowiol 6-98, Sigma Aldrich, St. Louis, MO 
H Sigma Aldrich, St. Louis, MO 
I SureBlue™ TMB Microwell Peroxidase Substrate, KPL, Gaithersburg, MD 
J KP, Gaithersburg, MD 
41 
 
plate readerK.  Results from the test sera were converted to an ELISA unit (EU) utilizing 
a linear trend line from the standard curve generated from each plate.  A coefficient of 
determination (r2) of ≥.90 was required for the plate to be considered valid.98   
 A positive cut-off of 55EU or greater was utilized based on non-challenged 
weanlings having an average of 33EU’s and a standard deviation of 7EU’s;10 these 
samples repeatedly tested negative via IPMA.  By setting the cut off at 55EU’s, this value 
is three standard deviation units above the negative control averages and represents the 
upper limit of a 99% confidence interval.   
 
Evaluation of assay repeatability 
 Twenty-four samples were selected for the ELISA repeatability test.  These 
represented a variety of negative (<55EU), low (55-119EU), mid (120-239EU), and high 
(≥240EU) samples.  For intra-assay repeatability, three replicates of each sample were 
performed on the same plate.  For inter-assay repeatability, three replicates of each 
sample were run on duplicate plates on different days.  Coefficient of variation (CV = 
SD/mean x100%) of the three replicates from each test were evaluated.  In addition, CV’s 
of the standard curve ODs from each plate was evaluated. 
 
Data analysis 
 Farms 8 and 9 were ultimately considered as one farm data set since the horses 
from these two farms were combined into one population once the foals were weaned.  
Likewise, Farms 22 and 23 were combined into one data set for the same reason.  
                                               
K Benchmark Plus, Bio-Rad, Philadelphia, PA 
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One-way analysis of variance (ANOVA) (Holm-Sidak methodL) was used to evaluate 
differences in ELISA unit values between farms categorized based on their past EPE 
status.  Post hoc t-tests were performed to evaluate the differences between groups.  Chi-
square analyses were used to assess seroprevalence results.  Calculated P values <0.05 
were considered to be statistically significant.   
                                               
L SigmaStat, SPSS Inc., Chicago, IL 
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Results 
 
 In order to validate our ELISA, serum samples of varying EU’s were run in 
triplicate with an overall intra-assay CV of 6.73 and inter-assay CV of 9.60.  For the 
standard curve, CV’s ranged from 2.08 to 7.69 with a mean of 4.85 and the most dilute 
sample (1:3840 dilution) had the highest CV.   Additionally, ELISA analysis of serial 
serum samples from L. intracellularis-challenged weanlings demonstrated 
seroconversion on or before day 20 post-challenge with all weanlings obtaining EU’s > 
120 and a maximum of 746 EU while all non-challenged weanlings remained below 55 
EU’s.10  Appendix I is provided to illustrate the relationship between OD and EU values 
for the standard curve, which is run on every ELISA plate and used to calculate EU 
values of unknown samples. 
 Provided in Figure 2.1 are all EU results for non-challenged controls and all 
positive values from experimentally challenged weanlings,10 as well as clinically affected 
field cases from the study period (EU values shown are those found at the initial time of 
presentation).  Clinically EPE affected weanlings demonstrated similar, and in some 
cases greater, serum antibody levels against L. intracellularis when compared with 
experimentally challenged weanlings.  Figure 2.2 includes EU results from all horses in 
the present study divided into two groups; study horses that failed to seroconvert 
(<55EU) during the study and study horses that seroconverted (≥55EU) at any point 
during the study period but failed to show clinical signs of EPE.  A number of the non-
clinical, seropositive horses exhibited very high EUs. 
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Figure 2.1: ELISA Unit (EU) values for non-challenged weanling controls, L. 
intracellularis-challenged weanlings, and clinical EPE cases.  Dashed bar represents 
55EU, the cut-off for positive samples. 
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Figure 2.2: All study time points from those weanlings that remained seronegative 
(<55EU) for the entire study and those that seroconverted at any point (≥55EU) 
during the study period.  Each column for the study horses represents an individual 
horse.  Dashed bar represents 55EU. 
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 Overall, a total of 337 horses were included in the seroprevalence data set as they 
were present on the farms through at least November 2010.  Of these 337 horses, a total  
of 229 horses, or 68.0% of the study population, tested positive (≥55 EU’s) for L. 
intracellularis-specific antibodies via the ELISA at one or more time points.  The 
monthly percentage of previously seronegative horses that seroconverted during a given 
month and the accruing totals are shown in Figure 2.3.  Overall there was a steady 
increase in the number of seropositive horses over time with marked increases in monthly 
seroconversion during October 2010 and January 2011.  As shown in Figure 2.4, the 
majority of the seropositive animals for a given month had EU values in the range of 55-
119EU.   Beginning in October, one sees an increase in the frequency of high antibody 
levels (>120 EU) paralleling the increase in seroconversions noted in Figure 2.3.    
 Serological results from individual farms including past EPE status of the farm, 
EPE status during the study period, and calculated seroprevalence for L. intracellularis 
are shown in Table 2.1.  A total of 8 farms experienced presumptive cases of EPE during 
the study period and no farms had suspected cases.  Seven of these farms had already 
been classified as recently experiencing presumptive cases of EPE and one had 
previously experienced suspected cases of EPE.  Farms without a recent history of EPE 
experienced no cases during the study period.  Calculated farm-specific seroprevalences 
ranged from 14.3% to 100%.  Figure 2.5 shows the average monthly seroconversion rate 
grouped by recent EPE history.  While those farms with a recent history of EPE 
(presumptive or suspected) had some horses seroconvert each month, the farms with no 
recent history of EPE (none) had several months where zero or only one horse 
seroconverted.  Table 2.2 shows the overall average seroprevalence as well as the average 
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positive and maximum EU values obtained from farms grouped by recent EPE status. 
Those farms with a presumptive history of EPE had significantly (p<0.001) higher 
average seroprevalences compared to those with suspected or no recent cases of EPE. 
Additionally, the average EU (p=0.079) and average maximum EU values (p=0.056) 
were found to be lower on farms with no recent history of EPE cases compared to the 
other groups.  Moreover, the range of maximum EU values is much smaller for the farms 
with no recent EPE cases. 
 
 
 
 
Figure 2.3: The percentage of previously seronegative horses that seroconverted (55EU or greater) during a given month as 
well as the cumulative number of seropositive horses. 
48 
 
 
 
Figure 2.4: The monthly distribution of positive ELISA results reported as ranges of EU’s.
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Table 2.1. Seroprevalence by farm according to previous EPE history and EPE 
status during the study period. Farm-specific seroprevalences ranged from 14.3% to 
100%. 
 
Farm 
History of 
Previous 
EPE Cases 
2010 
Foaling 
Season EPE 
Cases 
Total ELISA 
Positive 
Horses 
Total # 
of 
Horses  
Sampled Seroprevalence 
1 No No 11 15 73.3% 
2 Suspected No 3 15 20.0% 
3 Presumptive Presumptive 9 9 100% 
4 Presumptive No 7 12 58.3% 
5 Presumptive No 10 15 66.7% 
6 Presumptive Presumptive 9 10 90.0% 
7 No No 2 14 14.3% 
8 & 9 Presumptive No 16 26 61.5% 
10 Presumptive Presumptive 9 15 60.0% 
11 No No 10 15 66.7% 
12 Presumptive No 5 9 55.6% 
13 Suspected Presumptive 13 15 86.7% 
14 Presumptive No 9 15 60.0% 
15 Suspected No 9 15 60.0% 
16 Presumptive Presumptive 11 11 100% 
17 Presumptive Presumptive 14 15 93.3% 
18 Presumptive No 15 15 100% 
19 Presumptive No 12 16 75.0% 
20 No No 2 7 28.6% 
21 Presumptive Presumptive 11 14 78.6% 
22 & 23 Presumptive Presumptive 24 29 82.8% 
24 No No 10 15 66.7% 
25 No No 8 15 53.3% 
 
 
 
 
 
Figure 2.5: Monthly seroconversions for groups (presumptive, suspected, none) of farms based on recent EPE history. 
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Table 2.2. Average seroprevalence, positive EU’s, and maximum EU’s grouped by EPE history. 
Previous EPE 
Cases 
Average 
Seroprevalence Average Positive EU Average Max EU 
Presumptive 76.3%* (55.6-100%) 228.1 (85.5-378.9) 1683.4 (193.8-4312.3) 
Suspected 55.6% (20-86.7%) 218.0 (59.7-326.2) 1604.6 (62.2-3319.4) 
None 53.1% (14.3-73.3%) 123.9# (59.5-175.6) 453.9## (55.6-904.1) 
   *p<0.05; #p<0.079; ##p<0.056 
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Discussion 
 
 Here we described the use of an ELISA method to characterize the serological 
response of Thoroughbred weanlings to L. intracellularis on central Kentucky farms.  
This ELISA used column chromatography purified, whole L. intracellularis, thus 
optimizing reproducibility, as evidenced by an overall intra-assay CV of 6.73 and inter-
assay CV of 9.60. Using this method, farm-specific seroprevalences ranged from 14.3 – 
100%.  As such, these results are comparable with a past screening study in the central 
Kentucky region which used the IPMA method and showed an EPE endemic farm to 
have a seroprevalence of approximately 60% while a non-endemic farm had a 
seroprevalence of 17%.19   
 Not surprisingly, seroprevalences corresponded well with the past history of EPE 
cases on the farm.  Significant difference between groups based on recent EPE history 
was seen with respect to average seroprevalence.  Additionally, farms with no recent 
clinical cases of EPE had both lower average EU and average maximum EU values for 
their positive samples.  One possible explanation is that farms with no history of EPE 
cases likely had lower environmental burdens of L. intracellularis resulting in fewer 
horses being exposed to the bacterium (lower seroprevalence) and less antigenic 
stimulation per exposure (lower EU values).  Evidence for this assertion is provided by 
the non-endemic farm from a previous study,19 which is also represented in the current 
study (Farm 15).  While originally considered non-endemic, the farm has since reported 
suspected cases of EPE and was re-classified for the purpose of this study.  Accordingly, 
the farm’s seroprevalence was found to be 60% with an average positive EU of 326.2 and 
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a maximum EU of 3319.4.  Given that the epidemiology of EPE remains poorly defined, 
these data begin to indicate that relative burdens of L. intracellularis in the environment 
may explain why certain farms have an endemic problem with EPE.   
 Monitoring of weanlings by the enrolled farms ultimately identified 8 farms with 
presumptive cases of EPE during the study period from August 2010 through February 
2011.  Perhaps not surprisingly, these 8 farms represented only those with prior 
presumptive or suspected cases of EPE (7 and 1, respectively).  While definitive 
antemortem diagnosis of EPE remains controversial, elevated L. intracellularis-specific 
antibody levels are commonly seen in clinically affected horses.10,11  These presumptive 
cases likewise exhibited an elevated antibody response, as was also detected in the L. 
intracellularis-challenged weanlings,10 using this ELISA. 
   While previous reports from the central Kentucky region suggest a single peak 
of exposure occurring during late-Fall/early-Winter,11,19 we provide new evidence of 
bimodal exposure occurring both in the fall and winter.  These results correspond directly 
with anecdotal evidence indicating a large increase in the number of cases of EPE in this 
area during the months of January and February 2011.  The reason for this increased 
incidence of EPE has yet to be elucidated.  Possible explanations include changes in 
weather patterns, changes in management, and increased exposure to the unknown 
reservoir, which could include clinically or subclinically affected horses.  With respect to 
these possibilities, it should be noted that the summer and fall of 2010 experienced less 
rainfall when compared with average amounts for the region.  Additionally, there were 
lower daily temperatures starting in November with increased amounts of both rain and 
snow, beyond what is normal for central Kentucky during the early winter months. 
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 While the ELISA method affords ease of use and reliability, the establishment of 
a cut-off value to separate negative and positive samples is critical.  The current positive 
cut-off (≥55EU) utilized the average EU plus three standard deviations from non-
challenged weanlings, reported elsewhere,10 and differentiated between known 
seropositive and seronegative horses.  Twelve field cases evaluated using the ELISA 
demonstrated high levels of L. intracellularis-specific antibodies, equaling or surpassing 
those EUs detected in experimentally challenged weanlings.  Also noted were several 
non-clinically affected weanlings with markedly elevated EU values.  These could be 
indicative of a successful immunological response to infection or a subclinical case that 
was not detected by the farm; both situations were observed in the previous challenge 
study.10  As such, these findings provide further evidence that the new ELISA 
successfully detects antibodies to L. intracellularis in clinical and non-clinical horses.   
 There were two inherent limitations with the design of this study.  First, there was 
an over representation of farms with presumptive or suspected cases of EPE in the data 
set.  This likely reflected the fact that those farms with a prior history of what they 
consider a frustrating disease were more willing to participate and provide data.  
Additionally, the stigma associated with this disease in central Kentucky may have 
contributed to the large number of farms that declined to participate due to fears that their 
status with respect to L. intracellularis and EPE would become public.  As such, the 
overall seroprevalence of 68% should not be considered representative of the equine 
population in this region without further, randomized sampling.  Nevertheless, 20% of 
the horses surveyed came from farms with no recent history of EPE and we reported both 
farm-specific and group-specific seroprevalences.  The other limitation and potential 
56 
 
source for error revolves around the possibility of cross-reaction of this ELISA with other 
bacteria.  Phylogenetic studies have found that while L. intracellularis appears to be a 
member of unique pathogens,104 more recent work has shown L. intracellularis shares 
similarities with some rickettsial families.105  As such, potential cross-reactivity between 
other potential organisms cannot be excluded without further testing.  However, work to 
validate the ELISA from which the method reported here was adapted failed to detect any 
cross-reactivity between L. intracellularis and related bacterial species.99     
 By screening a large population of central Kentucky Thoroughbreds using a 
newly validated and equine-adapted ELISA, a high seroprevalence for L. intracellularis-
specific antibodies was detected with variable farm-specific seroprevalences.  Previous 
history of EPE on the farms was associated with significant differences in average 
seroprevalence indicating lower levels of exposure are present on farms with no history 
of EPE.  Additionally, a bimodal, seasonal distribution of exposure was documented.  
The high farm-specific seroprevalences and bimodal distribution of exposure to L. 
intracellularis were unexpected and suggest that farms with a previous history of EPE 
remain at risk due to heightened exposure levels beyond early winter, as has been 
suggested previously. 
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CHAPTER THREE: 
Determining the role of passively-acquired antibodies in infection and immunity to 
Lawsonia intracellularis 
 
Summary 
 
 Much like the other proliferative enteropathies caused by Lawsonia 
intracellularis¸ equine proliferative enteropathy typically affects weanlings and is rarely 
seen in older horses.  Multiple hypotheses to explain age-based susceptibility to develop 
L. intracellularis include the decline of passively-acquired antibodies; this has never been 
examined in horses.  A total of 369 mare and foal pairs from 15 central Kentucky 
Thoroughbred farms were ultimately used in this study.  Serum samples were collected 
from mares and foals within 48 hours of parturition, and then monthly from foals through 
February of their yearling year.  L. intracellularis-specific antibody levels were 
determined using an ELISA previously validated for use in horses.  No effect of passively 
acquired antibodies on the occurrence of presumptive EPE or suspected infection with L. 
intracellularis was noted.  In total, 5.3% and 6.3% of seropositive horses developed 
presumptive EPE or suspected infection with the bacterium, respectively.  Using multiple 
logistic regression, it was found that colts were at a significantly greater risk than fillies 
of developing presumptive EPE or a combination of presumptive EPE or suspected 
infection with the bacterium.  Additionally, those horses that were weaned in September 
or later months were at a significantly lower risk of developing a combination of either 
presumptive EPE or suspected infection.  A geographical difference in the timing of 
exposure to the bacterium was identified, although no reason for this difference was 
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elucidated.  This is the first study to show that passively-acquired antibodies to L. 
intracellularis do not have an effect on the occurrence of EPE or infection with the 
bacterium.  A number of novel findings, including identification of the disease rate 
amongst exposed horses, warrant additional work as they may help to identify potential 
risk factors for L. intracellularis exposure and/or the reservoir host(s) of the bacterium. 
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Introduction 
 
 Lawsonia intracellularis is an obligate, intracellular, gram-negative curved rod 
that invades intestinal crypt cells, primarily in the distal small intestine, and causes 
proliferation of the intestinal epithelium.4  This proliferation leads to thickening of the 
intestinal mucosa and the clinical signs associated with proliferative enteropathy.14  
While initially described as a pathogen of pigs,4 L. intracellularis is now viewed as an 
emerging cause of proliferative enteropathy in a variety of mammalian species,91,92 
including horses.14,93-95  In the horse, L. intracellularis infection results in equine 
proliferative enteropathy (EPE) which has been reported worldwide.15,25   Affected horses 
suffer weight loss and some ultimately succumb to the disease despite aggressive 
treatment.19  
 Equine proliferative enteropathy typically affects weanlings and is rarely seen in 
older horses.30,31  Diagnosis and preventative measures for EPE are poorly defined while 
clinical signs in infected horses are non-specific and include anorexia, fever, lethargy, 
depression, and dependent edema, with colic and diarrhea infrequently seen.18  
Ultrasonographic thickening of the small intestinal wall (>3mm) in weanlings, although 
not reliably seen, is highly suggestive of EPE.14  Antemortem diagnosis of EPE revolves 
around clinical signs, ultrasonographic findings, and evidence of hypoproteinemia and 
hypoalbuminemia, as well as results from commercially available diagnostic tests.11  The 
presence of hypoalbuminemia may be one of the best, most rapid, and inexpensive tests 
for EPE in weanlings with other compatible clinical signs.11  Commercially available 
antemortem tests include fecal polymerase chain reaction and serum serology using the 
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immunoperoxidase monolayer assay (IPMA).  While definitive diagnosis of EPE can 
only be made at necropsy and relies upon the immunohistochemical (IHC) detection of 
the organism in characteristic intestinal lesions,31 IPMA has been widely used as an 
antemortem diagnostic tool for cases of EPE.11,19   The IPMA utilizes a commercially 
available antigen coated plate and a HRP-detection method which requires only an 
inverted microscope for analysis; however, this method is highly subjective and 
dependent on operator experience.106  Enzyme-linked immunosorbent assays (ELISA) are 
a more reliable and sensitive test that are readily automated and free of operator 
interpretation.  ELISAs are frequently used for the detection of antibodies to specific 
pathogens and we have recently validated an L. intracellularis-specific ELISA for use in 
horses.20 
 Multiple hypotheses for the predilection of L. intracellularis for weanlings exist, 
including the stress of weaning and the decline of maternal antibodies.11,18  While the 
nature of the immune response to L. intracellularis remains ill defined, IgG antibodies 
have been implicated in protection against both porcine and equine PE.50,88  Past work 
has shown that passively acquired antibodies specific to L. intracellularis were detectable 
by the IPMA method for 1-3 months post-parturition.107  Given the aforementioned 
limitations of the IPMA method, this approach may fail to completely define the true 
duration and quantity of the passively acquired antibodies.  Our previous work has shown 
the incidence of L. intracellularis-seropositive weanlings in the central Kentucky region 
approaches 68%, with some farms experiencing 100% weanling seroconversion.20  This 
high incidence provides the opportunity to follow groups of foals with varying levels of 
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passively-acquired antibodies against L. intracellularis in order to determine the role 
these antibodies play in protection from infection and EPE. 
 Very little is known regarding control of L. intracellularis exposure or other 
preventative measures for EPE as risk factors for this disease remain unknown.  While 
there is interest in the use of a vaccine to prevent this disease,88 no product is currently 
licensed for use in horses nor are the protective immunological mechanisms against EPE 
defined.  If passively-acquired antibodies are protective against the development of EPE, 
new preventative measures such as maternal vaccination or administration of L. 
intracellularis hyperimmune plasma to foals may be warranted as a means of decreasing 
the incidence of clinical disease.  Here, we have examined the role that passively-
acquired antibodies to L. intracellularis play in immunity and infection using a large 
scale, prospective field study.   
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Materials and Methods 
 
Study Farms and Horses 
 Fifteen Thoroughbred farms in central Kentucky were enrolled in this study 
which took place from January 2012 through February 2013.  The only requirements for 
inclusion were that the farm population of horses be 75% or greater Thoroughbreds and 
that the farm be located within a 25 mile radius of Lexington, Kentucky.  Preference for 
inclusion was given to those farms with a documented history of EPE.  Approval to 
conduct this study was obtained from the University of Kentucky's Institutional Animal 
Care and Use Committee and forms documenting informed consent for inclusion of 
privately-owned horses was obtained from the farm managers or farm veterinarians, 
whom were authorized to act on the behalf of private owners.   
 Immediately prior to the study's initiation, one farm elected to withdraw its 
participation (Farm 10) while Farm 16 was added as a portion of the foals originally 
located on Farm 4 were relocated to Farm 16.  Farms 13 and 14 were ultimately regarded 
as the same farm as they were part of a complex of farms and, after weaning, study 
horses were comingled together. 
 
Sample Collection, Processing, and Storage 
 Within 48hrs of parturition, whole blood samples (7 mls of peripheral blood 
collected via aseptic venipuncture from the jugular vein) were collected from the mare 
and newborn foal and allowed to settle in a refrigerator at 4oC.  Samples were 
individually labeled with regard to the mare/foal’s name, as well as the date the sample 
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was collected. If foals received hyperimmune plasma (i.e. Rhodococcus equi) or high IgG 
plasma for failure of passive transfer, the farms were requested to obtain the blood 
sample after plasma had been administered in an effort to accurately represent L. 
intracellularis-specific antibodies obtained from both colostrum and the hyperimmune 
plasma.  Treatment with these products was noted for later analysis.   
 After the initial collection time point, samples were subsequently collected 
approximately every four weeks only from the foals starting at 4 weeks of age through 
the middle of July, as described above.  Samples were stored at 4oC on the farm until 
returned to the Maxwell H. Gluck Equine Research Center at the University of Kentucky 
for centrifugation (800g x 10min) followed by freezing of serum at -20oC until all 
samples collected through July from mare/foal pairs could be run concurrently (see 
below).   
 Starting at the end of July, all study horses (ranging in age from two months to six 
months) had blood samples collected during the same three day period every four weeks 
to ensure that all horses, irrespective of the farm, were sampled during the same time 
period.  Samples were submitted by the farms and held at centralized laboratories at 4oC 
for less than 24hrs before they were collected and transported to the Gluck Equine 
Research Center.  Upon arrival, samples were immediately centrifuged at 800xg for 10 
min and held at 4oC for no more than 4 days before all samples were analyzed as below. 
 
Detection of L. intracellularis-specific antibodies 
 Serological status in regards to L. intracellularis was determined using the ELISA 
method as previously described (see also Chapter 2),20 except that plates were blocked 
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with polyvinyl alcohol 1% (w/v) in distilled water for one hour instead of two hours.  
Results from the tested sera were converted to an ELISA unit (EU) utilizing a linear 
regression line from a standard curve generated on each plate.  A positive cut-off of 
55EU or greater was utilized based on previous work.10  
 
Data Obtained from Farms 
 Farms were asked to provide a range of information about each study horse, 
including sex, date of birth, post-foaling IgG result, whether hyperimmune or high IgG 
plasma was administered, whether the foal was treated for Rhodococcus equi, weaning 
date, and any other pertinent comments.   
 
Total Protein and Albumin Determination 
 Total protein levels were determined via refractometry for all seropositive 
samples.  For those samples with total protein levels below 5.3 g/dL, albumin levels were 
obtained using an ACE Alera (Alfa-Wassermann, West Caldwell, NJ) at the University of 
Kentucky’s Veterinary Diagnostic Laboratory.  Albumin levels below 3.2 g/dL were 
considered to be low.  During each sampling period from September to February (those 
periods in which seropositive horses were present), between 12-20 seronegative samples 
were randomly chosen as negative controls for total protein levels while a subset of those 
samples were used as albumin negative controls, all for comparison to total protein and 
albumin results from the other groups (see below).  Additionally, forty seropositive 
samples with total protein levels at or above 5.3 g/dL were randomly chosen for albumin 
determination and comparison between the other groups. 
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Classification of Study Horse EPE Status 
 At the end of the study, horses were placed into one of four categories to describe 
their L. intracellularis/EPE status following the typical L. intracellularis "season" of 
October to February: presumptive EPE, suspect L. intracellularis-infected, seropositive, 
or non-exposed.  Based on our previous work,20 presumptive EPE affected horses were 
those that experienced concurrent clinical signs compatible with EPE, moderate to severe 
hypoproteinemia (<4.5g/dL) and hypoalbuminemia (<2.5g/dL), and a positive L. 
intracellularis-specific ELISA result.  For the purpose of this study, compatible clinical 
signs for EPE were anorexia, fever, lethargy, depression, dependent edema, rapid weight 
loss, colic, and diarrhea.  Given that definitive diagnosis of EPE can only be made at 
necropsy and relies upon the immunohistochemical (IHC) detection of the organism in 
characteristic intestinal lesions,31 all clinical diagnoses of EPE were considered 
presumptive.  Suspect L. intracellularis-infected horses were those with mild 
hypoproteinemia (4.5-5.2 g/dL) and hypoalbuminemia (2.5-3.1 g/dL) plus a positive L. 
intracellularis-specific ELISA result without concurrent clinical signs compatible with 
EPE.  L. intracellularis-infected horses can experience a transient decrease in total 
protein and albumin levels along with a positive L. intracellularis-specific ELISA result 
in the absence of other clinical signs.10,39  However, since there was no demonstration of 
the presence of L. intracellularis (either via fecal PCR or necropsy sampling), these cases 
are referred to as "suspect L. intracellularis-infected".  Seropositive horses were those 
with only a positive L. intracellularis-specific ELISA result (excluding passively-
acquired L. intracellularis antibodies) and no other indication of L. intracellularis 
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infection.  Horses with no detectable L. intracellularis-specific antibodies for the entirety 
of the study (excluding passively-acquired antibodies) were classified as seronegative. 
 
Data Analysis 
 Logistic regression analysis was used to identify significant effects of different 
variables on EPE/L. intracellularis status including, but not limited to initial EU value, 
use of any hyperimmune plasma, Rhodococcus equi infection, and weaning month.  One-
way analysis of variance (ANOVA) was used to detect significant differences between 
seropositive groups (presumptive EPE, suspected infected, and seropositive-only) with 
respect to age at weaning, age at seroconversion, and time from weaning to 
seroconversion, as well as differences in the age at weaning between seronegative and 
seropositive horses.  One-way ANOVA was also used to detect total protein and albumin 
differences between classification groups.  Additionally, survival analysis (Kaplan-
Meier) was used to determine the effect of initial serological status of the foal on time to 
seroconversion.  To determine the effect of passively-acquired antibodies on 
seroconversion rates in the study population, analysis was performed using proportional 
hazards regression analysis (Cox PH regression) with maternal and initial foal antibody 
EU values as variables and seroconversion as the event.  Calculated P values <0.05 were 
considered to be statistically significant. 
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Results 
 
 A total of 453 mare and foal pairs were initially enrolled in the study, from which 
initial, post-partum samples were collected.  From these pairs, 253 mares were 
seronegative (<55EU) and 200 (44.2%) were seropositive post-parturition (55-1297 EU) 
while 281 foals were seronegative and 172 (38.0%) were seropositive (55-2552.6 EU).  
Average positive EU values for mare and foal post-partum samples were 135.5 and 164.7 
EU, respectively.  Interestingly, 41 foals were seropositive at parturition while samples 
from their mares were seronegative; these values ranged from 55.2 EU to 155.7 EU.  Of 
these 41 foals, 35 had received Rhodococcus equi hyperimmune plasma.  A variety of R. 
equi hyperimmune plasmas given to study foals were tested for L. intracellularis-specific 
antibodies and found to vary greatly; an average EU value of 130 EU was noted, although 
samples ranged from negative (<55EU) to a maximum of 919 EU.  Passively-acquired 
antibodies to L. intracellularis above the 55EU cutoff were not detected in foals beyond 
the third collection (2 months of age), although two foals from the same farm (Farm 14) 
appeared to seroconvert during April and May (data not shown) as their mare and prior 
samples had been negative.   
 From the initial 453 mare and foal pairs, a total of 369 study horses were present 
through at least October 2012 and included in the final statistical analysis.  Information 
regarding individual farms with respect to the number of study horses present through at 
least October, the number of presumptive EPE cases and suspect infected horses, and 
farm-specific seroprevalence from August 2012 to February 2013 is included in Table 
3.1.  Also included in Table 3.1, if available, is the previous year’s seroprevalence for  
 
 
Table 3.1: Pertinent information regarding individual farms including the study-period seroprevalence and previous year's 
seroprevalence, if available. 
Farm 
Number 
Initial # of 
Study 
Horses 
# of Study Horses 
Present Through At 
Least October 
# of 
Presumptive 
EPE Cases 
# of Suspect, L. 
intracellularis 
Cases 
Study Period 
Seroprevalence 
Previous 
Year's 
Seroprevalence 
1 16 7 0 0 50.0% 60.0% 
26 128 92 44 2 55.4% 56.7% 
3 15 15 0 0 11.8% 27.8% 
4 30 19 0 2 68.0% 71.9% 
5 9 8 0 0 70.0% 20.0% 
6 39 38 2 4 73.7% 23.6% 
7 4 4 0 0 25.0% 75.0% 
8 28 28 1 0 52.9% 28.1%1 
9 17 16 2 1 77.8% 72.2%2 
11 10 10 1 1 36.4% 57.1%3 
12 11 10 0 1 80.0% 33.3%3 
13 & 14 109 89 15 0 36.4% N/A 
156 21 18 0 2 72.7% N/A 
166 16 15 0 0 75.0% N/A 
1 Samples collected early October to January 2012 
    2 Samples collected late October to January 2012 
    3 Samples collected late November to January 2012 
    4 One presumptive EPE case occurred in March 2013 and another in April- both were included in the data set 
5 The presumptive case of EPE was euthanized and a necropsy could not be performed in a timely manner 
6 Farm had at least one case of presumptive EPE in a non-study horse 
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each farm, which was collected with methods similar to as above from September 2011 
to January 2012.  
 The combined seroprevalence for all study horses was 56.4% (208 seropositive 
horses) while farm-specific seroprevalences ranged from 11.8% to 80% (Table 3.1).  
Figure 3.1 shows the monthly percentage of previously seronegative horses that 
seroconverted during a given month where peak seroconversion rates were noted in 
October and January.  Additionally, the cumulative percentage of all seropositive study 
horses during a given month is also included on Figure 3.1.  Seroconversion data from 
each of the previous three years (2010-11, 2011-12, and 2012-13), using approximate 
dates for comparison, are provided in Figure 3.2.  Figure 3.3 shows a representation of 
first-time seroconversions from the current study by each farm's geographic region and 
Figure 3.4 is provided to demonstrate the respective geographic regions. 
 During the study, a total of 11 horses developed presumptive EPE (3.0% of all 
study horses and 5.3% of seropositive horses) while an additional 13 developed suspected 
L. intracellularis infection (3.5% of all study horses and 6.3% of seropositive horses).  
Two horses from Farm 2 developed presumptive EPE outside of the scheduled serum 
screening period (one in March 2013 and another in April 2013) but were included in the 
presumptive EPE data set as they met the criteria for inclusion.  Tables 3.2 and 3.3 
contain signalment and other pertinent information for the presumptive EPE and suspect 
infected horses, respectively. 
 Total protein and albumin values for the four classification groups were analyzed 
using one-way ANOVA with significant differences noted for total protein and albumin  
 
 
 
Figure 3.1: Monthly seroconversion rate and the monthly total percentage of seropositive horses. 
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Figure 3.2: Regional seroconversion data from 2010-11,20 2011-12, and 2012-13. Dates are approximate. 
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Figure 3.3: 2012-13 seroconversion data based on each farm's geographical location. 
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Figure 3.4: Approximations of the geographical categories used in Figure 3.3.  The map has been modified from Google Earth. 
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Table 3.2: Signalment and other pertinent information from study horses with presumptive EPE. 
Horse 
ID Farm DOB Sex IgG 
High-
IgG 
Plasma 
R. equi 
Plasma 
R. equi 
Treatment 
Weaning 
Month 
Mare 
EU 
Value 
Initial 
Foal EU 
Value EPE Date 
Total 
Protein 
(g/dL) 
Albumin 
(g/dL) 
075 2 3/10/12 Colt >800 No Yes No August Neg Neg 12/29/12 3.6 2.5* 
109 2 2/25/12 Colt >800 No Yes No July 83 82.6 3/18/13 3 1.6 
111 2 3/29/12 Filly >800 No Yes No August Neg Neg 2/8/13 3.8 2.1 
137 2 3/24/12 Colt >800 No Yes No August Neg Neg 4/3/13 3 1.2 
249 6 4/9/12 Colt 
Not 
Reported No Yes No Sept Neg Neg 10/16/12 3.2 2.3 
253 6 3/1/12 Filly >800 No Yes No July Neg Neg 10/15/12 2.6 1.4 
359 8 2/8/12 Colt >800 No Yes No July 92.2 309 12/31/12 2.5 1.1 
366 9 4/12/12 Colt >800 No No No August Neg Neg 10/8/12 3.7 2.2 
371 9 5/3/12 Colt >800 Yes No No August Neg Neg 10/21/12 3.8 2 
596 11 2/3/12 Colt >800 No No No July 89.4 59.6 10/15/12 3.6 1.7 
505 14 5/27/12 Colt 400-800 No Yes No Sept Neg Neg 1/27/12 2.6 1.2 
              *No albumin result was reported immediately after clinical signs were noted. The value 
reported here was recorded 2 weeks after the onset of clinical signs and not included in data 
analysis.  
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Table 3.3: Signalment and other pertinent information from study horses with suspected L. intracellularis infection. 
Horse 
ID Farm DOB Sex IgG 
High-
IgG 
Plasma 
R. equi 
Plasma 
R. equi 
Treatment 
Weaning 
Month 
Mare 
EU 
Value 
Initial 
Foal 
EU 
Value 
Date of 
Diagnosis 
Total 
Protein 
(g/dL) 
Albumin 
(g/dL) 
060 2 4/17/12 Colt >800 No Yes No October 95.3 Neg 1/14/13 4.6 2.8 
101 2 1/16/12 Colt >800 No Yes No June 96.2 146 2/11/13 5 2.9 
225 4 2/13/12 Filly 400-800 No Yes Yes August 58.5 Neg 12/19/12 5 3 
230 4 2/14/12 Colt >800 No Yes No June 59.8 67.7 12/19/12 5.2 3.1 
255 6 3/11/12 Filly >800 No Yes No August Neg Neg 9/25/12 4.6 2.8 
265 6 2/28/12 Filly >800 No Yes No July Neg Neg 10/23/12 5 2.9 
276 6 2/8/12 Colt >800 No Yes No June Neg Neg 10/23/12 5.2 2.9 
282 6 4/10/12 Colt >800 No Yes Yes August 61.7 159 12/19/12 5.2 2.9 
375 9 2/8/12 Colt >800 No No Yes May Neg Neg 10/23/12 5.1 2.7 
399 11 3/9/12 Filly >800 No No No August Neg Neg 10/23/12 5 3.1 
420 12 3/29/12 Colt 
Not 
Reported No No No August Neg Neg 10/23/12 4.8 2.3 
588 15 2/6/12 Colt >800 No Yes No July 106 123 10/23/12 4.8 2.8 
589 15 2/14/12 Colt 400-800 No Yes No July Neg Neg 10/23/12 5 3.1 
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between all of the groups except seronegative and seropositive (Figures 3.5 and 3.6).  
Table 3.4 provides values for each group, including minimum and maximum values 
observed, as well as the 95% confidence interval for each group.  While there was an 
overlap in the confidence intervals between suspect infected and seronegative horses, 
there were no seronegative horses that had values for both total protein and albumin 
outside the calculated confidence interval, nor were there any outside the reference range 
used for group classification (TP <5.3 g/dL and albumin <3.2 g/dL). 
 One-way ANOVA was used to examine the different seropositive groups 
(presumptive EPE, suspect infected, and seropositive-only) for differences in ages at 
weaning and seroconversion, as well as the amount of time elapsed between weaning to 
seroconversion.  Table 3.5 has values for each group, as well as an average of the three 
groups with respect to time from weaning to seroconversion and age at seroconversion.  
No significant differences were noted between the three groups; however, there was a 
significant difference (p<0.001) between the mean age at weaning between seronegative 
and all seropositive horses (152 days vs. 144 days, respectively).  The earliest detectable 
exposure to L. intracellularis occurred 8 days prior to weaning and the latest at 258 days 
after weaning while the overall average of time from weaning to seroconversion between 
the three groups was 125 days.  The youngest horse to seroconvert during the fall and 
winter months was 150 days old and the oldest 392 days old while the average age at 
seroconversion was 178 days (approximately 6.5 months). 
 The effect of passively-acquired antibodies on time to seroconversion in study 
horses was examined using a Kaplan-Meier curve (Figure 3.7) and no differences were 
noted between those foals that were seropositive versus seronegative immediately after 
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Figure 3.5: Total protein data from study horses based on their categorization. 
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Figure 3.6: Albumin data from study horses based on their categorization.
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Table 3.4: Minimum, maximum, and calculated 95% confidence intervals for total 
protein and albumin based on study horse categorization. Units are g/dL. 
TOTAL PROTEIN Reported Calculated 
Classification Minimum Maximum 
Low 
95% CI 
High 
95% CI 
Presumptive EPE 2.5 4 2.1 4.3 
Suspect LI Infection 4.6 5.2 4.6 5.4 
Seronegative 5.2 7 5.1 6.3 
Seropositive 5.2 6.9 5.2 6.4 
     ALBUMIN Reported Calculated 
Classification Minimum Maximum 
Low 
95% CI 
High 
95% CI 
Presumptive EPE 1.1 2.3 0.8 2.5 
Suspect LI Infection 2.3 3.1 2.4 3.3 
Seronegative 3.1 3.8 3.1 3.8 
Seropositive 2.9 3.8 3.0 3.8 
 
 
Table 3.5: Ages (in days) for the various horse classification categories. 
 
Presumptive 
EPE 
Suspect, L. 
intracellularis 
infection 
Seropositive 
Only1 
Average of 
All 
Seropositive 
Horses 
Seronegative 
Horses 
Average Age at Weaning 144 145 144 144 152 
Median Age at Weaning 149 147 144 145 152 
Standard Deviation Age at Weaning 19 23 21 21 22 
Minimum Age at Weaning 103 83 59 59 109 
Maximum Age at Weaning 164 177 213 213 213 
      Average Time from Weaning to Seroconversion 134 118 122 125 N/A 
Median Time from Weaning to Seroconversion 144 102 118 122 N/A 
Standard Deviation Time from Weaning to Seroconversion 67 52 49 57 N/A 
Minimum Time from Weaning to Seroconversion 32 54 -8 -8 N/A 
Maximum Time from Weaning to Seroconversion 234 240 258 258 N/A 
      Average Age at Seroconversion 277 263 269 266 N/A 
Median Age at Seroconversion 262 257 267 263 N/A 
Standard Deviation Age at Seroconversion 75 50 52 56 N/A 
Minimum Age at Seroconversion 172 197 150 150 N/A 
Maximum Age at Seroconversion 387 392 392 392 N/A 
1 Does not include two foals from Farm 14 that may have been exposed during April and May 
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Figure 3.7: Survival analysis of seroconversion time-point based on the foal's post-
partum antibody status.  Time-points are 1= July, 2=August, 3=September, 
4=October, 5=November, 6=December, 7=January, and 8=February. 
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birth.  Further, Cox proportional hazards analysis revealed no significant effect of either 
post-partum maternal or foal antibody status on the timing of seroconversion (data not 
shown).   
 Multiple logistic regression analysis of data obtained for each study horse was 
performed using the occurrence of presumptive EPE, suspected L. intracellularis 
infection, and a combination of presumptive EPE or suspected L. intracellularis infection 
as the dependent variables.  P-value results and odds ratios calculated from the analysis 
are included in Table 3.6.  Of the parameters analyzed, colts were at a significantly 
greater risk for the development of presumptive EPE (p=0.038, odds ratio 5.299) or a 
combination of presumptive EPE or suspected infection (p=0.006, odds ratio 3.861).  
There was a trend (p=0.086, odds ratio 2.955) for colts to be at greater risk of developing 
suspect L. intracellularis infection.  Additionally, those horses that were weaned in 
September or later months were at a significantly lower risk of developing a combination 
of either presumptive EPE or suspected infection (p=0.047, odds ratio 0.281).  Thirty-
eight study foals were treated for suspected Rhodococcus equi infection during the study, 
and while the use of hyperimmune R. equi plasma did not affect the occurrence of EPE, 
there was a trend for R. equi treatment to have a positive effect on the occurrence of 
suspected L. intracellularis infection (p=0.076, odds ratio 3.69). 
 
 
 
 
 
 
 
 
Table 3.6: Odds ratios calculated from multiple logistic regression analysis.  The parameter in () was analyzed as the positive 
response. 
 
Dependent Variable 
LOGISTIC REGRESSION ODDS RATIO Presumptive EPE 
Suspect, L. 
intracellularis 
infection 
Both Presumptive 
EPE & Suspected L. 
intracellularis 
Infection 
Sex (Colt) 5.299** 2.955* 3.861*** 
R. equi Plasma (Yes) 0.466 0.804 0.602 
High IgG Plasma (Yes) 2.298 0 0.89 
R. equi Treatment (Yes) 0 3.69* 1.393 
Weaning Month (Sep-Nov vs. May-Aug) 0.444 0.168* 0.281** 
Mare EU value at Parturition (Positive) 0.608 2.067 1.159 
Foal EU value at Parturition (Positive) 0.666 0.402 0.507 
    * p<0.1, **p<0.05, ***p<0.01 
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Discussion 
 
 Recognition of a necrotizing form of equine proliferative enteropathy,9 as well as 
previous work suggesting a significant economic impact of EPE,11 emphasizes the 
importance of understanding the principles of infection and immunity to L. intracellularis 
in horses.  Despite the decline of passively-acquired antibodies (especially maternally 
derived antibodies) as a possible explanation for the susceptibility of weanlings to L. 
intracellularis infection, very little work in any species has examined this possibility.  
Here, relying on a large field study with naturally occurring cases, we have examined the 
effect of passively-acquired antibodies and found that they do not have a significant 
effect on the occurrence of EPE or suspected L. intracellularis infection.  Further, we 
have identified and documented an accurate disease attack rate for EPE and shown that 
weanling/yearling age does not appear to be a risk factor for the occurrence of clinical 
EPE or L. intracellularis infection.   
 While only three of the eleven (27.3%) presumptive EPE cases and four of the 
thirteen (30.8%) suspected L. intracellularis infections had detectable, passively-acquired 
L. intracellularis-specific antibodies following birth, these proportions were similar to the 
total percentage of seropositive foals following birth (38%).  The overall percentage of 
mares that were seropositive at parturition (44.2%) was lower than had been expected, 
especially given that L. intracellularis appears to have become a relatively ubiquitous 
organism on many farms in central Kentucky and previous work by others has found 
seropositive rates in adult horses from 55-90+%.19,20,107,108  One potential confounding 
factor in this study was the prevalent use of Rhodococcus equi hyperimmune plasma on 
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many of the farms.  We believe that this plasma, which contained variable levels of L. 
intracellularis-specific antibodies, may have affected the initial post-partum foal 
antibody levels.  In fact, 35 of the 41 foals with seropositive post-partum samples while 
their mare's corresponding sample was seronegative received R. equi hyperimmune 
plasma.  Of the six remaining foals with positive values, their mare's L. intracellularis 
antibody levels likely fell slightly below the cutoff (55EU) and, thus, were reported as 
negative.  While data analysis failed to demonstrate an effect of the R. equi plasma on the 
occurrence of EPE, we opted to refer to the L. intracellularis-specific antibodies that 
were measured post-partum as passively acquired to account for those that were 
potentially obtained through hyperimmune plasma administration, rather than just from 
colostrum intake.   
 Gender was found to have a significant effect on the occurrence of EPE, with 
colts being significantly more likely to develop presumptive EPE or a combination of 
presumptive EPE or suspected infection.  Out of the 369 study horses present in that data 
analysis, 164 were colts, 177 were fillies, and 28 were not reported.  It is important to 
note that while data analysis indicated an increased risk for colts, fillies also developed 
both presumptive EPE and suspected L. intracellularis infections during the study and 
there have been numerous case reports of EPE in fillies as well.9,11,31,109  There was a 
trend (p=0.076) for those horses that were treated as foals for R. equi to be at greater risk 
(odds ratio 3.69) of developing suspect infections than those horses not treated for R. 
equi.  Likewise, there were no presumptive EPE cases that were treated for R. equi as 
foals.  While a larger sample set is needed to examine this further, it is possible that prior 
infection with R. equi may have some protective effects against L. intracellularis 
86 
 
infection given that they are both intracellular bacteria and likely require a competent 
interferon-gamma response by the immune system to clear the infection (see Chapter 5 
below).10,110,111  Prior R. equi infection may prime the foal's immature immune system 
such that, when challenged with L. intracellularis, the immune system is capable of 
recognizing the intracellular bacterium and responding appropriately.  Further study into 
the possibility of cross-protection, using either naturally occurring field cases or 
experimentally challenged horses, is warranted. 
 Interestingly, when looking for an effect of weaning date on EPE occurrence, 
those horses weaned between September and November were at a significantly lower risk 
of developing combined presumptive EPE and suspected L. intracellularis infection 
when compared to those horses weaned between May and August.  The reason for this 
difference is not immediately clear and testing over additional years is needed to identify 
whether this is a recurring predilection or a one-time occurrence.  One possible 
explanation could be that mares provide an unknown protective effect for their foals.  By 
not being weaned until during or after an exposure period (such as what was seen in this 
study during October), the late-weaned foals may be shielded from exposure.   
While clinical EPE is exceedingly rare in nursing foals, it appears as though several study 
horses were exposed to the bacterium prior to weaning since it takes approximately 14 
days for seroconversion to occur following exposure;10,39 in addition to the two foals that 
seroconverted during April and May while still on their mares, one seropositive horse 
seroconverted 8 days prior to weaning while two other horses seroconverted 9 and 10 
days after weaning (data not shown).  With prior work suggesting that horse-to-horse 
transmission of L. intracellularis is possible,39 as well as the suggestion that sows may 
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serve as a reservoir for the bacterium, 59 mares may play a role in the epidemiology of 
EPE, a possibility that is explored in Chapter 4. 
 Given that there were no significant differences in age at weaning and 
seroconversion or in the time from weaning to seroconversion between the three 
seropositive groups, it would appear that age does not play a factor in the development of 
EPE or L. intracellularis infection when exposed to the bacterium.  While it was found 
that seronegative horses were significantly older (by 8 days) at weaning than seropositive 
horses, there is no readily apparent explanation for this finding other than what has been 
mentioned above.  It seems unlikely that an additional 8 days with its mare would provide 
complete protection from detectable L. intracellularis exposure in the months following 
weaning, however, a large, risk-factor based study would be needed to examine this 
beyond the scope of what has been presented here. 
 We previously reported a regional seroprevalence of 68%,20 while in the study 
reported here the overall seroprevalence was 56.4%.  Given the preference to include 
those farms with prior EPE, neither of these rates are indicative of the overall 
seroprevalence rate in central Kentucky; instead, farm-specific seroprevalence levels 
allow for a better examination of L. intracellularis exposure.  To that end, the farm-
specific seroprevalences reported here, which ranged from 11.8-80%, were similar to 
those we have reported earlier where values ranged from 14-100%.20  Interestingly, the 
bimodal distribution of exposure noted in the previous study (2010-11) was again noted 
here (2012-13), with peak exposures in October and January, while only a single peak of 
exposure for the entire central Kentucky region was seen in 2011-12.  Upon examining 
the location of the current study's farms, it is evident that there is only a single peak of 
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exposure for each region in a given season.  Potential reasons for the regional differences 
include management practices, vaccination schedules, reservoir and/or wildlife 
population changes/fluctuations, and weather patterns.  For those farms with 
seroprevalence data available from the prior year, the change in seroprevalence was 
varied, with some farms experiencing large increases or decreases, while others remained 
static; no immediate reasons for these changes were evident, however, this study was not 
designed to examine for differences between farms.  In-depth examination of the 
potential reasons behind the regional and year-to-year farm exposure differences might 
help to identify potential risk factors for L. intracellularis exposure and/or the reservoir 
host(s) of the bacterium.   
 The fall and winter months (October through February) continue to be the primary 
time during which exposure to L. intracellularis is detected and when the majority of 
EPE cases occur in central Kentucky.  However, the occurrence of EPE cases beyond 
February,20 including the March and April 2013 cases reported here, suggest that this 
range should be extended.  Further, the apparent seroconversion of two nursing foals in 
April and May of 2012, while only a fraction of the entire study population, would also 
seem to support this assertion.   
 Hypoproteinemia with hypoalbuminemia has long been recognized as a common 
occurrence with EPE and is unique amongst the species L. intracellularis infects.  This 
upset in total protein and albumin levels is what leads to dependent edema, one of the 
non-specific but common findings with EPE cases.  Prior to data analysis and based on 
our clinical experience, we set the ranges listed above (TP: <4.5g/dL and 4.5-5.2 g/dL, 
albumin: <2.5g/dL and 2.5-3.1 g/dL) for presumptive EPE cases and suspect L. 
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intracellularis-infected horses, respectively.  Not surprisingly, total protein and albumin 
were significantly different between the various groups, except for those differences 
between seronegative and seropositive-only horses.  Further, the values that we set prior 
to analysis held up fairly well when compared to the calculated 95% confidence interval 
values.  Although variations in sample analysis will exist between methods and 
laboratories, the references ranges we have provided for presumptive EPE (TP <4.5 g/dL 
and albumin <2.5 g/dL) and suspected infection (TP 4.5-5.2 g/dL and albumin 2.5-3.1 
g/dL) cases appear to provide a good starting point for the classification of EPE cases.  
While there were several seronegative and seropositive horses with either total protein or 
albumin values below the reference ranges used here, none of them had concurrent 
hypoproteinemia and hypoalbuminemia, stressing the importance of evaluating both 
parameters in tandem.  There can be several other causes of low total protein and albumin 
in young horses, and given that total protein and/or albumin have been targeted as a 
cheap and effective means of screening for EPE (including weekly screening of total 
protein by one farm in this study), it remains important to follow-up abnormal values 
with serologic screening prior to initiating treatment for L. intracellularis infection. 
 A point of discussion for several years has been how infrequently clinical disease 
occurs in weanling and yearling horses exposed to L. intracellularis.  While this study 
sought to examine some of the potential risk factors for EPE, another goal was to 
determine the disease and infection rate among exposed horses.  Traditionally, estimates 
of 5-10% of clinical EPE in seropositive horses have been used, but this assumption has 
never been proven in a large scale, field study before.  Much like the overall 
seroprevalence we reported above, the attack rates amongst the entire study population 
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should be used with caution as the preferential inclusion of EPE endemic farms likely 
introduced a sampling bias.  Among L. intracellularis-exposed horses, we found a 
clinical EPE attack rate (using the presumptive EPE cases) of 5.3% and an infection 
attack rate (using cases with suspected infections) of 6.3%; combined, there was an 
overall attack rate of 11.6% among seropositive horses.  Current experimental L. 
intracellularis challenge models in horses induce clinical EPE at a rate of 33% or 
higher,10,39,57 suggesting that these models fail to mimic natural exposure to the bacterium 
and likely over-expose horses to elicit disease.  With this newly documented attack rate, 
it should be possible to refine the experimental challenge models used to induce EPE, 
likely by decreasing the challenge doses, such that they more closely mimic natural 
disease. 
 By showing that passively-acquired antibodies specific for L. intracellularis failed 
to have a significant, protective effect against the occurrence of EPE, we have eliminated 
a potential explanation for the unique predisposition of young horses to EPE.  Given that 
passively-acquired IgG is short-lived, IgG is the predominant immunoglobulin in 
colostrum and hyperimmune plasma products, and L. intracellularis infection is not a 
systemic infection but rather a localized, mucosal infection, it is not surprising that no 
significant effect of passively-acquired antibodies was noted in this study.  Other 
potential reasons for weanling predisposition to EPE continue to include management 
changes associated with weaning and the post-weaning period (including stress), loss of 
maternally-derived nutrition and immunological factors (i.e. IgA), and the immune 
response to intracellular infection.  Based on the findings presented here, age does not 
appear to have an effect on EPE occurrence amongst seropositive horses while age at 
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weaning might have an effect on seroconversion.  Colts were found to be significantly 
more at risk for the development of EPE and L. intracellularis infection, however, fillies 
do account for many clinical cases of EPE.  The identification of geographical exposure 
differences within a relatively small area is a novel finding that warrants further 
exploration as the reason(s) behind this difference may provide the first clues towards 
understanding the epidemiology of L. intracellularis infections on horse farms.  Even 
though the disease rate demonstrated here (approximately 11% of seropositive horses) is 
relatively low compared to other equine diseases, the growing economic and welfare 
aspects of EPE suggest that it is a disease which should not be ignored. 
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CHAPTER FOUR: 
Determining whether mares play a role in the epidemiology of Lawsonia 
intracellularis and equine proliferative enteropathy on an endemic farm 
 
Summary 
 
 The epidemiology of equine proliferative enteropathy is poorly characterized, 
although it is known that a large number of animal species are capable of shedding 
Lawsonia intracellularis in feces.  Recently it has been suggested that horse-to-horse 
transmission of the bacterium may be possible, although no work has examined the role 
mares may play in the epidemiology of EPE.  The goal of this study was to utilize 
serological screening to detect exposure to L. intracellularis.  Serum samples were used 
to determine whether mares show signs of exposure to the bacterium prior to their foals 
and whether seropositive mares were more or less likely to have seropositive 
foals/weanlings.  Ultimately, 95 mares and 91 foals from a central Kentucky 
Thoroughbred farm with endemic EPE were utilized for this study and all foals were 
weaned by the end of October.  Serum samples were analyzed using an equine-validated 
ELISA for L. intracellularis.  Chi-square analysis found that those mares with 5 or more 
seropositive months through October had a significantly higher number of 
foals/weanlings with evidence of exposure to the bacterium and these foals were 5.667 
times more likely to be seropositive from July 2012 through January 2013 of their 
yearling year than those foals from mares with fewer than 5 seropositive months through 
October.  There was no effect of mare sero-status on the occurrence of presumptive EPE 
or suspected L. intracellularis infection in their offspring.  While this study found that 
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previously seronegative mares and weanlings experienced similar seroconversion events 
in December and January, a role for mares in the epidemiology of EPE or spread of L. 
intracellularis could not be ruled out based on the results of this study.   
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Introduction 
 
 Lawsonia intracellularis is the causative agent of equine proliferative enteropathy 
(EPE),14 a disease typically seen in weanlings and young yearling horses during the fall 
and early winter months.11  The most common clinical signs observed with EPE include 
anorexia, fever, depression, dependent edema, colic, and diarrhea.  Diagnosis revolves 
around the presence of clinical signs, clinicopathologic disturbances including 
hypoproteinemia and hypoalbuminemia, and thickened small intestinal segments detected 
via abdominal ultrasound.  Additional antemortem tests for the detection of L. 
intracellularis infection include analysis for presence of the pathogen shed in feces by 
use of an L. intracellularis–specific PCR assay and analysis of serum samples for 
bacterium-specific antibody detection.   
 With respect to the epidemiology of L. intracellularis, a fecal-oral route of 
infection is suspected, and what little else is known has been primarily discovered 
through research with porcine PE and extrapolated into other species.  In addition to 
horses, pigs, and hamsters, several studies have revealed the presence of L. intracellularis 
a variety of species, including blacktailed jackrabbits, cottontailed rabbits, cats, striped 
skunks, Virginia opossums, coyotes, guinea pigs, mice, rats, hamsters, hedgehogs, ferrets, 
rabbits, wild pigs, dogs, foxes, calves, wolves, deer, ostriches, emus, monkeys, and 
giraffes.1,45-47  Thus far, attempts to incriminate any of these species in the spread or 
maintenance of L. intracellularis within susceptible populations have only been 
suggestive and not proven conclusively; this includes a recent study in which weanling 
horses were challenged with feces from L. intracellularis-infected rabbits.44  In that 
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study, the challenged horses failed to develop EPE, however they did seroconvert 
following challenge.  Work with porcine PE has, however, implicated subclinically 
affected pigs in the spread of the bacterium in swine operations 52 and recent work with 
EPE has suggested a role for clinically affected horses.39  Further, some have suggested 
the potential for sows to harbor and transmit the bacterium to their offspring,59 an aspect 
of which has never been examined with EPE.  Given that most Thoroughbred foals are 
co-housed in stalls with their respective mares for multiple hours per day, as well as the 
propensity for foals to exhibit coprophagic tendencies, it seems tenable that mares could 
act as asymptomatic shedders of the bacterium and expose their foals to L. intracellularis 
prior to weaning. 
 The goal of this study was to utilize monthly serum sampling of mares and foals 
on an EPE endemic farm to detect exposure to L. intracellularis and determine whether 
mares show signs of exposure to the bacterium prior to their foals.  Additionally, we 
sought to determine whether seropositive mares were more or less likely to have 
seropositive foals/weanlings.  Should we show that mares may play a role in the exposure 
of foals/weanlings to L. intracellularis, this finding would warrant further exploration 
with regards to the epidemiology of EPE, as well as examination of potential steps for 
mitigation of this exposure as a means of decreasing equine proliferative enteropathy. 
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Materials and Methods 
 
Study Farms and Horses 
 A Thoroughbred farm in central Kentucky, located within 20 miles of the 
University of Kentucky, was enrolled in this study, which took place from January 2012 
through January 2013.  The farm was considered endemic for EPE as it experienced 
multiple (3+) cases of clinical EPE in each of at least the three prior years.  Approval to 
conduct this study was obtained from the University of Kentucky's Institutional Animal 
Care and Use Committee and forms documenting informed consent for inclusion of 
privately-owned horses were obtained from the farm veterinarian, who was authorized to 
act on behalf of private owners. 
 
Sample Collection, Processing, and Storage 
 Within 48hrs of parturition, whole blood samples (7 mls of peripheral blood 
collected via aseptic venipuncture from the jugular vein) were collected from the mare 
and newborn foal and allowed to settle in a refrigerator at 4oC.  Samples were labeled 
with the mare/foal’s name and the date of collection.  After collection, samples were 
stored at 4oC on the farm until returned to the Maxwell H. Gluck Equine Research Center 
at the University of Kentucky for centrifugation (800g x 10min) followed by freezing of 
serum at -20oC.    
 After the initial collection time point, samples were subsequently collected 
approximately every four weeks from each mare and foal through the middle of July, as 
described above.  Starting at the end of July, all study horses (mares and foals) had blood 
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samples collected during the same three day period every four weeks to ensure that all 
horses were sampled during the same time period.  These samples were transported to the 
Gluck Equine Research Center and immediately centrifuged at 800xg for 10 min.  
Foal/weanling samples were held at 4oC for no more than 4 days before all samples were 
analyzed each month, as below, while mare samples were frozen at -20oC.  After the final 
collection of blood samples in January, samples from each mare were thawed and run 
concurrently on the same plate using an L. intracellularis-specific ELISA (see below). 
 
Detection of L. intracellularis-specific antibodies 
 Serological status in regards to L. intracellularis was determined using the ELISA 
method as previously described (see also Chapter 2),20 except that plates were blocked 
with polyvinyl alcohol 1% (w/v) in distilled water for one hour instead of two hours.  
Results from the tested sera were converted to an ELISA unit (EU) utilizing a linear 
regression line from the standard curve generated from each plate.  A positive cut-off of 
55EU or greater was utilized based on previous work.10  
 
Classification of Study Horse EPE Status 
 At the end of the study, horses were placed into four categories to describe their 
L. intracellularis/EPE status following the typical L. intracellularis "season" of October 
to February: presumptive EPE, suspect L. intracellularis-infected, seropositive, or non-
exposed.  Based on our previous work,20 presumptive EPE affected horses were those 
that experienced concurrent clinical signs compatible with EPE, moderate to severe 
hypoproteinemia (<4.5g/dL) and hypoalbuminemia (<2.5g/dL), and a positive L. 
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intracellularis-specific ELISA result.  For the purpose of this study, compatible clinical 
signs for EPE were anorexia, fever, lethargy, depression, dependent edema, rapid weight 
loss, colic, and diarrhea.  Given that definitive diagnosis of EPE can only be made at 
necropsy and relies upon the immunohistochemical (IHC) detection of the organism in 
characteristic intestinal lesions,31 all clinical diagnoses of EPE were considered 
presumptive.  Suspect L. intracellularis-infected horses were those with mild 
hypoproteinemia (4.5-5.2 g/dL) and hypoalbuminemia (2.5-3.1 g/dL) plus a positive L. 
intracellularis-specific ELISA result without concurrent clinical signs compatible with 
EPE.  L. intracellularis-infected horses can experience a transient decrease in total 
protein and albumin levels along with a positive L. intracellularis-specific ELISA result 
in the absence of other clinical signs.10,39  However, since there was no demonstration of 
the presence of L. intracellularis (either via fecal PCR or necropsy sampling), these cases 
are referred to as "suspect L. intracellularis-infected".  Seropositive horses were those 
with only a positive L. intracellularis-specific ELISA result (excluding passively-
acquired L. intracellularis antibodies) and no other indication of L. intracellularis 
infection.  Horses with no detectable L. intracellularis-specific antibodies for the entirety 
of the study (excluding passively-acquired antibodies) were classified as seronegative. 
 
Data Analysis 
 Fisher's exact test was used to determine whether mare serological status had an 
effect on the occurrence of EPE while Chi-square and risk factor analysis were used to 
determine whether the number of seropositive months a mare experienced had a 
significant effect on seroconversion in her foal.  Additionally, survival analysis (Kaplan-
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Meier) was used to detect an effect of mare serological status on foal seroconversion.  
Calculated P values <0.05 were considered to be statistically significant.   
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Results 
 
 Initially, 130 mare and foal pairs were enrolled in this study, however only 95 
mares and 91 foals were ultimately included in the final data analysis as they were 
present on the farm from parturition through at least October.  Of the 95 mares, 42 
(44.2%) were seropositive (≥55EU) at parturition, which ranged from January through 
May, while a total of 67 mares (70.5%) were seropositive at some point during the study.  
There was an overall decline in the percentage of mares that were seropositive for L. 
intracellularis-specific antibodies over the course of the study from January 2012 to 
January 2013 (Figure 4.1).  The total number of positive samples varied, with 29.5% of 
mares remaining seronegative across all of their samples while a total of 46.3% of mares 
were seropositive for six or more months during the study (Table 4.1).  The average mare 
seropositive ELISA value was 108.1EU while the maximum during the study was 
1106.3EU. 
 To allow for easy comparison of antibody levels between mares, mare EU values 
were standardized to a fold-change scale by dividing each month's value by the first 
result that was reported for that mare; if the first recorded result was negative, a 
numerical value of 54.9 EU was assigned while all negative values were disregarded 
when averaging positive EU fold changes.  Figure 4.2 demonstrates the monthly average 
fold changes that were noted amongst the mare samples (a fold change of 1 is equal to no 
change).  Also included on Figure 4.2 are the first-time seroconversions for mares and 
weanlings which were used as an indicator of exposure to the bacterium.  Mares had to 
have been 
 
 
 
Figure 4.1: Total percentage of study mares that were seropositive during a given month and the average monthly positive EU  
value. 
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Table 4.1: The number and percentage of study mares that were either seronegative for the entirety of the study or 
seropositive for a range of months. 
 
Negative 
Positive for <3 
months Positive for 3-5 months Positive for 6-9 months 
Positive for 10+ 
months 
Number of Mares 28 17 6 31 13 
Total Percentage 29.5% 17.9% 6.3% 32.6% 13.7% 
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Figure 4.2: Mare EU fold changes by month, as well as mare and foal seroconversion percentages.
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seronegative since the beginning of the study and for the two following samplings for a 
subsequent positive sample to be considered seroconversion resulting from exposure to L. 
intracellularis.  Peak fold changes amongst previously seropositive mares were noted in 
June to August, November, and January while small peaks in mare seroconversion were 
noted in July and October, with a large peak in mare seroconversion seen in January.  
Small increases in foal/weanling seroconversion occurred in June and July (0.8% of foal 
population) and November (1%) while large increases in seroconversion occurred in 
December and January.  All study foals were weaned by the November sample 
collection. 
 Chi-square analysis determined that those mares with 5 or more seropositive 
months through October had a significantly higher number of foals/weanlings with 
evidence of exposure to the bacterium between July and January (p<0.001).  Further, 
foals/weanlings from mares with 5 or more seropositive months through October were 
found to be 5.667 times more likely to be seropositive from July through January than 
those from mares with fewer than 5 seropositive months through October.  No significant 
effect of mares with 5 or more seropositive months through October was noted on the 
occurrence of presumptive EPE or suspected L. intracellularis infection.  Based on 
survival analysis, no significant difference in the time to seroconversion was noted 
between foals/weanlings from mares that were seropositive versus seronegative from 
parturition through October (Figure 4.3). 
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Figure 4.3: Survival analysis of the time to foal seroconversion based on whether the 
foal's mare was seropositive or seronegative through October. Time-points are 1= 
July, 2=August, 3=September, 4=October, 5=November, 6=December, and 
7=January. 
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Discussion 
 
 Amongst the many aspects of Lawsonia intracellularis infections that have been 
researched in the years since the bacterium's discovery, maintenance within a population 
and spread from animal to animal remains one of the most poorly characterized.  Here we 
have utilized an ELISA to screen mares and their foals for exposure to L. intracellularis 
and examined for a potential effect of seropositive mares on their foals with respect to 
seroconversion or the occurrence of clinical EPE/L. intracellularis infection.  Based on 
results of this study, we were unable to rule out mares as possible sources of L. 
intracellularis infection for their foals. 
 Based on the endemic EPE status of the farm used in this study (Farm 21 in 
Chapter 2 and Farm 2 in Chapter 3), as well as work by others that has shown 99% of 
adults to be seropositive for L. intracellularis antibodies,108 the fact that only 70.5% of 
the mares reported here were seropositive during the study was surprising.  Regardless, 
the reporting of high L. intracellularis exposure in adult horses continues to suggest 
regular exposure of horses, regardless of age, to the bacterium, as well as the potential for 
adults to serve as asymptomatic carriers/shedders of L. intracellularis.  Further, finding 
46.3% of the mare study population to be seropositive for 6 or more months while 13.7% 
was seropositive for 10 or more months may indicate either regular exposure or 
prolonged exposure to the bacterium, such as would be seen in a carrier state.  EPE has 
long been known to be a disease of young horses and, while the ELISA used in this study 
utilizes a cut-off value validated for use in the at risk population,10,20 it is reasonable to 
expect exposure of adults to the bacterium on farms with affected young horses.  Given 
107 
 
that we reported seronegative mares and weanlings towards the end of the study that 
seroconverted during the same time period there appears to be no reason to suspect that 
the method and cut-off are not valid for use in adult horses.  To our knowledge, this is the 
first year-long study to serologically follow mares for exposure to L. intracellularis.  As 
such, this was a pilot study and further sero-screening accompanied by regular fecal PCR 
testing of persistently seropositive mares would be useful to further help identify the role 
that mares may play in the spread of L. intracellularis on EPE endemic farms. 
 The steady decline in the overall percentage of study mares that were seropositive 
over the 13 month period of the study was unexpected.  Based on work with younger 
horses, an increase in the overall number of seropositive mares during the fall and winter 
months was anticipated.  Instead, only a small increase in seropositive mares was noted in 
December while a larger peak was noted between July and August.  The peak during the 
summer is mirrored by a fold-change increase between June and August, as well as a 
small increase in first-time mare seroconversions during July and August.  The 
combination of these findings would seem to suggest that mares may be exposed to L. 
intracellularis outside of the "normal" exposure period.  While additional data from 
subsequent years is needed to confirm these findings, this could have a profound impact 
on our understanding of EPE epidemiology. 
 Supporting the theory that mares play a role in spreading L. intracellularis, we 
found that mares with five or more seropositive months through October (the last month 
in which foals were weaned) had foals/weanlings that were significantly more likely to 
exhibit evidence of exposure to L. intracellularis while mare sero-status had no effect on 
the occurrence of presumptive EPE or suspected L. intracellularis infection.  Based on 
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experimental challenge studies in horses, a 14-21 day incubation period has been 
proposed for EPE with seropositive titers typically detected approximately 14 days after 
exposure.10,39  However, as presented in Chapter 3, the rate of naturally occurring EPE 
cases and L. intracellularis infections amongst exposed horses is significantly lower 
(~11% vs. 33-66%) than is seen with experimental EPE models.10,39,57  This difference 
likely originates from the large challenge doses that are used to induce clinical disease in 
experimental settings.  As such, it is feasible that naturally occurring cases are induced by 
lower doses, which may exhibit prolonged incubation and seronegative periods.  If this 
were to be true, mares could be seeding their foal's environment with the bacterium, 
leading to detectable seroconversion several months after weaning.  However, the large 
increase in seroconversions that occurred between December and January in both mares 
and weanlings, as well as the large increase in mare EU fold changes during that same 
time period would seem to suggest that mares and weanlings were exposed at the same 
time, making it unlikely mares are exposing their foals to L. intracellularis.  Further, the 
lack of an effect of mare seropositivity on the time period during which her foal/weanling 
seroconverted also suggests mares may not play a role in exposing young horses to the 
bacterium. 
 The apparent exposure of mares to L. intracellularis during the summer months, 
without a concurrent, substantive event in the foal population, may suggest that mares are 
actually providing protection to their foals prior to weaning.  The most likely mechanism 
by which mares would protect their foals would be through immunoglobulin A ingested 
by the foal in mare's milk.  IgA has been suggested to play a significant role in immunity 
to L. intracellularis in pigs given its propensity to accumulate in enterocytes within close 
109 
 
proximity to the bacterium, as well as the production of mucosal L. intracellularis-
specific IgA following experimental infection.89,112  Given that IgA is present within 
mare's milk at high concentrations and is complexed with a secretory component that 
provides increased resistance to digestion within the gastrointestinal tract,113 milk-derived 
IgA could confer immunity to L. intracellularis while foals are nursing.  Further, 
cessation of milk intake at weaning and beyond would lead to loss of this immunity, 
placing the weanlings at risk for the development of EPE.  It seems plausible that IgA 
could play a significant role in immunity to the bacterium in horses and may warrant 
further examination.  
 This study set out to determine whether mares play a role in the spread and 
maintenance of Lawsonia intracellularis on EPE endemic farms and, based on the data, 
we were unable to rule-out a role for mares.  Further, foals/weanlings from repeatedly 
seropositive mares (5 or more seropositive months from parturition to October 2012) 
were significantly more likely to exhibit signs of exposure to the bacterium as detected by 
an L. intracellularis-specific ELISA.  This finding would seem to implicate mares in the 
spread of the bacterium, however, there was no effect of mare sero-status on the 
occurrence of presumptive EPE or suspected L. intracellularis infection in their foals.  
Additional work is needed to replicate naturally-occurring clinical EPE cases to 
determine whether the incubation and/or seronegative period is longer than 14-21 days, 
as has been reported previously with large-dose, experimental models.  Interestingly, 
there appeared to be a protective effect of mares on nursing foals during the summer as 
there was evidence of mare seroconversion to the bacterium with very little concurrent 
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corresponding seroconversion in foals.  One hypothesis for this protective effect could be 
milk-derived IgA.  
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CHAPTER FIVE: 
Characterization of the interferon gamma response to Lawsonia intracellularis using 
an equine proliferative enteropathy challenge model 
 
Summary 
 
 Lawsonia intracellularis is the etiological agent of infectious intestinal 
hyperplasia for which several clinical diseases have been described including 
proliferative enteropathy (PE), intestinal adenomatosis, and ileitis. While initially 
recognized as the causative agent of PE in pigs, L. intracellularis is now viewed as an 
emerging cause of intestinal hyperplasia in a wide range of mammalian species, including 
horses.  Equine proliferative enteropathy (EPE) has been reported worldwide though 
definitive diagnosis is difficult and the epidemiology of the disease remains poorly 
understood.  Weanlings and short yearlings, in particular, appear to be most at risk for 
infection, though the reasons for their particular susceptibility is unknown.  Using an 
infectious challenge model for EPE, we demonstrate that EPE, as in porcine proliferative 
enteropathy, can exhibit three clinical forms; classical, subclinical and acute.  Out of six 
pony weanlings, one developed signs of classic EPE, one developed acute EPE, and two 
developed subclinical EPE.  Attempts to induce pharmacological stress through the use of 
dexamethasone failed to have any effect on outcome.  Peripheral blood cells collected 
from those weanlings that developed clinical EPE exhibited decreased expression of 
interferon-gamma (IFN-γ) following in vitro stimulation with L. intracellularis.  By 
contrast, those weanlings that did not develop clinical disease generated a robust IFN-γ 
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response.  These results indicate IFN-γ likely plays a significant role in protection from 
disease caused by L. intracellularis in the equid.  
 
 
This chapter has been previously published and the copyright is held by Veterinary 
Immunology and Immunopathology.  The manuscript is reproduced here in 
accordance with the VII Copyright Agreement.  An abstract from this manuscript 
was presented at the 2010 American Association of Equine Practitioners Annual 
Convention. 
Page AE, Loynachan AT, Bryant U, Stills HF, Jr., Adams AA, Gebhart CJ, Pusterla N, 
Horohov DW. Characterization of the interferon gamma response to Lawsonia 
intracellularis using an equine proliferative enteropathy challenge (EPE) model. Vet 
Immunol Immunopathol 2011;143:55-65. 
 
 
  
113 
 
Introduction 
 
 Lawsonia intracellularis, an obligate intracellular, gram-negative rod, is the 
causative agent of proliferative enteropathy.1  While initially described as a pathogen of 
pigs,4 L. intracellularis is now viewed as an emerging cause of proliferative enteropathy 
in a variety of mammalian species,91,92 including horses.14,93-95  In the horse, L. 
intracellularis infection results in equine proliferative enteropathy (EPE) which has been 
reported worldwide.15,25  The bacterium infects the crypt epithelial cells primarily of the 
distal small intestine, causing hyperplasia and proliferation of the infected cells.114  
Several possible mechanisms for L. intracellularis pathogenicity have been proposed 
including perturbations in cell cycle processes of crypt epithelia; alterations of factors 
involved in the differentiation of normally immature and proliferative crypt cells; 
disturbances of relevant growth factor receptors; and inhibition of apoptotic cell death in 
the crypt.40,41  
 Typical clinical signs of EPE include anorexia, fever, lethargy, depression, 
dependent edema, intermittent colic, and diarrhea.  A common diagnostic test used by 
many practitioners is abdominal ultrasonography where a small intestinal wall thickness 
of >3mm can be considered pathognomonic for EPE when accompanied by compatible 
clinical signs; however, false negative results can occur in some cases of EPE.11  The 
presence of hypoproteinemia caused by hypoalbuminemia is also highly suggestive of 
EPE in weanlings.11  Definitive diagnosis of EPE is based on the presence of histologic 
changes and immunohistochemistry of small intestinal sections obtained at necropsy.  
Available commercial antemortem tests for EPE consist of fecal L. intracellularis-
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specific PCR and the serum immunoperoxidase monolayer assay (IPMA).  Both of these 
tests are adapted from their use in pigs where the tests are highly specific.  However, 
sensitivity is quite variable for the fecal PCR assay.32,34,115  By contrast, sensitivity is 
reported to be high for the IPMA,53 though the method is cumbersome, requiring visual 
interpretation of the samples.  Recently, we have described an L. intracellularis-specific 
ELISA for the detection of serum antibodies.20 
 Cases of EPE are typically seen in weanling horses.11,18,94-96  While the 
epidemiology of L. intracellularis is poorly defined, a fecal-oral route of infection is 
suspected.46  Several hypotheses exist as for the reason of this age predilection for EPE, 
which include a decline in maternal antibodies (see Chapter 3), management changes that 
occur during the weaning period, the stress of weaning and changing barns and/or 
pastures, as well as implementation of new vaccination and deworming practices.11,18  
Additionally, the underdeveloped cell-mediated immunity in younger horses may not be 
as capable of combating L. intracellularis compared with adult horses.11  
 The immunological aspects of EPE remain undefined and recent work has 
focused on the antibody response of horses to L. intracellularis.88  However, results from 
other animal models indicate that cell-mediated immune mechanisms likely play a pivotal 
role in resistance to this infection.54,76   Descriptive immunocytological studies of 
intestinal tissue sections of pigs have shown evidence of cell-mediated immune response 
to L. intracellularis.4   Oral vaccination of pigs with an avirulent live strain of L. 
intracellularis, which is associated with protection from disease,54 results in Lawsonia-
specific IFN-γ expression by PBMC.70  Thus, it appears likely that IFN-γ and other cell-
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mediated immune mechanisms would play a central role in the horse’s immune response 
to this bacterium.  
  Unlike porcine proliferative enteropathy, there had been no established 
experimental infection model for L. intracellularis in the equid until recently.39  The pig 
infection model has facilitated studies looking at a variety of issues, including vaccine 
development,54 comparison of available diagnostic tests,53,116 creation of additional 
diagnostic tests,99 and evaluation of feed and feed additives on PPE.117,118  The lack of an 
experimental infection model in the horse has left a gap in our knowledge of EPE, with a 
large portion of our understanding of the disease adapted from swine research.   The 
purpose of this study was to experimentally induce equine proliferative enteropathy in 
weanlings using a recently isolated and cultivated equine-origin L. intracellularis strain.  
Clinical disease was confirmed using available, routine diagnostic techniques, as well as 
post-mortem findings.  Additionally, we identify a potential role for IFN-γ in protection 
from clinical EPE.    
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Materials and Methods 
 
Horses 
 Six nursing pony foals between 16 and 19 weeks of age were selected based on 
their close age grouping from the University of Kentucky’s research herd where mares 
and foals were maintained on pasture.  Prior to the study start (day -7), all six foals were 
determined to be healthy on physical exam by a licensed veterinarian with complete 
blood count, fibrinogen, and serum biochemistry profiles within normal ranges.  At no 
time during the study, or in the week prior to challenge, were antimicrobials 
administered.  The study was approved by the University of Kentucky’s Biosafety and 
Institutional Animal Care and Use Committees. 
 
Experimental design 
 The day prior to challenge (day -1), the foals were weaned and immediately 
transported to the Maxwell H. Gluck Equine Research Center where each weanling was 
housed separately in an indoor stall for the remainder of the study.  Weanlings were 
allowed ad libitum water and mixed grass hay.  Additionally, each weanling received ¼ 
quart of sweet feed grain twice a day starting on day +2 as a means of detecting partial or 
total anorexia.  Each foal received omeprazoleM (4mg/kg, q 24h, PO) from day -7 
through day +2. An additional fifteen pony foals of approximately the same age remained 
at the farm for the duration of the challenge study serving as serological controls only and 
were not euthanized or necropsied at the end of the study. 
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Immune suppression assessment 
 Immune suppression was induced using physiologic stress (weaning) and 
pharmacologic methods.  The first involved weaning the foals on the day prior to 
challenge.  Recent work in our laboratory has shown that the stress of weaning is 
significant enough to cause a decrease in cell-mediated immunity.80  Additionally, three 
of the six weanlings (1, 3, and 5) were randomly assigned to be administered 
dexamethasoneN at 0.25mg/kg, q 24 h, IV on day -1, 0.125mg/kg, q 24 h, IV on days 0 
and +1, and 0.04mg/kg, q 24 h, IV on day +2.  To assess immune suppression, peripheral 
blood (~3.0 mls) was collected directly into PaxgeneO tubes prior to weaning and daily 
afterwards for the determination of nascent expression of IFN-γ mRNA.78  Total RNA 
was isolated from the Paxgene tubes according to the manufacturer’s directions and the 
RNA converted to cDNA using avian leukosis virus reverse transcriptase.119  Cytokine-
specific cDNA was amplified using real-time PCR and primers and probes specific for 
IFN-γ.  Beta-glucuronidase was used as the housekeeping gene for RNA normalization.78  
The efficiency of the PCR reaction was confirmed using LinReg.120  Results are 
expressed as relative quantities121 with the average of pretreatment blood samples used as 
the calibrator. 
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Live-cultured Lawsonia intracellularis and challenge 
 Low passage, equine-origin L. intracellularis was grown by GBI LaboratoriesP, 
using previously described methods.6,39  Using the direct-count method,37 the number of 
organisms was found to be 4.45x108/ml.  The inoculum was stored at -80oC until the day 
prior to challenge (day -1), when the entire sample of L. intracellularis was placed into a 
4oC refrigerator to thaw slowly overnight.  On day 0, 45mL of live L. intracellularis was 
placed into six individual 60cc catheter-tipped syringes.  The six pony weanlings were 
then challenged with the equine-origin L. intracellularis (2x1010 organisms/weanling) via 
nasogastric intubation.  No weanlings were sedated for this process and feed was not 
withheld pre- or post-inoculation. 
 
Monitoring of physical health 
 The six weanlings were monitored daily for pyrexia (>101.5oF), anorexia, colic, 
dependent edema, and diarrhea.  Additionally, each study weanling was weighed and an 
abdominal ultrasound was performed weekly.   
 
Antemortem diagnostic testing 
 On days -16 and -7 all six foals, as well as controls, tested negative for the 
antibodies to L. intracellularis via ELISA.  Testing involved collecting 7ml of whole 
blood via jugular venipuncture into sterile 7 ml plain blood tubes.  Blood was allowed to 
clot for 1-2 hours, after which time the tubes were centrifuged at 800xg for 10min.  1ml 
of serum was removed and placed into individual 1.5ml tubes that were labeled with the 
                                               
P Fergus Falls, MN 
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horses’ ID number and date of collection.  Samples were frozen at -20oC until analyzed 
via ELISA.  The method for this ELISA is provided in Chapter 2.   
 Fecal samples were collected from each weanling from day 0 through day +6 and 
biweekly thereafter.  Each sample was stored in a separate, labeled 50ml conical tube at -
20oC until a batch of samples was shipped overnight in cooler boxes to the University of 
California, Davis for real-time PCR detection of the aspartate ammonia lyase (aspA) 
gene of L. intracellularis as previously described.46  Biweekly blood samples were 
collected and submitted for total protein (ref: 5.3-7.5 g/dL) and albumin (ref: 3.0-4.0 
g/dL) levels.  Serum total protein and albumin levels were obtained using an ACE Alera 
at the University of Kentucky’s Veterinary Diagnostic Laboratory. 
 
In vitro stimulation of peripheral blood, RNA isolation, storage, processing, and 
analysis 
 Green-top, lithium heparin blood tubes were collected from each weanling via 
jugular venipuncture on days -7, 0, +7, +14, +21, and +28 (when available).  To each of 
the three tubes was aseptically added nothing (“control”), 10µl phorbol 12-myristate 13-
acetateQ (PMA; 25 ng/ml) and ionomycin (1 mM; Sigma), or 250uL modified-live L. 
intracellularis vaccineR.  Tubes were then placed into a 37oC humidified incubator for 24 
hours.  After 24 hour incubation, 2.5 mL of blood was removed from each tube and 
placed into a corresponding PaxGene tube.  Total RNA isolation and subsequent 
processing were completed per the manufacturer’s directions. 
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Euthanasia and post-mortem evaluation 
 All six weanlings were to be humanely euthanized at the end of the four week 
study (day +29); however, the severity of clinical disease in two of the weanlings (1 and 
4) necessitated their euthanasia on day +21.  Immediately following euthanasia, all six 
weanlings had full necropsies performed by boarded and board-eligible pathologists at 
the University of Kentucky’s Veterinary Diagnostic Laboratory.  Mucosal scrapings from 
each weanling’s ileum were sent to the University of California, Davis for L. 
intracellularis-specific PCR testing, as above.  Immunohistochemistry was utilized to 
detect the presence of L. intracellularis in the intestinal tract.  The presence of the 
challenge strain of L. intracellularis obtained from necropsy samples was confirmed 
through the use of variable number tandem repeat (VNTR) analysis, as previously 
described.122 
 
Immunohistochemistry 
 Tissue sections were stained using the EnVision+ Dual Link System-HRPS 
immunohistochemical staining technique.  Briefly, paraffin embedded tissue sections 
were placed on electrostatically charged glass slides, deparaffinized with xylene, and 
rehydrated.  Endogenous hydrogen peroxide was quenched by applying a 3% hydrogen 
peroxide solution for 10 minutes.  Slides were then rinsed with deionized water 3 times.  
Antigens were retrieved by adding 0.05% protease K to the tissues for 2 minutes, and 
then slides were re-rinsed an additional 3 times with deionized water.  A 1:500 dilution of 
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L. intracellularis-specific monoclonal antibodyT was added to the slides for 45 minutes 
after which slides were rinsed with Tris-buffered-saline (TBS).  A polymer conjugated 
with secondary antibodies was then applied to the tissue, allowed to incubate for 30 
minutes, and then washed with TBS.  Slides were incubated for 5 minutes with a 
substrate-chromogen solution and then were cover slipped.  Tissues were finally analyzed 
for the presence or absence of L. intracellularis specific staining by light microscope.  
Negative controls consisted of both a negative reagent control and negative tissue 
control.  The negative reagent control was performed by the procedure listed above with 
the exception that the primary monoclonal L. intracellularis antibody was substituted 
with a universal negative control mouse antibody (product #N1698, Dako North 
America, Inc.).   Ileum from a single age-matched foal, which was euthanized for 
neurologic disease, was used as the negative tissue control.     
 
Case Definition 
 After the conclusion of the study, weanlings were classified into three different 
categories (clinically affected, subclinically affected, and non-affected) based on the 
severity of observed clinical signs, the severity of clinicopathologic abnormalities, 
consistent fecal shedding of L. intracellularis as determined by fecal PCR for the aspA 
gene (as described above), the presence of gross or histologic changes consistent with 
EPE (pronounced rugation of the ileum and/or mucosal hyperplasia), and the presence or 
absence of L. intracellularis organisms in the distal small intestine as determined by 
immunohistochemistry and/or PCR for the organism on mucosal scraping samples.  Due 
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to the shortened nature of this study, ELISA unit values were not considered when 
categorizing the weanlings.  Weanlings were considered to be clinically affected with 
EPE when they experienced all of the following: overt clinical signs compatible with 
EPE, moderate to severe hypoproteinemia and hypoalbuminemia (less than 5.0 g/dl and 
2.5 g/dl, respectively), more than two consecutive fecal samples PCR positive for L. 
intracellularis, and gross ileal mucosal proliferation with confirmed presence of L. 
intracellularis organisms either by IHC or PCR.  Overt clinical signs were defined as the 
presence of two or more clinical signs compatible with EPE (anorexia, lethargy, 
depression, dependent edema, fever, colic, and diarrhea).   Weanlings were considered to 
be subclinically affected if they did not experience all of the criteria listed for clinically 
affected weanlings.  Non-affected weanlings were defined as those with none of the 
criteria listed for clinically affected weanlings. 
 
Data analysis  
 Two-way repeated measures-analysis of variance (RM-ANOVAs) (Holm-Sidak 
methodU) was used to evaluate IFN-γ gene expression.  Post hoc t-tests were performed 
to evaluate the differences between groups at each time point.  Calculated P values <0.05 
were considered to be statistically significant.  
  
                                               
U SigmaStat, SPSS Inc., Chicago, IL 
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Results 
 
The effect of weaning and dexamethasone treatment on IFN-γ production 
 Due to treatment randomization, the dexamethasone-treated foals had higher 
nascent IFN-γ mRNA expression prior to treatment; nevertheless, weaning significantly 
suppressed IFN-γ mRNA expression in both groups (Figure 5.1).  This suppression was 
further exacerbated by treatment with dexamethasone on days 1 and 6.   
 
Clinical signs, clinicopathologic changes, and necropsy findings 
 None of the control ponies demonstrated overt clinical signs compatible with EPE 
during the study or the two month period following the conclusion of the study.  Overall, 
out of the six weanlings that were challenged with L. intracellularis, four weanlings (1, 2, 
3, and 4) were ultimately diagnosed with EPE based on the combination of clinical signs, 
clinicopathologic findings, histologic changes, or PCR results (Table 5.1).   Treatment 
with dexamethasone had no effect on clinical outcome as each of the treated ponies fell 
into one of the outcome groups (clinical, subclinical, and non-affected). 
 Weanling #1 exhibited signs of classic EPE including hypoproteinemia (Figure 
5.2) and hypoalbuminemia (Figure 5.3).  For welfare reasons, this weanling was 
euthanized on day 21.  Histological examination at necropsy revealed elongated ileal villi 
and blunted, frequently branching crypts.  Weanling #4 was the other clinically affected 
weanling; this weanling’s condition declined acutely leading to euthanasia on day 21.  On 
necropsy, the ileum and distal jejunum were mildly to moderately proliferative and 
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Figure 5.1: Weaning and dexamethasone treatment suppressed nascent IFN-γ 
mRNA expression.  Results are expressed as relative quantity (RQ) with the average 
of the day -7 samples used as the calibrator and time points significantly different 
(p<0.02) from d-7 are denoted with “#”.  Significant differences (p<0.05) between 
treated and non-treated weanlings at each time point are designated “*”. 
 
 Table 5.1: Gender, clinical signs, serum total protein and albumin levels, fecal PCR status, and ultrasonographic findings for 
each horse and the first day that the finding occurred, if applicable. 
Horse # Gender Anorexia? Edema? 
Febrile? 
Temp? 
Colic or 
Diarrhea? Low TP? Low Alb? 
PCR + 
feces? 
U/S SI 
thickening? 
Size? 
Mucosal  
Proliferation Rugation 
Mucosal  
Scrapings  
PCR IHC 
Clinical EPE 
Status* 
1*** Filly Y, D13 Y, D17 
Y, 101.7F, 
D21 None Y, D16 Y, D16 Y, D13 Y, 5mm, D20 Mild Mild + + Clinical 
4 Filly Y, D19 No 
Y, 104.1F, 
D20* None Y, D20 Y, D20 Y, D13 None Mild/Mod Mild/Mod + + Clinical 
2 Filly No No None** None Y, D23 Y, D23 Y, D16 Y, 5mm, D20 Mild Mod + - Subclinical 
3*** Colt No No None None Y, D29 No No None Mild/Mod Mod + + Subclinical 
5*** Colt No No None None Y, D16 No No None Min/Mild Min - - Non-affected 
6 Colt No No None None Y, D23 No No None Mild Mild - - Non-affected 
Y=Yes, D= Day, TP= total protein, Alb= albumin, U/S= ultrasound, IHC= immunohistochemistry, Min= minimal, Mod= moderate 
 
Horses are ordered based on clinical status 
 
*"Clinical EPE Status" refers to those ultimately classified as clinically affected, subclinically affected, or non-affected 
** Mildly febrile on D-1- attributed to stress of relocation and weaning 
*** Treated with dexamethasone 
Low TP ≤5.3 mg/dL 
Low Albumin <3.0 mg/dL 
Febrile >101.5F 
Normal SI size ≤3mm 
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Figure 5.2: Serum total protein levels in L. intracellularis challenged weanlings. 
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Figure 5.3: Serum albumin levels in L. intracellularis challenged weanlings.  
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rugated.  Histologically, areas of mucosal necrosis and crypt herniation with branching 
were noted, as well as hyperplasia of the crypt epithelium (Figure 5.4).  Additionally, 
both IHC (Figure 5.5) and mucosal scrapings PCR were positive for the bacterium.  
Subsequent testing for other causes of severe, acute necrotizing enteritis, including 
Salmonella sp. (both direct and enrichment broth culture), Clostridium perfringens, C. 
difficile, and Neorickettsia risticii was negative.  Both weanlings #1 & 4 experienced 
weight loss during the course of the study, compared with the other four weanlings 
(Figure 5.6). 
 Weanlings #2 & 3 were diagnosed with subclinical EPE based on the absence of 
all of the required criteria to be classified as clinically affected.  Weanling #2 
demonstrated a mild, transient decrease in total protein and albumin levels beginning on 
day 23 (Figures 5.2 and 5.3), in contrast to the more profound decrease seen in the 
clinically affected group.  While this weanling did test fecal PCR positive for L. 
intracellularis on days 16 and 20 it was consistently a weak positive.  No L. 
intracellularis organisms were detected by IHC; however, the bacteria were detected by 
mucosal scrapings PCR.  By comparison, weanling #3 demonstrated no signs of EPE and 
no feces tested PCR positive for aspA.  However, the ileal mucosa was mildly to 
moderately proliferative and exhibited moderate rugation.  Additionally, IHC 
examination of the distal ileum revealed positive staining for L. intracellularis within the 
enterocytes and mucosal scrapings PCR returned a positive result.  While weanlings #2 
and 3 had net weight gains during the study, their weight gain was less than that achieved 
by weanlings #5 and 6 (Figure 5.6).
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(a)  
(b)  
Figures 5.4 a & b: Representative photomicrographs of ileal sections from an age-
matched control and infected weanlings.  (a) Normal small intestinal histology 
(mag=10x), (b) Ileal histologic section from weanling #4, showing marked epithelial 
hyperplasia as well as branching of the crypts (mag=10x). 
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(a)  
(b)  
Figures 5.5 a & b: Immunohistochemistry detection of L. intracellularis.  (a) 
Negative control small intestine (mag=40x), (b) Representative staining of ileal 
section from weanling #4 showing positive staining in the crypt epithelial cells for L. 
intracellularis. (mag=40x) 
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Figure 5.6: Net percent weight change for each weanling.    
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 Neither weanling #5 nor weanling #6 demonstrated any signs of EPE; 
additionally, feces from both weanlings tested PCR negative for L. intracellularis.  On 
necropsy, both weanlings had minimal to mild ileal mucosal proliferation with mild 
rugation of the distal ileum.  No L. intracellularis organisms were detected in either 
weanling using IHC or PCR of the mucosal scrapings.   Both of these weanlings achieved 
the highest weight gains over the course of the study (Figure 5.6). 
 
Lawsonia intracellularis-specific ELISA 
 The average L. intracellularis-specific ELISA value for the 15 serological control 
ponies was 33EU, with a standard deviation of 7EU with a maximum ELISA of 49EU 
and a minimum of 22EU.  The control ponies remained ELISA negative through the last 
day of the study.  Based on these controls, an ELISA value > 55EU (serological control 
mean plus 3 standard deviation units) was considered positive.  Of the two clinically 
affected weanlings, weanling #1’s first positive ELISA test (56 EU) occurred on day 6 
and the values continued to increase until the day of euthanasia, day 21 (Table 5.2).  In 
comparison, weanling #4’s first positive ELISA value was on day 20.  From the two 
subclinically affected weanlings, weanling #2’s first positive ELISA value was first 
detected on day 20 and increased through day 29, while weanling #3’s initial positive 
value was detected on day 13 and increased slowly until the end of the study.  Both non-
affected weanlings seroconverted on day 13 and remained seropositive through the end of 
the study (day 29).   
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Table 5.2: ELISA unit values for each horse in relationship to the day of challenge 
with L. intracellularis.  Positive samples are denoted with a *.  NS= No Sample 
Horse 
# Day -7 Day 0 Day 6 Day 13 Day 20 Day 21 Day 27 Day 29 
#1 31 36 *56 *106 NS *394 NS NS 
#2 39 30 44 32 *538 NS *425 *746 
#3 36 34 37 *141 *235 NS *267 *452 
#4 38 32 34 52 *368 *400 NS NS 
#5 27 26 27 49 *198 NS *148 *186 
#6 22 34 22 27 *241 NS *202 *227 
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In vitro stimulation of whole blood with L. intracellularis 
 Interferon-gamma mRNA expression data in response to whole blood stimulation 
with L. intracellularis are presented in Figure 5.7.  The clinically affected weanlings 
produced significantly (p<0.001) less IFN-γ mRNA following antigen stimulation than 
the other weanlings on day 20.  A similar, though non-significant, difference was also 
seen on day 13 post-challenge.  There were no significant differences between the groups 
in terms of their IFN-γ mRNA expression in response to PMA-ionomycin (data not 
shown). 
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Figure 5.7: L. intracellularis-induced IFN-γ production by peripheral blood cells.   
Results are expressed as relative quantity (RQ) with unstimulated control samples 
used as the calibrator.   
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Discussion 
 
 As an emerging disease of horses, the development of an effective and reliable 
challenge model for equine proliferative enteropathy is critical to further our 
understanding of this disease.  This is particularly true with respect to developing new 
and improved diagnostics, as well as understanding the pathogenesis and immunology of 
EPE.  These are the first results published from a Lawsonia intracellularis challenge in 
equids with infection confirmed by postmortem examination, demonstrating that equine 
proliferative enteropathy can exhibit three clinical forms.  As such, one weanling 
demonstrated signs of classical EPE, another showed clinical signs and histological 
changes compatible with acute PPE (“acute EPE”), and two others exhibited signs of sub-
clinical disease.  The remaining two weanlings seroconverted, but exhibited no clinical or 
pathological signs indicating that they successfully cleared their infections.   
With respect to porcine proliferative enteropathy, three different forms have also 
been identified: 1.) chronic, 2.) subclinical, and 3.) acute.  In the chronic form, the most 
common signs are diarrhea, rough hair coat, decreased feed consumption, and reduced 
weight gain.123  In subclinically infected pigs, the most common clinical sign is poor 
weight gain,123 with younger pigs typically affected.124  The acute form of PPE usually 
affects older pigs, with severe intestinal hemorrhage, fever, and sudden death being the 
most common clinical signs,123 though necrotizing enteritis can be seen with cases of 
acute porcine proliferative enteropathy.125   
 This is the first study to document successful induction of EPE confirmed by 
postmortem findings.  Possible reasons for the success of this model include the large 
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inoculation dose used for each horse (4.45x108/ml or 2x1010 organisms per pony), as well 
as the use of pony weanlings rather than horse weanlings.  This led to a larger 
concentration of L. intracellularis organisms/kg of body weight than if horse weanlings 
had been used.  In pigs, an infectious dose of 104-106 has been suggested as infective.126   
While the natural infectious dose needed to induce EPE in the horse is unknown, their 
larger body size, greater intestinal volume, and differences in the gastro-intestinal 
environment could account for the higher dose requirement.  Additionally, it is also 
possible that natural infection occurs through repeated exposure to lower doses rather 
than a single, large bolus dose.  Since all of the weanlings seroconverted in this study, it 
seems likely that our challenge dose was sufficient to cause infection.  Corticosteroids 
were unlikely to have contributed to disease induction in this study since of the four 
affected weanlings, two were treated with dexamethasone and two were not.  A more 
likely reason for the success of this model is that challenge coincided with the weaning 
period and the associated stress likely impacted cell-mediated immunity.  Indeed, all foals 
exhibited depressed nascent IFN-γ mRNA expression in response to weaning.  
Dexamethasone treatment further diminished the IFN-γ response, yet there was no effect 
of this added suppression on clinical outcome.  Either weaning alone provided sufficient 
reduction of cellular immunity for the infection to develop or depression of nascent IFN-γ 
mRNA expression played little role in the susceptibility of the weanlings to infection.   
Results from other animal models indicate that cell-mediated immune 
mechanisms likely play a pivotal role in resistance to L. intracellularis infection.54,76   
Descriptive immunocytological studies of intestinal tissue sections of pigs have shown 
evidence of cell-mediated immune response to L. intracellularis.4   Peripheral blood 
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mononuclear cells from infected pigs exhibit increased production of L. intracellularis-
induced IFN-γ post challenge.70  Similarly, studies in mouse models have identified a 
significant role for IFN-γ in protective immunity to L. intracellularis.74,76  Genetic 
mapping studies in horses suggest a similar role for IFN-γ,127 though no direct 
demonstration has yet been provided.  Here we show an association between the IFN-γ 
response following in vitro stimulation of peripheral blood with L. intracellularis and 
clinical outcome.  Peripheral blood from the two weanlings that succumbed to the 
challenge infection produced significantly less IFN-γ compared to the surviving 
weanlings after incubation with L. intracellularis.  Thus, it appears likely that IFN-γ and 
other cell-mediated immune mechanisms play a central role in the horse’s response to 
this bacterium.   
 The  precise contribution of cell-mediated immunity to protection against 
EPE is also somewhat unclear.  Since L. intracellularis replicates in the intestinal 
epithelium it could induce a cellular cytotoxic immune response against the infected 
cells, as is the case for other intracellular microorganisms.76  However, L. intracellularis 
infection are generally associated with modest cellular infiltration,74 therefore a direct 
effect of IFN-γ on cellular proliferation is thought to be the likely mechanism of 
action.74,76  A similar mechanism of action is seen in other intracellular infections, as 
well.128,129  Oral vaccination of pigs with an avirulent live vaccine of L. intracellularis is 
associated with protection from disease54 and the induction of IFN-γ by L. intracellularis-
stimulated PBMC.89  The robust IFN-γ recall response we observed in those weanlings 
that were protected from clinical infection indicates a similar protective role for this 
cytokine in EPE.   
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CHAPTER SIX: 
 
Conclusions and Future Research Directions 
 
 As an emerging disease of horses, there are many answered questions that revolve 
around equine proliferative enteropathy.  Unfortunately, because of the relative rarity 
with which EPE occurs outside of central Kentucky, and even amongst exposed horses 
for that matter, all but the most basic of studies into EPE have yet to be performed.  The 
research presented within this dissertation utilized the tremendous resource central 
Kentucky Thoroughbred farms provide to offer additional insight into why EPE occurs 
sporadically despite high exposure rates. 
 
All farms in central Kentucky experience exposure to L. intracellularis and previous 
EPE suggests future risk 
 Perhaps one of the most surprising findings from this research came from Chapter 
2, in which all farms, regardless of their prior EPE history, had evidence of 
weanling/yearling exposure to L. intracellularis.  Given the other finding from that 
chapter in which prior history of EPE was associated with an increased seroprevalence 
rate, as well as a likelihood of developing disease in subsequent years, possible 
explanations for the differences between the groups would be L. intracellularis strain 
pathogenicity, exposure burdens, or a combination of the two.  Titration challenge 
studies, much like those that have been performed in pigs,50 would help to elucidate 
whether there are differences in disease occurrence and antibody levels between dosages 
while experimental challenge with different strains of the bacterium would show whether 
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there truly are strain differences.  Given that there is currently only one known isolated 
strain of equine-origin L. intracellularis available for use, this second part is currently not 
possible.  An alternative might include regular collection of fecal material from the at-
risk population followed by genetic typing122 of the bacterium to look for similarities and 
differences on farms with endemic versus no EPE. 
 
Passively-acquired antibodies to L. intracellularis do not protect against EPE 
 It is not surprising, given the enteric location of L. intracellularis infection, that 
passively-acquired and systemically circulating antibodies do not have a protective role 
against EPE, despite a recent suggestion to the contrary in pigs.68  A larger number of 
EPE cases would have helped to strengthen these conclusions especially given the lower-
than-expected number of mares that were seropositive at parturition.  However, given that 
the rates of disease and infection and foal seropositivity following parturition were 
similar, there is little reason to question the findings presented here. 
 
Disease "attack" rates of ~11% can be expected in L. intracellularis-exposed horses 
 Traditionally, estimates of 5-10% of seropositive horses developing clinical EPE 
have been used, but this assumption has never been proven in a large scale, field study 
before.  With L. intracellularis-exposed horses, we found a clinical EPE attack rate 
(using the presumptive EPE cases) of 5.3% and an infection attack rate (using cases with 
suspected infections) of 6.3%; combined, the overall attack rate was 11.6% among 
seropositive horses.  An accurate attack rate will allow for refinement of experimental 
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challenge models and testing of numerous hypotheses with respect to EPE epidemiology 
and disease susceptibility. 
 
Mares cannot be ruled out as playing a role in the epidemiology of EPE 
 Given the amount of time that foals spend with their respective mares prior to 
weaning, as well as the relatively high number of mares that were seropositive for 6+ 
months (46.3%), mares must be regarded as a potential source of L. intracellularis for 
their foals.  The data in this study did not eliminate mares as possible sources of the 
bacterium on an EPE-endemic farm.  Since this was a pilot study, further serum screening 
accompanied by regular fecal PCR testing of persistently seropositive mares and all 
foals/weanlings on an endemic farm will be necessary to identify what role mares play in 
the spread of L. intracellularis.  Because of the rarity with which nursing foals develop 
EPE, one of the possibilities is that mares, through milk-derived IgA, are protecting their 
foals from exposure and disease.  This idea could be easily tested by weaning nursing 
foals and comparing their EPE susceptibility with that of nursing, non-weaned foals. 
 
IFN-γ plays a significant role in protection against the development of EPE 
 This was the first study in any of the main target species to correlate L. 
intracellularis-induced IFN-γ production with disease protection.  As has been mentioned 
earlier, IFN-γ seems the most likely effector of CMI in response to L. intracellularis 
infection and here we showed that failure to produce IFN-γ in response to infection may 
have ultimately led to the occurrence of EPE.  Given that IFN-γ production increases with 
age in horses,78 one possible experiment would entail challenging neonates, foals, 
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weanlings, yearlings, and adults with L. intracellularis.  It would then be possible to 
correlate their IFN-γ response in vitro to the bacterium with the presence of infection 
and/or disease as detected on necropsy.  Likewise, with recent work from our lab 
showing that a dirty barn atmosphere is capable of stimulating an increase in IFN-γ+ 
lymphocytes, as well as work in pigs showing a markedly higher disease rate amongst 
challenged pigs, another experiment could examine the difference in disease rates 
between foals/weanlings raised only in pastures, a dirty barn, or a "clean" barn.  Lastly, 
given the suggestion in Chapter 3 that prior Rhodococcus equi infection may protect 
against clinical EPE, a two-tiered challenge study (first, as foals with R. equi, followed by 
challenge, as weanlings, with L. intracellularis) would be useful to determine whether 
this relationship does exist and the potential mechanisms for it. 
 
Other directions 
 As elucidated in Chapter 1, L. intracellularis appears to be capable of avoiding 
multiple arms of the immune system given the lack of an inflammatory response 
following infection.  With our recent reporting of N-EPE cases, in addition to PHE cases, 
it is possible that these occur because the bacterium is detected via the CMI or innate 
immune system, or Tregs fail to down-regulate the localized immune response.  Given 
that TGF-β is important for suppression of Th1 and Th2 function, the differentiation of 
inducible Tregs, and has been shown to increase following infection with L. 
intracellularis68, TGF-β knockout mice could possibly be used to examine its role in the 
pathology of L. intracellularis infection.  If TGF-β is important in limiting overt 
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inflammation following infection with the bacterium, we would expect to see pathology 
similar to N-EPE or PHE in these mice.   
 
 This dissertation has provided both novel data as well as data to show that L. 
intracellularis infection and disease in horses is similar to what has been reported in other 
species.  This all serves to provide the building blocks for future work into EPE from 
both epidemiology and immunology standpoints as a better understanding of L. 
intracellularis and its mechanisms of disease induction and immune evasion is necessary 
to develop strategies for combating and preventing equine proliferative enteropathy. 
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 APPENDIX I: 
Graph of Standard Curve Optical Density (OD) Values for Each Lawsonia intracellularis-Specific ELISA Unit Value 
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APPENDIX II: 
Acute Deterioration and Death with Necrotizing Enteritis Associated with Lawsonia 
intracellularis in Four Weanling Horses 
 
This chapter has been previously published and the copyright is held by the Journal 
of Veterinary Internal Medicine.  The manuscript is reproduced here in accordance 
with the JVIM Copyright Agreement. 
Page AE, Fallon LH, Bryant UK, et al. Acute deterioration and death with necrotizing 
enteritis associated with Lawsonia intracellularis in 4 weanling horses. J Vet Intern Med 
2012;26:1476-1480. 
 
 
Cases 
 
Case 1: 
 An 8-month-old Thoroughbred colt was evaluated in October 2010 with a less-
than-one-day history of inappetence.  Physical examination in the field revealed throat 
latch edema, depression, and a fever (103.8oF) (ref 99-101.5 oF).  A complete blood count 
revealed leukocytosis (18.0 K/uL; ref 5.0-12.6 K/uL) with a relative neutropenia (49%; 
ref 55-65%) and lymphopenia (26%; ref 35-45%), as well as a toxic left shift (25% 
bands; ref 0-5%).  Serum biochemistry abnormalities included  hypoproteinemia (3.3 
g/dL; ref 6-7.9g/dL), hypoalbuminemia (1.2 g/dL; ref 3.4-4.1 g/dL), and an increased 
BUN (45 mg/dL; ref 11-26 mg/dL), along with other abnormalities (Table A.1).  
 Table A.1. All available blood work results.  Day 0= day initial signs of EPE were noted.  Reference ranges are provided for 
each parameter in ( ). 
 
 Case #1 
Day 0 
Case #1 
Day +2 
 Case 
#2 Day 
0 
 Case #2 
Day +1 
 Case #2 
Day +3 
 Case #3 
Day +3 
 Case #3 
Day +4 
 Case #4 
Day +1 
WBC (5-12.6 K/ul) 18.0 (H) 35.4 (H)   6.2 1.6 (L) 31.5 (H) 42.4 (H) 7.7 
RBC (6.5-9.99 M/ul) 12.9 (H) 10.8 (H)   11.3 (H) 16.5 (H) 15.18 (H) 8.17 9.64 
HGB (11-16 g/dL) 15.3 12.8   15.1 21 (H) 19.9 (H) 10.7 (L)   
HCT (33-48%) 44.8% 39.2%   45% 
63.9% 
(H) 
50.4% 
(H) 27.4% (L) 34.9% 
PLT (115-450 K/uL) 600 (H) 83 (L)   508 (H) 644 (H) 700 (H) 125   
Neut (55-65%) 49% (L) 49% (L)   
 
18% (L) 78% (H) 76% (H) 14 (L) 
Bands (0-5%) 25% (H) 
26% 
(H)   
 
12% (H) 15% (H) 9% (H) 0 
Lymph (35-45%) 26% (L) 25% (L)   
 
70% (H) 7% (L) 15% (L) 84 (H) 
Mono (0-6%) 0% 0%   
 
0% 0% 0% 2 
Na (133-140 mEq/L) 122 (L) 115 (L)   134 123 (L) 118 (L) 125 (L) 133 
K (2.5-5 mEq/L) 3.4 3.2   3.9 3.3 3.3 4.4 4.0 
Cl (97-105 mEq/L) 90 (L) 86 (L)   97 89 (L) 85 (L) 100 92 (L) 
CO2 (25-32 mEq/L) 19 (L) 14 (L)   25 17 (L) 20 (L) 20 (L)   
Anion Gap 13 15   12 17 13 5   
BUN (11-26 mg/dL) 45 (H) 59 (H)   32 (H) 50 (H) 33 (H) 47 (H) 4.7 (L) 
Creatinine (0.8-1.8 
mg/dL) 1.3 1.8   1.2 2.4 (H) 1.4 1.9 (H) 0.7 (L) 
Calcium (11.6-13.2 
mg/dL) 9.1 (L) 12.6   9.6 (L) 8.5 (L) 8.0 (L) 8.2 (L)   
Total Protein (6-7.9 g/dL) 3.3 (L) 3.5 (L)   5.1 (L) 3.7 (L) 2.3 (L) 1.7 (L) 3.6 (L) 
Albumin (3.4-4.1 g/dL) 1.2 (L) 1.1 (L) 2.8 (L) 2.5 (L) 1.5 (L) 0.9 (L) 0.6 (L) 1.8 (L) 
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Lawsonia intracellularis-induced equine proliferative enteropathy (EPE) was suspected 
because of the combination of hypoproteinemia, hypoalbuminemia, inappetence, and the 
autumn presentation. Treatment consisted of intravenous oxytetracyclineV (6.6 mg/kg IV 
q24hr), flunixin meglumineW (1 mg/kg IV q12h), oral omeprazoleX (1 mg/kg PO q24hr), 
dexamethasoneY (0.1 mg/kg IV q24hr), intravenous crystalloid fluidsZ (10 ml/kg IV 
bolus once), and intravenous colloidsAA (10 ml/kg IV bolus once).  Despite treatment, the 
weanling was euthanized within 48 hours of presentation due to continued deterioration 
and signs of pulmonary disease characterized by nasal discharge, epistaxis, and 
tachypnea.  Blood work submitted the morning of euthanasia revealed a worsening 
leukocytosis (35.4 x103/uL) with an unchanged differential, as well as continued 
hypoproteinemia (3.5 g/dL), hypoalbuminemia (1.1 g/dL), and an increased BUN (59 
mg/dL). 
 
Case 2: 
 An 8-month-old Thoroughbred filly from the same farm as case #1 presented in 
October 2011 with inappetence of less than 12-hours duration.  Physical examination 
revealed fever (102.5oF) and an unthrifty appearance, including a poor hair coat.  
Examination of the serum albumin concentration at presentation revealed 
hypoalbuminemia (2.8 g/dL).  A complete blood count the following morning revealed 
no significant abnormalities, but hypoproteinemia (5.1 g/dL) and a worsening 
                                               
V Liquamycin LA-200, Pfizer Animal Health, New York, NY 
W Banamine, Merck Animal Health, Summit, NJ 
X UlcerGard, Merial Ltd.,  Duluth, GA 
Y Dexium, Bimeda, Le Sueur, MN 
Z Normosol-R, Hospira, Lake Forest, IL 
AA Hetastarch, Hospira, Lake Forest, IL 
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hypoalbuminemia (2.5g/dL) were seen on serum biochemistry; additionally, an L. 
intracellularis immunoperoxidase monolayer assay (IPMA) titer of ≥1:240 was reported.  
Other abnormalities were also noted (Table A.1).    On the basis of the time of year, the 
presence of anorexia, hypoproteinemia, hypoalbuminemia, and the weanling’s positive 
IPMA titer, in addition to the farm’s previous history, a presumptive diagnosis of EPE 
was made.  Treatment initially consisted of oral doxycyclineBB (10 mg/kg PO q12h) and 
flunixin meglumine (1 mg/kg IV q12h); however, due to the continued decline of the 
weanling, the doxycycline was discontinued and intravenous oxytetracycline (6.6 mg/kg 
IV q24hr) initiated two days after presentation.   
 The following morning (approximately 60 hours after initial signs were noted), 
the filly was depressed and lethargic, with a fever of 105.9oF.  CBC revealed severe 
leukopenia (1.6 x103/uL), neutropenia (18%), lymphocytosis (70%), and toxic left shift 
(12%). The serum biochemistry abnormalities included azotemia as well as a decline of 
serum total protein (3.7 g/dL) and albumin (1.5 g/dL)(Table S1).  Concerns about the 
filly’s condition prompted referral for more intensive care.  On arrival, the filly remained 
depressed and lethargic with a fever of 103.1oF.  Additionally, the filly was tachycardic 
(78 bpm; ref 20-44 bpm) and tachypneic (48 bpm; ref 8-24 bpm).  Abdominal ultrasound 
revealed thickened small intestinal wall (6mm; ref ≤3mm) and free fluid in the abdominal 
cavity.  Abdominocentesis was performed, and fluid analysis revealed a WBC count of 
77,500 cells/uL (90% neutrophils and 10% mononuclear cells) (ref 0.5 - 5.0x103/uL 
WBC and 1:1 ratio of neutrophils:mononuclear cells) and total protein of 2.0 g/dL (ref 
                                               
BB Hagyard Pharmacy, Lexington, KY 
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0.5-1.5 g/dL).  In addition, a moderate number of short Gram-negative rods and rare 
Gram-positive cocci were noted, but no plant or fecal material was seen in the peritoneal 
fluid sample.  Culture results of the abdominal fluid revealed Actinobacillus equuli.  
Within several hours of hospitalization, the filly became agitated, developed cyanotic 
mucous membranes, and exhibited agonal activity.  The filly was euthanatized 
approximately 72 hours after initial presentation at the farm. 
 
Case 3: 
 A 6-month-old Thoroughbred colt was evaluated on the farm in November 2011 
due to a 72-hour history of lethargy.  On presentation, the colt was lethargic, tachycardic 
(68 bpm), and febrile (103.5oF).  Additionally, the colt had dark red/purple mucous 
membranes and delayed capillary refill time.  The colt had developed diarrhea within the 
previous 12 hours, and severe throatlatch and preputial edema were noted.  Immediately 
prior to referral to the McGee Medicine Center, treatment was initiated at the farm and 
included intravenous oxytetracycline (6.6 mg/kg IV q24hr), flunixin meglumine (1 mg/kg 
IV q12h), and synthetic colloids (10 ml/kg IV bolus once).  A complete blood count 
indicated leukocytosis (31.5 x103/uL) with neutrophilia (78%), lymphopenia (7%), and a 
left shift (15%).   Serum biochemistry abnormalities included hypoproteinemia (2.3 g/dL) 
and hypoalbuminemia (0.9 g/dL), along with other metabolic abnormalities (Table S1).  
Abdominal ultrasound demonstrated thickening of the small intestinal wall and a 
preliminary diagnosis of EPE was made. 
 Following referral, the colt remained febrile despite non-steroidal anti-
inflammatory drug (NSAID) treatment; further, epistaxis developed, with progressively 
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increasing volumes of blood exiting both nostrils, ultimately leading to respiratory 
distress.  The respiratory distress was partially alleviated with the placement of a 
nasotracheal tube.  Spontaneous epistaxis continued and the colt also began passing 
dark/bloody diarrhea and blood tinged urine.  Because of welfare concerns in the face of 
suspected disseminated intravascular coagulation (DIC), the colt was euthanized less than 
96 hours after developing clinical signs.  Blood work values collected prior to euthanasia 
revealed an increased leukocytosis (42.4 x103/uL), as well as a progressive 
hypoproteinemia (1.7 g/dL) and hypoalbuminemia (0.6 g/dL) (Table S1). 
 
Case 4: 
 A 6-month-old Thoroughbred colt presented in late October 2011 with a fever 
(105oF) five hours prior to initial evaluation; the fever was immediately treated by the 
farm with flunixin meglumine (1 mg/kg IV q12h).  The weanling was small for its age 
despite having received regular preventative health care and physical examination 
revealed no other significant findings.  A complete blood count revealed a normal white 
blood cell count (7.7 x103/dL) with a neutropenia (14%) and lymphocytosis (84%).  The 
serum biochemistry abnormalities included hypoproteinemia (3.6g/dL) and 
hypoalbuminemia (1.8g/dL)(Table A.1).  EPE was tentatively diagnosed, and treatment 
was initiated with oxytetracyclinei (10 mg/kg IV q24hr).  At the time antimicrobial 
treatment was initiated, the colt was eating and had normal vital sign values.  Four hours 
after examination, the colt developed peracute signs of shock and gastrointestinal crisis, 
including tachycardia (108 bpm), tachypnea (40-50 bpm), dark purple mucous 
membranes, and general signs of severe abdominal discomfort (rolling on the ground).  
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Despite emergency intravenous fluid resuscitative care consisting of IV crystalloids (7 
ml/kg bolus) and colloids (2 ml/kg bolus), the weanling quickly became recumbent and 
died less than 45 minutes into the crisis and approximately 24 hours after initial 
presentation. 
 
Necropsy Findings: 
 Necropsy findings involving the small intestine were similar in all 4 cases.  
Segments of the mucosa of jejunum, ileum, or both were thickened (cases #1- 4), variably 
reddened (cases #1, 2, and 4), and corrugated (cases #2 and 4).  Regions of ulceration and 
greenish-brown necrotic mucosal plaques were occasionally evident (case #3).  Peyer’s 
patches were hemorrhagic (case #4), and the intestinal lumen contained a moderate 
amount of dilute reddish-brown fluid (cases #1, 3, and 4).   The cecal and colonic walls 
were moderately edematous in cases #2 and 3.  Additional lesions identified at necropsy 
included: pneumonia and gastric ulcers (case #1); cestodiasis, fibrinous peritonitis, and 
vegetative valvular endocarditis (case #2); multiple acute renal infarcts (case #3); and 
mesenteric lymphadenopathy (case #4).        
 L. intracellularis was associated with the small intestinal lesions in all 4 cases.  L. 
intracellularis DNA was detected in ileal mucosal scrapings by PCR in all four cases. L. 
intracellularis specific immunohistochemistry was performed on two cases (#2 and 4) 
and directly identified the bacterium in the necrotic lesions of both cases.   
 Various bacteria were cultured from the intestines and systemic organs; culture 
results and tetracycline antibiograms, given that tetracycline-class drugs are typically the 
first antimicrobial administered to animals with suspected EPE in central Kentucky,11 are 
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presented in Table A.2.  The gram positive cocci noted in the abdominal fluid sample of 
case #2 were not noted at necropsy.  This could possibly be due to the administration of 
antimicrobials or the cocci were anaerobic and not cultured at necropsy. 
 Histologically, small intestinal lesions were morphologically diagnosed as severe 
subacute segmental necroulcerative enteritis (cases #1 and 4) or severe chronic segmental 
proliferative and necroulcerative enteritis (cases #2 and 3).  All 4 cases exhibited regions 
of mucosal necrosis, erosion, and ulceration that were covered by mats of small amounts 
of fibrin, cell debris, and acidophilic proteinaceous material, low number of neutrophils 
and macrophages, and mixed populations of bacteria (Figures 3 and 4).  The lamina 
propria and submucosa, subjacent to the ulcers, were edematous and infiltrated with low 
numbers of neutrophils, macrophages, and lymphocytes.  Multifocal blood vessels 
contained fibrin thrombi.  Additionally in cases #2 and 3, multifocal regions of the 
mucosa were proliferative and exhibited elongated villi, branched crypts, and crypt and 
glandular epithelial hyperplasia.  Few crypts contained cell debris and acidophilic 
proteinaceous material.  Tertiary findings included: necrotizing glomerulonephritis, 
hepatitis, and embolic pneumonia (case #1); vegetative valvular endocarditis and 
peritonitis (case #2); renal infarction (case #3); and renal glomerular thrombosis (case 
#4).       
 
 
 
 
Table A.2.  Bacteriology results obtained at necropsy.  Includes the bacterial species, isolation location, and tetracycline-class 
antimicrobial sensitivity. 
Case # Bacterium Isolation Location 
Tetracycline/Doxycycline 
Sensitivity 
1 Streptococcus zooepidemicus Lung Susceptible 
  E. coli Liver Moderately Susceptible 
  Actinobacillus equuli subsp equuli Lung Resistant 
2 Actinobacillus equuli subsp equuli Peritoneal cavity Not Reported 
  E. coli Heart Resistant 
3 No pathogenic organisms isolated N/A N/A 
4 E. coli Small intestine Resistant 
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Figure A.1: Ileum, age-matched control.  Villi are distinct and of normal length.  
H&E (40X total magnification). Bar = 1mm 
  
 
 
 
Figure A.2: Ileum, chronic EPE.  Villi are segmentally blunted and fused.  Crypts 
are hyperplastic, elongated, and multifocally branched.  H&E (40X total 
magnification). Bar = 1mm 
 
  
 
 
 
Figure A.3: Ileum, necrotizing EPE, case 2.  Villi are shortened and the crypts are 
mildly hyperplastic.  Superficial villar tips are necrotic and covered by small 
amounts cell debris.  H&E (40X total magnification). Bar = 1mm 
  
 
 
 
Figure A.4: Ileum, necrotizing EPE, case 2.  Higher magnification of the necrotic 
villar tips.  H&E (400X total magnification). Bar = 100um 
  
 
 
Discussion 
 
 Proliferative enteropathies induced by Lawsonia intracellularis infections have 
been noted to occur in a variety of species worldwide.  Most notable is L. intracellularis 
infection in pigs where financial losses from porcine proliferative enteropathy are 
significant.7  The majority of what is known with respect to L. intracellularis has been 
discovered from work in pigs and largely extrapolated to the horse.  Porcine proliferative 
enteropathy exhibits several clinical entities, including the subclinical form in which 
affected pigs exhibit no clinical signs but shed the bacterium, the chronic form where 
affected pigs fail to grow as well as littermates, and the acute form (normally referred to 
as porcine hemorrhagic enteritis or PHE), which is often characterized by hemorrhagic 
diarrhea and acute death.  While acute morbidity and mortality has long been recognized 
as a common clinical presentation of Lawsonia intracellularis infection in swine,1 this 
clinical presentation has never, to the authors’ knowledge, been described in multiple 
field cases of EPE.  Here we have presented four cases detailing an acute clinical entity 
with necrotic enteritis, which we suggest be referred to as a necrotizing form of EPE (N-
EPE).  This designation serves to provide not only a pathologic description, but also an 
inference to the observed severity of clinical disease and rapid deterioration of the 
affected animal. 
 With EPE, clinical signs of anorexia, dependent edema secondary to 
hypoproteinemia and hypoalbuminemia, depression, lethargy, and weight loss are 
typically observed during the fall and winter months (August-February);11,19,20 fever, 
colic, and diarrhea are less frequently seen.  Ultrasonographic detection of thickened 
 
 
small intestinal walls in weanlings is highly suggestive of EPE, although the finding can 
be inconsistent.11  Clinical cases of EPE generally develop slowly over several days, but 
during an EPE challenge study one challenged weanling developed what we termed 
"acute EPE" given the rapid deterioration and necrotizing enteritis that was noted in the 
weanling.10  Since this was an experimental challenge study that likely failed to 
adequately replicate the field conditions in which L. intracellularis infection is typically 
contracted, we surveyed local practitioners for other, "acute EPE" cases.  During the span 
of thirteen months (October 2010-November 2011), the four cases detailed above were 
identified in the central Kentucky region.  A literature review found that the first 
published description of EPE by Duhamel and Wheeldon13 recounted the acute 
deterioration (5 days) and death of a foal, similar to the 24-96 hour time courses of our 
cases, whereas a more recent report documented the occurrence of necrotizing enteritis 
associated with L. intracellularis infection in one horse with a 10+ day history of EPE.130  
Based on the short timeframe in which we selected cases, as well as the occasional report 
of various facets of the N-EPE clinical entity, it is highly likely that cases of N-EPE have 
occurred with regularity and simply not been recognized until now.  Likewise, the 
previous case of "acute EPE" we reported10 should, instead, be considered a case of N-
EPE based on the criteria listed above.  Given that not all cases of N-EPE will expire as a 
result of EPE or secondary bacterial infections, practitioners may elect to diagnose 
surviving animals with "acute clinical EPE" and reserve N-EPE as a pathologic 
diagnosis. 
 In pigs, it has been suggested that Lawsonia associated necrotic enteritis develops 
from inflammation and necrosis induced by secondary bacterial invaders.131  The clinical 
 
 
signs observed with these four weanlings were highly unusual for EPE.  Damage induced 
to the intestinal mucosal barrier by secondary pathogens likely predisposed these 
weanlings to endotoxemia or bacteremia and resulted in secondary systemic sequelae.  
This assertion appears to be supported by the presence of thickened mucosa associated 
with the necrotizing and ulcerative enteritis, suggesting that alimentary damage preceded 
bacterial translocation.  The clinicopathologic, gross necropsy, and histologic findings in 
cases #1 and #2 suggest that the observed clinical signs resulted directly from secondary 
bacteremia.  Interestingly, these two cases originated from the same farm but 12 months 
apart.  Finding regular, yearly cases of EPE on certain farms has been reported 
previously,19,20 but the occurrence of two separate cases of N-EPE on the same farm in 
different years is a novel finding.  This could suggest that the particular strain of L. 
intracellularis on this farm is potentially more virulent and that this farm should monitor 
diligently for reoccurrence of N-EPE.  Case #3 survived the longest after initial 
presentation (~96 hours); however, treatment for EPE was not started until approximately 
72 hours post-presentation.  This weanling appeared to develop fulminant disseminated 
intravascular coagulation after treatment was initiated, as demonstrated by the occurrence 
of uncontrolled epistaxis, hematuria, melena/hematochezia, and multiple renal infarcts.  
Possible causes for the development of DIC in this weanling include 
septicemia/bacteremia, endotoxemia, or a decrease in circulating antithrombin-3 due to 
hypoproteinemia.  The last case, Case #4, survived for the shortest amount of time (<24 
hours post-presentation) and was the only weanling to die spontaneously.  Based on the 
renal glomerular tuft thrombosis, this weanling likely died due to cardiovascular 
compromise initiated by acute DIC. 
 
 
 Equine proliferative enteropathy has been a disease viewed as having a well-
defined clinical presentation and a high treatment success rate when properly 
diagnosed.11,19,30  The cases presented here provide an important repudiation to this 
commonly held view in that, despite the correct preliminary diagnosis and appropriate 
treatment, all four of these weanlings succumbed to complications arising from EPE.  
This would suggest that treatment of N-EPE cases (those with signs of secondary 
bacterial infection and/or endotoxemia) should be treated aggressively with broad-
spectrum antimicrobials to ensure coverage against both Gram-positive and Gram-
negative bacteria, anti-thrombotics, and anti-endotoxic measures such as low-dose 
flunixin meglumine27 and/or intravenous polymyxin-B.28  Care must be taken, however, 
when administering NSAIDs and/or polymyxin-B due to their potential nephrotoxic 
effects in patients with hypovolemia or in which there is a predisposition for azotemia: 
additionally, NSAID use could exacerbate existing mucosal compromise.  While no 
anaerobes were isolated from the cases presented above, practitioners should be aware of 
the possibility of secondary infections with anaerobic bacteria and consider 
metronidazole treatment if they believe it to be warranted. 
 More work is needed to understand the risk factors for the development of N-
EPE, which could include environmental/husbandry differences, genetic 
polymorphisms,127 the infectious dose, L. intracellularis strain, concurrent disease, or 
animal’s immune status.  Our previous work with an experimental challenge model 
seems to suggest that the host immune system likely plays the largest role in this type of 
clinical presentation as the infectious dose and strain used in that study was consistent 
across six challenged weanlings, yet only one developed N-EPE;10 however, based on the 
 
 
occurrence of two N-EPE cases on the same farm in consecutive years, a significant role 
of bacterial strain cannot be ruled out.  Regardless, practitioners must be cognizant of the 
necrotizing form of EPE as weanlings may fail to demonstrate the classic, chronic clinical 
signs associated with EPE (including weight loss and dependent edema) and/or require 
emergency treatment to prevent secondary complications such as septicemia, 
endotoxemia, and DIC, all of which could ultimately lead to acute death. 
 
 
 
  
 
 
REFERENCES 
 
 1. Lawson GH, Gebhart CJ. Proliferative enteropathy. J Comp Pathol 2000;122:77-
100. 
 2. Biester HE, Schwarte LH. Intestinal Adenoma in Swine. Am J Pathol 1931;7:175-
185 176. 
 3. Rowland AC, Lawson GH, Maxwell A. Intestinal adenomatosis in the pig: 
occurrence of a bacterium in affected cells. Nature 1973;243:417. 
 4. McOrist S, Gebhart CJ, Boid R, et al. Characterization of Lawsonia intracellularis 
gen. nov., sp. nov., the obligately intracellular bacterium of porcine proliferative enteropathy. 
Int J Syst Bacteriol 1995;45:820-825. 
 5. Stills HF, Jr. Isolation of an intracellular bacterium from hamsters (Mesocricetus 
auratus) with proliferative ileitis and reproduction of the disease with a pure culture. Infect 
Immun 1991;59:3227-3236. 
 6. Lawson GH, McOrist S, Jasni S, et al. Intracellular bacteria of porcine 
proliferative enteropathy: cultivation and maintenance in vitro. J Clin Microbiol 1993;31:1136-
1142. 
 7. McOrist S, Smith SH, Green LE. Estimate of direct financial losses due to porcine 
proliferative enteropathy. Vet Rec 1997;140:579-581. 
 8. McOrist S. Defining the full costs of endemic porcine proliferative enteropathy. 
Vet J 2005;170:8-9. 
 9. Page AE, Fallon LH, Bryant UK, et al. Acute deterioration and death with 
necrotizing enteritis associated with Lawsonia intracellularis in 4 weanling horses. J Vet Intern 
Med 2012;26:1476-1480. 
 10. Page AE, Loynachan AT, Bryant U, et al. Characterization of the interferon 
gamma response to Lawsonia intracellularis using an equine proliferative enteropathy challenge 
(EPE) model. Vet Immunol Immunopathol 2011;143:55-65. 
 11. Frazer ML. Lawsonia intracellularis infection in horses: 2005-2007. J Vet Intern 
Med 2008;22:1243-1248. 
 12. Page AE, Gebhart C, Horohov DW, et al. Incidence of Yearly Lawsonia 
intracellularis Assay Variations From Horses in Kentucky. AAEP 2012 Proceedings 2012:504-505. 
 13. Duhamel GE, Wheeldon EB. Intestinal adenomatosis in a foal. Vet Pathol 
1982;19:447-450. 
 14. Williams NM, Harrison LR, Gebhart CJ. Proliferative enteropathy in a foal caused 
by Lawsonia intracellularis-like bacterium. J Vet Diagn Invest 1996;8:254-256. 
 15. Wuersch K, Huessy D, Koch C, et al. Lawsonia intracellularis proliferative 
enteropathy in a filly. J Vet Med A Physiol Pathol Clin Med 2006;53:17-21. 
 16. McClintock SA, Collins AM. Lawsonia intracellularis proliferative enteropathy in 
a weanling foal in Australia. Aust Vet J 2004;82:750-752. 
 17. Guimaraes-Ladeira CV, Palhares MS, Oliveira JS, et al. Faecal shedding and 
serological cross-sectional study of Lawsonia intracellularis in horses in the state of Minas 
Gerais, Brazil. Equine Vet J 2009;41:593-596. 
 18. Lavoie JP, Drolet R, Parsons D, et al. Equine proliferative enteropathy: a cause of 
weight loss, colic, diarrhoea and hypoproteinaemia in foals on three breeding farms in Canada. 
Equine Vet J 2000;32:418-425. 
 
 
 19. Page AE, Slovis NM, Gebhart CJ, et al. Serial use of serologic assays and fecal PCR 
assays to aid in identification of subclinical Lawsonia intracellularis infection for targeted 
treatment of Thoroughbred foals and weanlings. J Am Vet Med Assoc 2011;238:1482-1489. 
 20. Page AE, Stills HF, Chander Y, et al. Adaptation and validation of a bacteria-
specific enzyme-linked immunosorbent assay for determination of farm-specific Lawsonia 
intracellularis seroprevalence in central Kentucky Thoroughbreds. Equine Vet J 2011;43 Suppl 
40:25-31. 
 21. Wong DM, Alcott CJ, Sponseller BA, et al. Impaired intestinal absorption of 
glucose in 4 foals with Lawsonia intracellularis infection. J Vet Intern Med 2009;23:940-944. 
 22. Wattanaphansak S, Singer RS, Gebhart CJ. In vitro antimicrobial activity against 
10 North American and European Lawsonia intracellularis isolates. Vet Microbiol 2009;134:305-
310. 
 23. Yeh JY, Lee JH, Yeh HR, et al. Antimicrobial susceptibility testing of two Lawsonia 
intracellularis isolates associated with proliferative hemorrhagic enteropathy and porcine 
intestinal adenomatosis in South Korea. Antimicrob Agents Chemother 2011;55:4451-4453. 
 24. Bihr TP. Protein-losing enteropathy caused by Lawsonia intracellularis in a 
weanling foal. Can Vet J 2003;44:65-66. 
 25. Feary DJ, Gebhart CJ, Pusterla N. Lawsonia intracellularis proliferative 
enteropathy in a foal. Schweiz Arch Tierheilkd 2007;149:129-133. 
 26. Atherton RP, McKenzie HC, III. Alternative antimicrobial agents in the treatment 
of proliferative enteropathy in horses. Journal of Equine Veterinary Science 2006;26:535-541. 
 27. Semrad SD, Hardee GE, Hardee MM, et al. Low dose flunixin meglumine: effects 
on eicosanoid production and clinical signs induced by experimental endotoxaemia in horses. 
Equine Vet J 1987;19:201-206. 
 28. MacKay RJ, Clark CK, Logdberg L, et al. Effect of a conjugate of polymyxin B-
dextran 70 in horses with experimentally induced endotoxemia. Am J Vet Res 1999;60:68-75. 
 29. Plumb DC. Plumb's veterinary drug handbook. 5th ed. Stockholm, Wis. 
Ames: Pharma Vet Inc. ; 
Distributed by Blackwell Pub., 2005. 
 30. Dauvillier J, Picandet V, Harel J, et al. Diagnostic and epidemiological features of 
Lawsonia intracellularis enteropathy in 2 foals. Can Vet J 2006;47:689-691. 
 31. McGurrin MK, Vengust M, Arroyo LG, et al. An outbreak of Lawsonia 
intracellularis infection in a standardbred herd in Ontario. Can Vet J 2007;48:927-930. 
 32. Jacobson M, Aspan A, Konigsson MH, et al. Routine diagnostics of Lawsonia 
intracellularis performed by PCR, serological and post mortem examination, with special 
emphasis on sample preparation methods for PCR. Vet Microbiol 2004;102:189-201. 
 33. Machiels BM, Ruers T, Lindhout M, et al. New protocol for DNA extraction of 
stool. Biotechniques 2000;28:286-290. 
 34. Herbst W, Hertrampf B, Schmitt T, et al. [Diagnosis of Lawsonia intracellularis 
using the polymerase chain reaction (PCR) in pigs with and without diarrhea and other animal 
species]. Dtsch Tierarztl Wochenschr 2003;110:361-364. 
 35. Knittel JP, Jordan DM, Schwartz KJ, et al. Evaluation of antemortem polymerase 
chain reaction and serologic methods for detection of Lawsonia intracellularis-exposed pigs. Am 
J Vet Res 1998;59:722-726. 
 36. Moller K, Jensen TK, Jorsal SE, et al. Detection of Lawsonia intracellularis, 
Serpulina hyodysenteriae, weakly beta-haemolytic intestinal spirochaetes, Salmonella enterica, 
and haemolytic Escherichia coli from swine herds with and without diarrhoea among growing 
pigs. Vet Microbiol 1998;62:59-72. 
 
 
 37. Guedes RM, Gebhart CJ, Deen J, et al. Validation of an immunoperoxidase 
monolayer assay as a serologic test for porcine proliferative enteropathy. J Vet Diagn Invest 
2002;14:528-530. 
 38. Gebhart CJ, Page AE, Kelly M, et al. Comparative Study of Serology Assays for 
Equine Proliferative Enteropathy. American Association of Equine Practitioners Annual 
Convention 2012;502-503. 
 39. Pusterla N, Wattanaphansak S, Mapes S, et al. Oral infection of weanling foals 
with an equine isolate of Lawsonia intracellularis, agent of equine proliferative enteropathy. J 
Vet Intern Med 2010;24:622-627. 
 40. McOrist S, Roberts L, Jasni S, et al. Developed and resolving lesions in porcine 
proliferative enteropathy: possible pathogenetic mechanisms. J Comp Pathol 1996;115:35-45. 
 41. Oh YS, Lee JB, McOrist S. Microarray analysis of differential expression of cell 
cycle and cell differentiation genes in cells infected with Lawsonia intracellularis. Vet J 2009. 
 42. Alberdi MP, Watson E, McAllister GE, et al. Expression by Lawsonia 
intracellularis of type III secretion system components during infection. Vet Microbiol 
2009;139:298-303. 
 43. Sait M, Aitchison K, Wheelhouse N, et al. Genome Sequence of Lawsonia 
intracellularis Strain N343, Isolated from a Sow with Hemorrhagic Proliferative Enteropathy. 
Genome Announc 2013;1. 
 44. Pusterla N, Sanchez-Migallon Guzman D, Vannucci FA, et al. Transmission of 
Lawsonia intracellularis to weanling foals using feces from experimentally infected rabbits. Vet J 
2013;195:241-243. 
 45. Herbst W, Willems H, Baljer G. [Distribution of Brachyspira hyodysenteriae and 
Lawsonia intracellularis in healthy and diarrhoeic pigs]. Berl Munch Tierarztl Wochenschr 
2004;117:493-498. 
 46. Pusterla N, Mapes S, Rejmanek D, et al. Detection of Lawsonia intracellularis by 
real-time PCR in the feces of free-living animals from equine farms with documented occurrence 
of equine proliferative enteropathy. J Wildl Dis 2008;44:992-998. 
 47. Pusterla N, Mapes S, Gebhart C. Further investigation of exposure to Lawsonia 
intracellularis in wild and feral animals captured on horse properties with equine proliferative 
enteropathy. Vet J 2012;194:253-255. 
 48. Vannucci FA, Pusterla N, Mapes SM, et al. Evidence of host adaptation in 
Lawsonia intracellularis infections. Vet Res 2012;43:53. 
 49. Collins AM, Fell S, Pearson H, et al. Colonisation and shedding of Lawsonia 
intracellularis in experimentally inoculated rodents and in wild rodents on pig farms. Vet 
Microbiol 2011;150:384-388. 
 50. Collins AM, Love RJ. Re-challenge of pigs following recovery from proliferative 
enteropathy. Vet Microbiol 2007;120:381-386. 
 51. Collins A, Love RJ, Pozo J, et al. Studies on the ex vivo survival of Lawsonia 
intracellularis. Swine Health Production 2000;8:211-215. 
 52. Brandt D, Kaim U, Baumgartner W, et al. Evaluation of Lawsonia intracellularis 
infection in a group of pigs in a subclinically affected herd from weaning to slaughter. Vet 
Microbiol 2010;146:361-365. 
 53. Guedes RM, Gebhart CJ, Armbruster GA, et al. Serologic follow-up of a 
repopulated swine herd after an outbreak of proliferative hemorrhagic enteropathy. Can J Vet 
Res 2002;66:258-263. 
 
 
 54. Kroll JJ, Roof MB, McOrist S. Evaluation of protective immunity in pigs following 
oral administration of an avirulent live vaccine of Lawsonia intracellularis. Am J Vet Res 
2004;65:559-565. 
 55. Almond PK, Bilkei G. Effects of oral vaccination against Lawsonia intracellularis 
on growing-finishing pig's performance in a pig production unit with endemic porcine 
proliferative enteropathy (PPE). Dtsch Tierarztl Wochenschr 2006;113:232-235. 
 56. McOrist S, Smits RJ. Field evaluation of an oral attenuated Lawsonia 
intracellularis vaccine for porcine proliferative enteropathy (ileitis). Vet Rec 2007;161:26-28. 
 57. Pusterla N, Vannucci FA, Mapes SM, et al. Efficacy of an avirulent live vaccine 
against Lawsonia intracellularis in the prevention of proliferative enteropathy in experimentally 
infected weanling foals. Am J Vet Res 2012;73:741-746. 
 58. Nogradi N, Slovis NM, Gebhart CJ, et al. Evaluation of the field efficacy of an 
avirulent live Lawsonia intracellularis vaccine in foals. Vet J 2012;192:511-513. 
 59. Chouet S, Prieto C, Mieli L, et al. Patterns of exposure to Lawsonia intracellularis 
infection on European pig farms. Vet Rec 2003;152:14-17. 
 60. Jasni S, McOrist S, Lawson GH. Reproduction of proliferative enteritis in 
hamsters with a pure culture of porcine ileal symbiont intracellularis. Vet Microbiol 1994;41:1-9. 
 61. McOrist S, Jasni S, Mackie RA, et al. Entry of the bacterium ileal symbiont 
intracellularis into cultured enterocytes and its subsequent release. Res Vet Sci 1995;59:255-
260. 
 62. Abreu MT. Toll-like receptor signalling in the intestinal epithelium: how bacterial 
recognition shapes intestinal function. Nat Rev Immunol 2010;10:131-144. 
 63. Chen G, Shaw MH, Kim YG, et al. NOD-like receptors: role in innate immunity 
and inflammatory disease. Annu Rev Pathol 2009;4:365-398. 
 64. Nanthakumar N, Meng D, Goldstein AM, et al. The mechanism of excessive 
intestinal inflammation in necrotizing enterocolitis: an immature innate immune response. PLoS 
One 2011;6:e17776. 
 65. Sodhi CP, Neal MD, Siggers R, et al. Intestinal epithelial Toll-like receptor 4 
regulates goblet cell development and is required for necrotizing enterocolitis in mice. 
Gastroenterology 2012;143:708-718 e701-705. 
 66. O'Garra A. Cytokines induce the development of functionally heterogeneous T 
helper cell subsets. Immunity 1998;8:275-283. 
 67. Ohkura N, Kitagawa Y, Sakaguchi S. Development and maintenance of 
regulatory T cells. Immunity 2013;38:414-423. 
 68. Nogueira MG, Collins AM, Donahoo M, et al. Immunological responses to 
vaccination following experimental Lawsonia intracellularis virulent challenge in pigs. Vet 
Microbiol 2013. 
 69. Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations (*). 
Annu Rev Immunol 2010;28:445-489. 
 70. Guedes RM, Gebhart CJ. Onset and duration of fecal shedding, cell-mediated 
and humoral immune responses in pigs after challenge with a pathogenic isolate or attenuated 
vaccine strain of Lawsonia intracellularis. Vet Microbiol 2003;91:135-145. 
 71. Riber U, Boesen HT, Jakobsen JT, et al. Co-incubation with IL-18 potentiates 
antigen-specific IFN-gamma response in a whole-blood stimulation assay for measurement of 
cell-mediated immune responses in pigs experimentally infected with Lawsonia intracellularis. 
Vet Immunol Immunopathol 2011;139:257-263. 
 
 
 72. Pusterla N, Mapes S, Gebhart C. Lawsonia intracellularis-specific interferon 
gamma gene expression by peripheral blood mononuclear cells in vaccinated and naturally 
infected foals. Vet J 2012;192:249-251. 
 73. Riber U, Cordes H, Boutrup TS, et al. Primary infection protects pigs against re-
infection with Lawsonia intracellularis in experimental challenge studies. Vet Microbiol 
2011;149:406-414. 
 74. Smith DG, Mitchell SC, Nash T, et al. Gamma interferon influences intestinal 
epithelial hyperplasia caused by Lawsonia intracellularis infection in mice. Infect Immun 
2000;68:6737-6743. 
 75. Ruemmele FM, Gurbindo C, Mansour AM, et al. Effects of interferon gamma on 
growth, apoptosis, and MHC class II expression of immature rat intestinal crypt (IEC-6) cells. J 
Cell Physiol 1998;176:120-126. 
 76. Go YY, Lee JK, Ye JY, et al. Experimental reproduction of proliferative 
enteropathy and the role of IFN-gamma in protective immunity against Lawsonia intracellularis 
in mice. J Vet Sci 2005;6:357-359. 
 77. Wilson CB, Westall J, Johnston L, et al. Decreased production of interferon-
gamma by human neonatal cells. Intrinsic and regulatory deficiencies. J Clin Invest 1986;77:860-
867. 
 78. Breathnach CC, Sturgill-Wright T, Stiltner JL, et al. Foals are interferon gamma-
deficient at birth. Vet Immunol Immunopathol 2006;112:199-209. 
 79. Sun L, Adams AA, Page AE, et al. The effect of environment on interferon-
gamma production in neonatal foals. Vet Immunol Immunopathol 2011;143:170-175. 
 80. Adams AA, Horohov DW. The effect of an immunomodulator (parapoxvirus ovis) 
on cell-mediated immunity (CMI) in abruptly weaned foals. Vet Immunol Immunopathol 
2013;153:118-122. 
 81. Schoenborn L, Abdollahi H, Tee W, et al. A member of the delta subgroup of 
proteobacteria from a pyogenic liver abscess is a typical sulfate reducer of the genus 
Desulfovibrio. J Clin Microbiol 2001;39:787-790. 
 82. MacIntyre N, Smith DG, Shaw DJ, et al. Immunopathogenesis of experimentally 
induced proliferative enteropathy in pigs. Vet Pathol 2003;40:421-432. 
 83. McOrist S, Lawson GH. Interactions of porcine lymphocytes with 
Campylobacter-like organism membranes purified from proliferative enteropathy. Vet Microbiol 
1993;34:381-388. 
 84. Cordes H, Riber U, Jensen TK, et al. Cell-mediated and humoral immune 
responses in pigs following primary and challenge-exposure to Lawsonia intracellularis. Vet Res 
2012;43:9. 
 85. Mayer L, Eisenhardt D, Salomon P, et al. Expression of class II molecules on 
intestinal epithelial cells in humans. Differences between normal and inflammatory bowel 
disease. Gastroenterology 1991;100:3-12. 
 86. McOrist S, MacIntyre N, Stokes CR, et al. Immunocytological responses in 
porcine proliferative enteropathies. Infect Immun 1992;60:4184-4191. 
 87. Lunn DP, Holmes MA, Duffus WP. Equine T-lymphocyte MHC II expression: 
variation with age and subset. Vet Immunol Immunopathol 1993;35:225-238. 
 88. Pusterla N, Hilton H, Wattanaphansak S, et al. Evaluation of the humoral 
immune response and fecal shedding in weanling foals following oral and intra-rectal 
administration of an avirulent live vaccine of Lawsonia intracellularis. Vet J 2009;182:458-462. 
 
 
 89. Guedes RM, Gebhart CJ. Evidence of cell-mediated immune response and 
specific local mucosal immunoglobulin (Ig) A production against Lawsonia intracellularis in 
experimentally infected swine. Can J Vet Res 2010;74:97-101. 
 90. Lamm ME, Nedrud JG, Kaetzel CS, et al. IgA and mucosal defense. APMIS 
1995;103:241-246. 
 91. Drolet R, Larochelle D, Gebhart CJ. Proliferative enteritis associated with 
Lawsonia intracellularis (ileal symbiont intracellularis) in white-tailed deer. J Vet Diagn Invest 
1996;8:250-253. 
 92. Hotchkiss CE, Shames B, Perkins SE, et al. Proliferative enteropathy of rabbits: 
the intracellular Campylobacter-like organism is closely related to Lawsonia intracellularis. Lab 
Anim Sci 1996;46:623-627. 
 93. Cooper DM, Swanson DL, Gebhart CJ. Diagnosis of proliferative enteritis in 
frozen and formalin-fixed, paraffin-embedded tissues from a hamster, horse, deer and ostrich 
using a Lawsonia intracellularis-specific multiplex PCR assay. Vet Microbiol 1997;54:47-62. 
 94. Frank N, Fishman CE, Gebhart CJ, et al. Lawsonia intracellularis proliferative 
enteropathy in a weanling foal. Equine Vet J 1998;30:549-552. 
 95. Brees DJ, Sondhoff AH, Kluge JP, et al. Lawsonia intracellularis-like organism 
infection in a miniature foal. J Am Vet Med Assoc 1999;215:511-514, 483. 
 96. Schumacher J, Rolsma M, Brock KV, et al. Surgical and medical treatment of an 
Arabian filly with proliferative enteropathy caused by Lawsonia intracellularis. J Vet Intern Med 
2000;14:630-632. 
 97. Pusterla N, Higgins JC, Smith P, et al. Epidemiological survey on farms with 
documented occurrence of equine proliferative enteropathy due to Lawsonia intracellularis. Vet 
Rec 2008;163:156-158. 
 98. Kroll JJ, Eichmeyer MA, Schaeffer ML, et al. Lipopolysaccharide-based enzyme-
linked immunosorbent assay for experimental use in detection of antibodies to Lawsonia 
intracellularis in pigs. Clin Diagn Lab Immunol 2005;12:693-699. 
 99. Wattanaphansak S, Asawakarn T, Gebhart CJ, et al. Development and validation 
of an enzyme-linked immunosorbent assay for the diagnosis of porcine proliferative 
enteropathy. J Vet Diagn Invest 2008;20:170-177. 
 100. Boesen HT, Jensen TK, Moller K, et al. Evaluation of a novel enzyme-linked 
immunosorbent assay for serological diagnosis of porcine proliferative enteropathy. Vet 
Microbiol 2005;109:105-112. 
 101. Watarai M, Yamato Y, Horiuchi N, et al. Enzyme-linked immunosorbent assay to 
detect Lawsonia intracellularis in rabbits with proliferative enteropathy. J Vet Med Sci 
2004;66:735-737. 
 102. Jones GF, Ward GE, Murtaugh MP, et al. Enhanced detection of intracellular 
organism of swine proliferative enteritis, ileal symbiont intracellularis, in feces by polymerase 
chain reaction. Journal of Clinical Microbiology 1993;31:2611-2615. 
 103. Sorensen K, Brodbeck U. Assessment of coating-efficiency in ELISA plates by 
direct protein determination. J Immunol Methods 1986;95:291-293. 
 104. Dale CJ, Moses EK, Ong CC, et al. Identification and sequencing of the groE 
operon and flanking genes of Lawsonia intracellularis: use in phylogeny. Microbiology 1998;144 ( 
Pt 8):2073-2084. 
 105. Schmitz-Esser S, Haferkamp I, Knab S, et al. Lawsonia intracellularis contains a 
gene encoding a functional rickettsia-like ATP/ADP translocase for host exploitation. J Bacteriol 
2008;190:5746-5752. 
 
 
 106. Kranenburg LC, van Ree HE, Calis AN, et al. The seroprevalence of Lawsonia 
intracellularis in horses in The Netherlands. Tijdschr Diergeneeskd 2011;136:237-243. 
 107. Pusterla N, Jackson R, Wilson R, et al. Temporal detection of Lawsonia 
intracellularis using serology and real-time PCR in Thoroughbred horses residing on a farm 
endemic for equine proliferative enteropathy. Vet Microbiol 2009;136:173-176. 
 108. Kranenburg LC, Ree HEMIv, Calis ANM, et al. The seroprevalence of Lawsonia 
intracellularis in horses in the Netherlands. Tijdschrift voor Diergeneeskunde 2011;136:237-243. 
 109. Allen KJ, Pearson GR, Fews D, et al. Lawsonia intracellularis proliferative 
enteropathy in a weanling foal, with a tentative histological diagnosis of lymphocytic 
plasmacytic enteritis. Equine Veterinary Education 2009;21:411-414. 
 110. Lopez AM, Hines MT, Palmer GH, et al. Identification of pulmonary T-
lymphocyte and serum antibody isotype responses associated with protection against 
Rhodococcus equi. Clin Diagn Lab Immunol 2002;9:1270-1276. 
 111. Kohler AK, Stone DM, Hines MT, et al. Rhodococcus equi secreted antigens are 
immunogenic and stimulate a type 1 recall response in the lungs of horses immune to R. equi 
infection. Infect Immun 2003;71:6329-6337. 
 112. Lawson GH, Rowland AC, Roberts L, et al. Proliferative haemorrhagic 
enteropathy. Res Vet Sci 1979;27:46-51. 
 113. McGuire TC, Crawford TB. Identification and quantitation of equine serum and 
secretory immunoglobulin A. Infect Immun 1972;6:610-615. 
 114. Smith DG, Lawson GH. Lawsonia intracellularis: getting inside the pathogenesis 
of proliferative enteropathy. Vet Microbiol 2001;82:331-345. 
 115. Lindecrona RH, Jensen TK, Andersen PH, et al. Application of a 5' nuclease assay 
for detection of Lawsonia intracellularis in fecal samples from pigs. J Clin Microbiol 2002;40:984-
987. 
 116. Guedes RM, Gebhart CJ, Winkelman NL, et al. A comparative study of an indirect 
fluorescent antibody test and an immunoperoxidase monolayer assay for the diagnosis of 
porcine proliferative enteropathy. J Vet Diagn Invest 2002;14:420-423. 
 117. Boesen HT, Jensen TK, Schmidt AS, et al. The influence of diet on Lawsonia 
intracellularis colonization in pigs upon experimental challenge. Vet Microbiol 2004;103:35-45. 
 118. Whitney MH, Shurson GC, Guedes RC. Effect of dietary inclusion of distillers 
dried grains with solubles on the ability of growing pigs to resist a Lawsonia intracellularis 
challenge. J Anim Sci 2006;84:1860-1869. 
 119. Saulez MN, Godfroid J, Bosman A, et al. Cytokine mRNA expressions after racing 
at a high altitude and at sea level in horses with exercise-induced pulmonary hemorrhage. Am J 
Vet Res 2010;71:447-453. 
 120. Ramakers C, Ruijter JM, Deprez RH, et al. Assumption-free analysis of 
quantitative real-time polymerase chain reaction (PCR) data. Neurosci Lett 2003;339:62-66. 
 121. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-
time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-408. 
 122. Beckler D, Kapur V, Gebhart C. Molecular epidemiologic typing of Lawsonia 
intracellularis. Conference of Research Workers in Animal Diseases 2004;124. 
 123. Jacobson M, Fellstrom C, Jensen-Waern M. Porcine proliferative enteropathy: 
An important disease with questions remaining to be solved. Vet J 2009. 
 124. Stege H, Jensen TK, Moller K, et al. Infection dynamics of Lawsonia intracellularis 
in pig herds. Vet Microbiol 2004;104:197-206. 
 125. Straw BE. Diseases of swine. 9th ed. Ames, Iowa: Blackwell Pub., 2006. 
 
 
 126. Smith SH, McOrist S. Development of persistent intestinal infection and 
excretion of Lawsonia intracellularis by piglets. Res Vet Sci 1997;62:6-10. 
 127. Horin P, Smola J, Matiasovic J, et al. Polymorphisms in equine immune response 
genes and their associations with infections. Mamm Genome 2004;15:843-850. 
 128. Dimier IH, Bout DT. Interferon-gamma-activated primary enterocytes inhibit 
Toxoplasma gondii replication: a role for intracellular iron. Immunology 1998;94:488-495. 
 129. Dimier-Poisson IH, Bout DT, Quere P. Chicken primary enterocytes: inhibition of 
Eimeria tenella replication after activation with crude interferon-gamma supernatants. Avian Dis 
2004;48:617-624. 
 130. Deprez P, Chiers K, Gebhart CJ, et al. Lawsonia intracellularis infection in a 12-
month-old colt in Belgium. Vet Rec 2005;157:774-776. 
 131. McOrist A, Gebhart C. Proliferative Enteropathies In: Straw B, ZImmerman J, 
D'Allaire S, et al., eds. Diseases of Swine. 9th ed, 2006;727-737. 
 
 
  
 
 
VITA 
Allen E. Page 
 
   
Education and Post-D.V.M. Work Experience:    
 
Ph.D. Veterinary Science, 2009-Present   University of Kentucky 
Dissertation emphasis: L. intracellularis in horses  Lexington, KY 
G.P.A.  3.72       Advisor: Dr. David Horohov 
 
Rotating Intern, 2008-2009     Hagyard Equine Medical  
In-house internal medicine and ambulatory   Institute   
        Lexington, KY 
 
D.V.M., 2004-2008,       University of CA, Davis 
G.P.A.  3.83       Davis, CA 
 
B.S. Animal Science, 2000-2004    University of CA ,Davis 
Equine Emphasis       Davis, CA 
 
High School Class of 2000     La Jolla Country Day School 
        La Jolla, CA 
  
Honors and Awards 
2012  AAEP/EQUUS Foundation Research Fellow 
 
2009-Present Morris Animal Foundation/Zoetis Veterinary Scholars Research Fellow 
 
2008          Phi Zeta, Lamba Chapter, Honor Society of Veterinary Medicine, School 
of Veterinary Medicine, University of California, Davis 
 
Committees 
2013  Dean Search Committee, Student Representative, University of Kentucky, 
 College of Agriculture, Food, and Environment 
  
Manuscripts: 
1. Gurel, V., Lambert, K., Page, A.E., Loynachan, A.T., Huges, K., Timoney, J.F., 
Fettinger, M., Horohov, D.W., McMichael, J., 2013. Streptolysin-O/antibiotics 
adjunct therapy modulates site-specific expression of extracellular matrix and 
inflammatory genes in lungs of Rhodococcus equi infected foals. Vet Res Commun. 
2. Page, A.E., Fallon, L.H., Bryant, U.K., Horohov, D.W., Luna, T.W., Marsh, P.S., 
Slovis, N.M., Sprayberry, K.A., Loynachan, A.T., 2012. Acute Deterioration and 
Death with Necrotizing Enteritis Associated with Lawsonia intracellularis in 4 
Weanling Horses. J Vet Intern Med 26, 1476-1480. 
3. Ault, A., Zajac, A.M., Kong, W.P., Gorres, J.P., Royals, M., Wei, C.J., Bao, S., 
Yang, Z.Y., Reedy, S.E., Sturgill, T.L., Page, A.E., Donofrio-Newman, J., Adams, 
 
 
A.A., Balasuriya, U.B.R., Horohov, D.W., Chambers, T.M., Nabel, G.J., Rao, S.S., 
2012. Immunogenicity and clinical protection against equine influenza by DNA 
vaccination of ponies. Vaccine 30, 3965-3974. 
4. Page, A.E., Stills, H.F., Chander, Y., Gebhart, C.J., Horohov, D.W., 2011. 
Adaptation and validation of a bacteria-specific enzyme-linked immunosorbent 
assay for determination of farm-specific Lawsonia intracellularis seroprevalence in 
central Kentucky Thoroughbreds. Equine Veterinary Journal 43 Suppl 40, 25-31. 
5. Page, A.E., Loynachan, A.T., Bryant, U., Stills, H.F., Jr., Adams, A.A., Gebhart, 
C.J., Pusterla, N., Horohov, D.W., 2011. Characterization of the interferon gamma 
response to Lawsonia intracellularis using an equine proliferative enteropathy 
challenge (EPE) model. Vet Immunol Immunopathol 143, 55-65. 
6. Page AE, Slovis NM, Gebhart CJ, Wolfsdorf K, Mapes SM, Pusterla N. 2011. Serial 
use of serologic assays and fecal PCR assays to aid in identification of subclinical 
Lawsonia intracellularis infection for targeted treatment of Thoroughbred foals and 
weanlings. J Amer Vet Med Assoc 238: 1482-9. 
7. Sun, L., Adams, A.A., Page, A.E., Betancourt, A., Horohov, D.W., 2011. The effect 
of environment on interferon-gamma production in neonatal foals. Vet Immunol 
Immunopathol 143, 170-175. 
8. Horohov, D.W., Loynachan, A.T., Page, A.E., Hughes, K., Timoney, J.F., Fettinger, 
M., Hatch, T., Spaulding, J.G., McMichael, J., 2011. The use of streptolysin O 
(SLO) as an adjunct therapy for Rhodococcus equi pneumonia in foals. Vet 
Microbiol 154, 156-162. 
9. Pusterla, N., Mapes, S., Johnson, C., Slovis, N., Page, A., Gebhart, C., 2010. 
Comparison of feces versus rectal swabs for the molecular detection of Lawsonia 
intracellularis in foals with equine proliferative enteropathy. J Vet Diagn Invest 22, 
741-744. 
10. Madigan, J., Page, A., Pusterla, N., Dacre, K., 2007. How to Airlift a Horse.  In:  
American Association of Equine Practitioners, San Antonio, TX. Vol. 53, 2007. 
 
Book Chapters: 
1. Page, A.E., 2013. Screening Herds for Lawsonia intracellularis. In: Robinson, E., 
Sprayberry, K.A. (Eds.), Current Therapy in Equine Medicine, Vol. 7. In Press 
 
Abstracts: 
1. Page, A.E., Gebhart, C.J., Horohov, D.W., Loynachan, A.T.  Incidence of Yearly 
Lawsonia intracellularis Assay Variations from Horses in Kentucky.  In the 2012 
American Association of Equine Practitioners Proceedings. 
2. Page, A.E., Fallon, L.H., Bryant, U.K., Horohov, D.W., Luna, T.W., Marsh, P.S., 
Slovis, N.M., Sprayberry, K.A., Loynachan, A.T., 2012. Lawsonia intracellularis-
associated Necrotizing Enteritis in Four Weanling Horses. Journal of Equine 
Veterinary Science 32, S37. 
3. Page, A.E., Stills, H.F., Chander, Y., Gebhart, C.J., Horohov, D.W. Farm-Specific 
Lawsonia intracellularis Seroprevalence Detected by a Bacteria-Specific Enzyme-
Linked Immunosorbent Assay.  In the 2011 American Association of Equine 
Practitioners Proceedings. 
 
 
4. Page, A.E., Loynachan, A.T., Bryant, U., Stills, H.F., Jr., Adams, A.A., Gebhart, 
C.J., Pusterla, N., Horohov, D.W.  Development of an Equine Proliferative 
Enteropathy Challenge Model.  In the 2010 American Association of Equine 
Practitioners Proceedings. 
 
Local/State Presentations: 
1. Lawsonia intracellularis: What we know, what we don’t know, and where we go 
from here.  University of Kentucky Gluck Equine Research Center Seminar, 
Lexington, KY, 2010. 
2. Lawsonia intracellularis and Equine Proliferative Enteropathy.  Kentucky 
Veterinary Medical Association Annual Convention, Louisville, KY, 2012. 
3. Screening Herds for Lawsonia intracellularis and Equine Proliferative Enteropathy.  
University of Kentucky Veterinary Diagnostic Laboratory Series- In-Depth Seminar, 
Lexington, KY, 2012. 
 
National Presentations: 
1. Incidence of Yearly Lawsonia intracellularis Assay Variations from Horses in 
Kentucky.  2012 American Association of Equine Practitioners Convention, 
Anaheim, CA, 2012. 
2. Farm-Specific Lawsonia intracellularis Seroprevalence Detected by a Bacteria-
Specific Enzyme-Linked Immunosorbent Assay.  2011 American Association of 
Equine Practitioners Convention, San Antonio, TX, 2011. 
3. Development of an Equine Proliferative Enteropathy Challenge Model. 2010 
American Association of Equine Practitioners Convention, Baltimore, MD, 2010. 
 
International Presentations: 
1. Lawsonia intracellularis-associated Necrotizing Enteritis in Four Weanling Horses.  
IX Equine Infectious Disease Conference, Lexington, KY, 2012. 
 
 
